









Modulation of Neutrophil 
Migration by the Pneumococcal 
toxin, Pneumolysin 
Thesis  submitted in accordance with the requirements of the University of Liverpool for 
the degree of Doctor of Philosophy 




This thesis represents the unaided work of the author except where the help of other 



































Streptococcus pneumoniae is a common bacterial respiratory pathogen which often 
causes community-acquired pneumonia and is responsible for a huge burden of 
human disease and death. The initial innate immune response to promote clearance 
of this bacterium includes the heavy infiltration of neutrophils to the site of infection. 
However, excessive neutrophil recruitment, or uncontrolled neutrophil activity in 
response to the infection can result in massive damage to the host tissues. 
 
Pneumolysin (PLY), is a membrane-damaging toxin synthesized by S. pneumoniae, 
which plays a multifunctional role as a pneumococcal virulence factor during 
infection. It has various biological activities, with distinct cytolytic and sub-lytic 
effects that interfere with cell function. It has been suggested this toxin can directly 
modulate neutrophil migration. However, the precise effects on neutrophil motility, 
and the molecular mechanism underpinning these changes, remain unknown. The 
effects of PLY on neutrophil migration form the basis of this PhD project, with the 
aim to understand the molecular mechanism used by PLY to alter neutrophil 
migration and function in S. pneumoniae infection.  
 
We demonstrate that PLY inhibits murine neutrophil chemotaxis towards 
CXCL1/KC in 2- and 3-D, but does not competitively act as a chemoattractant for 
neutrophils. PdB, a toxoid derivative of PLY with greatly reduced haemolytic 
activity, did not inhibit neutrophil chemotaxis, suggesting full function of the toxin is 
required to inhibit chemotaxis. Consistent with this reduction in migration, we also 
show that PLY treated neutrophils have strong adhesion to tissue culture plastic, 
display enhanced actin polymerization, and express high levels of CD11b. Live 
bacteria were also able to inhibit neutrophil chemotaxis to varying degrees, but this 
did not strictly correlate with the haemolytic activity of the isolate.  
 
Quantitative label-free proteomics of PLY-treated neutrophils revealed four proteins 
related to cell migration that significantly changed in abundance in PLY-treated 
neutrophils: Tyrosine-protein kinase Fes/Fps (FES), Grancalcin (GCA), Tyrosine-
protein kinase CSK (CSK) and FYVE, RhoGEF and PH domain-containing protein 3 
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(FGD3). We also found a group of proteins changed in abundance in PLY-treated but 
not LPS treated neutrophils. These were enriched for cellular responses to calcium, 
and the presence of EF-hand domains, and were; Grancalcin (GCA), Peflin (PEF1) 
and Programmed cell death6 (PDCD6) Calpain (CAPN) and Sorcin(SRI) These 
proteins may offer potential clues to understanding the inhibitory effects of PLY on 
neutrophil chemotaxis. Preliminary experiments using HerbimysinA to inhibit Fes, 
revealed that chemotaxis of PLY-treated neutrophils towards KC could be partially 
restored.  
 
The data presented here provide new insight into how PLY regulates neutrophil 
migration and function. In addition to advancing our understanding of the 
pathogenesis of S. pneumoniae, it is useful to understand how neutrophils migrate 
through inflamed tissues in order to develop therapies which can prevent neutrophil-
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Chapter 1 - Introduction 
Chapter 1: Introduction 
 
Neutrophils, together with other immune cell such as macrophages, dendritic cells 
(DC), mast cells and natural killer (NK) cells, are members of the innate immune 
system.  Neutrophils are abundant in blood and are important first responders to sites 
of infection or inflammation, where they arrive rapidly in large numbers. Once there, 
they directly control infection three key processes: phagocytosis, degranulation and 
NETosis (release of neutrophil extracellular traps)(Kumar & Sharma 2010). 
Neutrophils can also modulate other aspects of the host innate and adaptive immune 
responses, for example (Amulic et al. 2012).  
Neutrophils are distinguished by possession of a multi-lobed nucleus and 
neutrophilic granules, which form sequentially during maturation and contain 
substances with potent antimicrobial activity (Borregaard 2010). At the site of 
infection, these granules aid in the killing and digestion of microorganisms, but may 
also damage host tissues if released inappropriately (Borregaard et al. 2007; Perobelli 
et al. 2015).  
The initial innate immune response to promote clearance of bacteria comprises a 
heavy infiltrate of neutrophils to the site of infection. However, excessive neutrophil 
recruitment, or uncontrolled neutrophil activity in response to the infection can result 
in massive damage to host tissues (Kolaczkowska & Kubes 2013; Craig et al. 2009).  
Better understanding of neutrophil migration and function is important both to 
optimising control of infection, and to protecting against host tissue damage (Kumar 
& Sharma 2010).  
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1.1 Neutrophil development  
 
Neutrophils are the most abundant leukocytes in human peripheral blood, and are 
constantly generated in the bone marrow from myeloid precursors (Kolaczkowska & 
Kubes 2013). Neutrophil production is termed granulopoiesis, and occurs in 
haematopoietic cords in the venous sinuses of the bone marrow. In the bone marrow, 
the granulopoietic compartment can be divided into three broad categories: a 
haematopoietic stem cell pool, a mitotic pool (proliferating and differentiating 
granulocytic progenitor cells) and a post-mitotic pool (mature, fully differentiated 
neutrophils, ready to be released into the blood on demand) (Summers et al. 2010).   
 
Before reaching maturation, neutrophils transition through the following 
developmental stages: haematopoietic stem cell, myeloblast, promyelocyte, 
myelocyte, metamyelocyte, band cell and PMN.  This is accompanied by sequential 
development of granules, and segmentation of the nucleus, and occurs in response to 
a cocktail of growth factors and cytokines (Amulic et al. 2012). The basal rate of 




neutrophils/day in healthy human (Summers et al. 2010; Borregaard 2010; Rankin 
2010). 
 
Humans neutrophils make up 50-70% of the circulating white blood cells, and in 
mice, 10-25% (Doeing et al. 2003; Mestas & Hughes 2004). Neutrophils have a 
relatively short life-span, with an average circulatory lifespan of 5.4 days. Typically, 
the circulating half-life for mature neutrophils is about  8 hours in blood for humans, 
and 8-10 hours for mice (Galli et al. 2011; Pillay et al. 2010). They can spend 
approximately 2-3 days in the tissues. Their lives are mainly devoted to protecting 
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our body from infecting microorganisms, and after completing this function, the cells 
will die (Pillay et al. 2010).  
 
1.1.1 Neutrophil release from bone marrow  
 
Chemokines tightly control the release of bone marrow neutrophils into the blood 
stream in the healthy individual, and at the same time sustain a pool of cells in the 
bone marrow in case of infection (Amulic et al. 2012). In steady-state  conditions, an 
equilibrium between signalling from the CXCR4 and CXCR2 chemokine receptors 
regulates the release of mature neutrophils from the bone marrow into the blood (Day 
& Link 2012). Bone marrow stromal cells produce the CXC chemokine, CXCL12 
(stromal derived factor1/SDF-1α), which is a ligand for CXCR4 on neutrophils and 
promotes binding of (VLA)-4 on neutrophils to (VCAM)-1 on bone marrow 
endothelial and stromal cells to maintain them in the bone marrow, ready for 
immediate release (Borregaard 2010; Sadik et al. 2011). 
Upon maturation of neutrophils CXCR4 will be down-regulated, and CXCR2 will be 
up-regulated. Bone marrow endothelial cells produce CXCL1 (KC) and CXCL2 
(MIP-2), which bind CXCR2 on neutrophils, allowing effective  mature neutrophil 
egress into the circulation (Summers et al. 2010; Sadik et al. 2011). During acute 
inflammation, neutrophils will be mobilized in greater numbers by a shifting balance 
between CXCL12 and CXCR2 ligands in the bone marrow, coordinated by G-CSF. 
G-CSF indirectly reduces production of CXCL12, at the same time increasing 
CXCL1 and CXCL2 production by bone marrow endothelial cells, promoting 
neutrophil egress (Summers et al. 2010; Sadik et al. 2011). During infection the 
lifespan of neutrophil will be prolonged, and together with increased granulopoiesis, 
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results in an increase in neutrophil numbers. This facilitates recruitment of large 
numbers of neutrophils to the site of infection (Quinn et al. 2014). 
 
1.1.2 Neutrophil Homeostasis  
 
Only around 1-2% of mature neutrophils circulate in blood, while the others are 
reserved in the bone marrow. Neutrophils adhere to blood vasculature, termed 
margination, to form intravascular pools in specific organs such as liver, spleen, bone 
marrow and lung. The size of the circulating neutrophil pool will be increased as the 
marginated pool of neutrophils decreases in these organs. During steady state, 
neutrophils will undergo apoptosis, which later promotes granulopoiesis through G-
CSF production by macrophages. During inflammation, extravasated neutrophils will 
undergo apoptosis or necrosis and, also trigger the production of G-CSF.  Thus, the 
rate of neutrophil development, release and death will determine the circulating 
number of neutrophils during infection and homeostatic conditions (Summers et al. 
2010).  
 
Neutrophils enter the site of infection, clear the pathogen and need to undergo 
apoptosis after that. However, if the dead cells are not cleared efficiently, they will 
cause inflammation and tissue damage by releasing cytotoxic proteins, such as MPO. 
At sites of inflammation, macrophages will clear apoptotic neutrophils (Summers et 
al. 2010). The uptake of apoptotic neutrophils by macrophages modulates 
macrophage inflammatory function. IL-23 production is suppressed, resulting in 
reduced IL-17 production by Th17 cells, ILCs, and others. As a result, G-CSF 
production is also reduced, decreasing granulopoiesis. This shifts the equilibrium 
between CXCR4-CXCR2 signalling towards CXCR4, retaining neutrophils in the 
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bone marrow, and attenuating the inflammatory response (Stark et al. 2005). 
Apoptotic neutrophil are not found in the circulation under non-inflammatory 
conditions. However, under homeostatic conditions, since neutrophils have a short 
half-life and are released in large numbers into the blood every day, they use a 
mechanism whereby the aging neutrophils will return to the bone marrow in response 
to the CXCR4/CXCL12 chemokine axis. In this process neutrophils are 
phagocytosed and thus, destroyed by resident macrophages, which in turn promotes 
the production of G-CSF, which further stimulates granulopoiesis (Rankin 2010).  
 
1.2 Neutrophil recruitment to the site of infection and inflammation 
 
Under steady state conditions neutrophils serve as security by patrolling in the blood 
vessels and looking for evidence of any initial inflammatory response without 
entering into the tissue. However, upon sensing inflammation or infection they will 
be primed and a recruitment cascade initiated, leading to migration from the blood 
into inflamed tissue, where they ingest and destroy invading microbes. Neutrophils 
are attracted to sites of infection after receiving chemoattractant signals which can be 
produced by resident macrophages, damaged cells, and bacteria. Neutrophil 
recruitment from blood to the site of infection involves a multistep process including 
extravasation from the vasculature, migration through the interstitial matrix, and at 
mucosal surfaces, transepithelial migration (Katanaev 2001; Bardoel et al. 2014).  
 
1.2.1 Neutrophil Extravasation 
 
Neutrophils have to move from the bloodstream to the site of infection in order to 
fight infection. In order to do this, endothelial cells must be activated to support 
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neutrophil attachment to the blood vessel endothelium. This multistep process 
involves slowing down of the neutrophil (tethering and rolling), firm adhesion of 
neutrophil (adhesion and crawling) and escape from blood vessel (transmigration). 
After crossing the endothelium and basement membrane, neutrophils enter the 
interstitial space and follow chemotactic cues towards the site of infection.  
Extravasation from blood into the tissues, starts when, circulating neutrophils are 
slowed down near the infection site (Vestweber 2007). Sentinel cells resident in 
tissues, such as macrophages, DC and mast cells, produce pro-inflammatory 
mediators (IL-1β, TNF-a, chemokines) when they bind pathogen- and danger- 
associated molecular patterns (PAMPs and DAMPs) with their pattern recognition 
receptors (PRRs). The release of these pro-inflammatory mediators results in 
expression of P-selectin and E-selectin on endothelial cells. P-selectin glycoprotein 
ligand-1 (PSGL-1) recognises co-receptors on the inflamed endothelium. For 
example, interactions between P-selectin and PSGL-1 result in loosely adhesive 
contacts between neutrophils and endothelial cells, and together with the shearing 
force of the flow of the blood, cause the neutrophil to tether and roll along the vessel 
wall (Moore et al. 1995). The second step is firm adherence and full arrest of the 
neutrophil on the endothelial cell surface. This firm adhesion, will be influenced 
initially by the activation of a cascade of kinases following engagement of PSGL-1 
and L-selectin on neutrophils (Amulic et al. 2012). At the same time, interactions 
between β2 (CD18) integrins, such as αLβ2 (LFA-1 or CD11a/CD18) and αMβ2 
(MAC-1 or CD11b/CD18) on the surface of neutrophils, with intercellular adhesion 
molecule 1(ICAM-1) on endothelial cells occur (Diamond et al. 1990). Rolling 
neutrophils are exposed to chemoattractants, cytokines and bacterial products. 
Through a process of inside-out signalling, these drive the activation and clustering 
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of β2 integrins on the neutrophil surface, increase of affinity and avidity of the 
interaction with their ligands on endothelial cells. This results in firm adhesion and 
crawling of the neutrophil on the endothelial cells. Besides β2 integrins, neutrophils  
also use VLA-4 to interact with VCAM-1 during the rolling process (Ley et al. 
2007). Subsequently, receptor-ligand interactions on both cells will result in 
transmigration to the interstitial space either through the endothelial junction 
(paracellular) or transcellularly through the endothelial cell (Phillipson et al. 2006; 
Spaan et al. 2013). It has been shown that neutrophils prefer paracellular migration. 
This is mediated by CD11b/CD18 and other adhesion molecules expressed in the 
endothelial junction, such as ICAM- 1 and 2, and PECAM-1 (Borregaard 2010). 
Subsequently, neutrophils cross the basement membrane and pericyte layers. 
 
1.2.2 Interstitial neutrophil migration  
 
Following extravasation, neutrophils will enter into the interstitial space where they 
encounter a large variety of chemotatic gradients. Studies have identified that there 
are significant differences in the adhesive, chemoattractant and signalling processes 
which regulate neutrophil migration in 2D- and 3D. In vitro, 2D migration is largely 
integrin-dependent, while 3D migration can be integrin-dependent or independent. 
Integrin-independent modes of migration are also dependent on actin polymerisation 
as it is the assembly and disassembly of the actin cytoskeleton that enables the cell to 
move toward cues such as chemoattractants.  
In the interstitium, neutrophil chemotaxis to the site of infection is regulated by two 
types of chemoattractant gradient: “intermediary chemoattractants” found in the 
general area of infection and beginning at the endothelium (e.g. IL-8, LTB4) and 
8 | P a g e  
Chapter 1 - Introduction 
“end-target chemoattractants” found at the infection site (e.g. complement, pathogen-
derived chemoattractants). Neutrophils have to prioritize these gradients by 
following a hierarchy favouring end-target chemoattractants to reach the site of 
infection (Heit et al. 2002). The prioritization process uses two different signalling 
pathways: p38MAPK and CD11b/CD18 for end-target chemoattractants and  PI3K 
and LFA-1 for intermediary chemoattractants (Heit 2005). This suggests that 
integrins play a role in neutrophil interstitial chemotaxis.  
 
1.2.3 Neutrophil Activation  
 
The interactions formed by neutrophils as they travel to sites of inflammation are 
accompanied by activation of complex signalling cascades that first prime 
neutrophils then result in their complete activation. At this point neutrophils 
elaborate killing functions such as phagocytosis, degranulation and NETosis. The 
activation of circulating neutrophils is crucial during inflammatory responses and 
involves a multistep process. Exposure of neutrophils to one stimulus (e.g. TNF α, 
IL-8, LTB4, microbial products, adhesion) leads to priming, and increases sensitivity 
to a second stimulus, which is necessary  for full activation (Condliffe et al. 1998; 
Mayadas et al. 2014). Priming starts during the neutrophil recruitment cascade in 
blood vessels, through interaction with activated endothelial cells (Summers et al. 
2010). Once neutrophils cross the endothelial barrier, the cells will become fully 
activated. These activated neutrophils, driven by chemoattractant cues, will release 
their antimicrobial contents at the site of infection. Activation also results in the 
release of cytokines by neutrophils, which recruit other immune cells (Amulic et al. 
2012). 
 
9 | P a g e  
Chapter 1 - Introduction 
1.2.3.1 Pattern-recognition receptors (PRRs) 
  
Neutrophils pattern recognition receptors (PRRs) recognise pathogen-associated 
molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs) 
(Mayadas et al. 2014).   
PRR families include Toll-like receptors (TLRs), C-type lectin receptors (CLRs), 
Retinoic acid-inducible gene (RIG)-I-like receptors (RLRs) and NOD-like receptors 
(NLRs) (Takeuchi & Akira 2010). PRRs allow neutrophils to recognise a broad 
range of microbial features facilitating generation of the right response (Thomas & 
Schroder 2013). The primary endocytic PRRs of the neutrophil are the C-type lectin 
receptors of which Dectin-1 is the most important as it  recognizes fungal β-glucan 
(Trinchieri & Sher 2007). Dectin-1 also induces the  activation  of CD11b/CD18  
which  is required for neutrophil cytotoxic responses (Chalovich & Eisenberg 2013). 
Meanwhile, the major type of non-phagocytic PRRs on neutrophils are the TLRs 
(Trinchieri & Sher 2007). Neutrophils  have been shown to express TLR1, -2, -4, -5, 
-6, -8 and -10 (and, after GM-CSF treatment, TLR9) at the RNA level (Hayashi et al. 
2003). It also been shown, neutrophils need to be ‘primed’ first before being fully 
activated. In the priming stage neutrophils can enhance their response to other stimuli 
by binding with TLR, which leads to increased cytokine release, and slows 
neutrophil apoptosis (Parker et al. 2005).  
Peptidoglycan-related molecules of gram-negative bacteria are recognized by NOD1, 
and gram-positive bacteria by NOD2, which are cytosolic microbial sensors 
(Kanneganti et al. 2007).  Recognition of PAMPs or DAMPS by NOD-like receptors 
results in nuclear translocation of NFkB, or activation of caspase 1 which cleaves 
pro-cytokines such as IL-1 and IL-18 to their active forms (Futosi et al. 2013). 
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NOD2 can also lead to IL-8 release after triggering by the appropriate proteoglycan 
(Ekman & Olaf 2009). RIG-like receptors are cytoplasmic receptors that mediate 
host defense against intracellular viruses (Futosi et al. 2013). 
 
1.2.3.2 Opsonic receptors 
 
Neutrophil-mediated uptake and degradation of opsonised pathogens occurs through 
Fcγ receptors or  complement receptors (Mayadas et al. 2014).  
 
1.2.3.3 G protein-coupled receptors 
 
Neutrophils express a variety of G protein– coupled receptors (GPCRs) with roles in 
host defense. GPCRS  are able to distinguish bacterial product (e.g. formyl peptides) 
and  endogenous molecules such as leukotrienes and chemokines (Rabiet et al. 2007; 
Manuscript 2013; Ba et al. 2011). These GPCRs can strongly activate the 
chemotactic migration of neutrophils. Nevertheless, some GPCR ligands, and in 
particular formyl-peptides, lipid mediators and C5a, can activate other neutrophil 
responses such as ROS production and degranulation (Mayadas et al. 2014; Futosi et 
al. 2013).  
 
1.2.4 Neutrophils and the elimination of pathogens   
 
Once a neutrophil meets the invading microbe, it can react in a variety of different 
ways. The three major antimicrobial functions are phagocytosis, degranulation and 
the generation of neutrophil extracellular traps (NETs) (Amulic et al. 2012).  
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1.2.4.1 Phagocytosis 
 
Neutrophils use phagocytosis as a major mechanism in removing pathogens and cell 
debris. Prior to phagocytosis, invading microbes are recognized by neutrophils, either 
directly (PRRs/PAMPs) or via recognition of an opsonin by opsonic receptors (e.g. 
Fcγ receptors or complement receptors). Following recognition, the neutrophil 
membrane engulfs the microbe into a vacuole called the phagosome. This process 
involves membrane lipids, intracellular signalling cascades and cytoskeletal 
rearrangements. The primary and secondary granule will release their antimicrobial 
contents after fusing with the phagosome to make a phagolysosome. The process is 
very rapid, particularly in the presence of opsonins, and can be enhanced by pre-
activation of the neutrophil (Kruger et al. 2015; Bardoel et al. 2014).  
 
During phagocytosis, the NADPH oxidase is formed  (Kruger et al. 2015). This will 
convert oxygen into oxidizing molecules called reactive oxygen species (ROS) such 
as superoxide, hydrogen peroxide and halic acids. Together with antimicrobial 
contents and ROS this will lead to efficient killing of microbes (Bardoel et al. 2014) 
 
1.2.4.2  Neutrophil Granules and Degranulation 
 
Neutrophil granules contents have potent antimicrobial activity (Borregaard 2010). 
Neutrophil granules are classified into three different subsets based on their enzyme 
content and function. Primary (azurophilic) granules contain potent hydrolytic 
enzymes like myeloperoxidase (MPO), which is essential for the oxidative burst, 
various antimicrobial peptides such as defensins and lysozyme. Secondary (specific) 
granules contain lactoferrin which is important for stopping bacteria growing and 
assisting in cell wall breakdown.  Tertiary (gelatinase) granules are rich in matrix 
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metalloproteinases (MMPs) (Borregaard 2010; Mayadas et al. 2014). In addition to 
this, secretory vesicles are classified as a granule subset. Secretory vesicles are 
highly mobilisable and serve as a reservoir for plasma membrane receptors, such as 
those involved in neutrophil adhesion and chemotaxis (Mayadas et al. 2014; Amulic 
et al. 2012).  
 
Upon activation, granules are mobilized and fuse with the phagosome during 
pathogen uptake. This results in the release of stored proteinases and antimicrobial 
peptides into the phagosome. In addition, granule fusion with the plasma membrane 
can cause extracellular release of contents into the local tissue environment (Amulic 
et al. 2012; Mayadas et al. 2014). Extracellular release of granules risks damage to 
host tissues.  Contents of secretory vesicles and tertiary vesicles can be released 
following modest activation, whereas release of secondary and primary granule 
contents most often occurs through unintentional leakage of the phagosome. In 
addition, during transmigration tertiary and secondary granules may mobilize to 
degrade the collagen in the basement membrane, assisting neutrophil exit into the 
tissue interstitium (Mayadas et al. 2014).  
 
At the site of inflammation, neutrophil granules aid in tissue remodelling and the 
killing and digestion of microorganisms, but also possible damage to the host if 
released inappropriately (Borregaard et al. 2007; Perobelli et al. 2015).  
 
1.2.4.3 Neutrophil Extracellular Traps (NETs) 
 
Upon stimulation, neutrophils can release neutrophil extracellular traps (NETs) in 
form of cell death known as NETosis. During NETosis, chromatin is processed, 
scattered with antimicrobial enzymes such as neutrophil elastase and MPO, and 
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released into the extracellular space in the form of NETs  (Amulic et al. 2012; 
Mayadas et al. 2014; Bardoel et al. 2014). NETs are involved in antimicrobial 
function by exposing pathogens to highly concentrated antimicrobial peptides and 
enzymes, and by physical trapping of microbes within the chromatin. They can also 
activate other immune cells.  
 
1.2.5 Effect of neutrophil activation on host tissues 
 
Neutrophil are considered to be the front line of defense against invading 
microorganisms, however the defensive mechanisms of neutrophils that aid in 
pathogen killing can also be harmful to host tissues. Inappropriate neutrophil 
activation is sometimes observed in sterile injury such as autoimmune and other 
chronic inflammatory diseases (Figure 1) (Mayadas et al. 2014). However, targeting 
specific neutrophil functions remains therapeutically challenging (Mayadas et al. 
2014).  
  
Figure 1:  Neutrophil Activation: The Good and Bad Sides 
(Green) indicate positive and (Red) indicate negative features related to neutrophils 
antimicrobial role which may affect the host. Picture adapted from (Bardoel et al. 2014) 
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1.3 Pathogen manipulation of neutrophil function 
 
The primary role of neutrophils is host defense against pathogens, and they must be 
recruited in great numbers to the site of infection in order to provide the first line of 
defence to the host. Thus, the failure of neutrophils to infiltrate the site of infection, 
and deficiencies in activation, can lead to severe infections in the host. Here we 
provide one example of invading microorganism manipulation of neutrophils 
function;  
 
A crucial defense system against Staphylococcus aureus is through neutrophil-
mediated killing. However, this pathogen has developed many strategies to avoid 
killing at all levels including; i) extravasation ii) chemotaxis iii) priming and 
activation iv) opsonisation and phagocytosis, and v) NET Formation. The pathogen 
secretes a variety of molecules that resist neutrophil attack at the site of infection 
such as during extravasation neutrophil rolling on endothelial cells can be inhibited 
when staphylococcal superantigen-like 5 (SSL5) blocks PSGL-1 interaction with P-
selectin and E-selectin on the neutrophil surface (Spaan et al. 2013). Another 
example, Liu et al have shown Staphylococcus aureus, produces a golden pigment (a 
virulence factor) with antioxidant properties and utilizes it to protect itself against 
ROS damage within the phagosome (Liu et al. 2005). In spite of the fact that S. 
aureus utilises multiple mechanisms to evade neutrophil responses, healthy people 
can still deal with this bacterium in an effective way. 
 
1.4 Neutrophil Migration 
 
To defend the host, neutrophils must migrate from the blood into the tissue through a 
multistep process, and then onwards through the tissue interstitium (Artemenko et al. 
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2011). During migration, the neutrophil activation state can be altered by 
extracellular signals which regulate the cytoskeleton, adhesiveness, shape and 
motility. These extracellular signals include; cytokines, chemokines, lipids, alarmins, 
formyl peptides, complement factors and adhesive ligands. From extracellular signal 
neutrophils will be able to  translate the signals to intracellular signals that cause 
morphological changes and cell polarisation, resulting in migration (Lämmermann & 
Germain 2014).  
 
1.4.1 Different types of migration  
 
Environmental signals experienced by neutrophils are integrated and translated into a 
range of different morphological changes and migration modes. These include 
cytoskeletal activation, chemokinesis, chemotaxis, haptokinesis and haptotaxis 
(Figure 2). 
Morphological shape changes without cell movement occur as a result of increased 
cytoskeletal activity in an homogeneous field of environmental signals. Chemotaxis 
and haptotaxis are directional, and occur along a soluble (chemotaxis) or substrate-
bound (haptotaxis) gradients of chemoattractant. Different modes of haptotaxis exist, 
including migration on ECM-bound gradients, and on cell surface bound gradients. 
Meanwhile, chemokinesis and haptokinesis are non-directional. Chemokinesis 
(soluble ), and haptokinesis (substrate-bound) occur in the presence of a uniformly 
applied stimulus (Tarabykina et al. 2000; Martin et al. 2015; Lyck & Enzmann 2015; 
Lämmermann & Germain 2014). 
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Figure 2: Changes in neutrophil shape, motility, and migration modes are induced by 
environmental signals 
Neutrophils receive multiple signals from their surroundings, and then integrate them into 
intracellular signalling cascades to stimulate morphological changes and select different 
migration modes as above. Picture adapted from (Lämmermann & Germain 2014). 
 
 
1.4.2  Methods for analysing neutrophil migration 
 
A range of different migration assays have been developed and investigated by 
researchers over the years.  They have been useful in unravelling the highly complex 
signalling pathways that contribute to different aspects of motility, such as two-
dimensional (2D) and in three-dimensional (3D) migration. The combined effort of 
many researchers has led to improvements in in vitro models to produce more 
complex, physiologically relevant model environments for cells to migrate in 
(Artemenko et al. 2011). Elucidating the signalling pathways controlling neutrophil 
migration could lead to possible therapeutic approaches for treating conditions where 
neutrophils cause significant tissue damage and morbidity. There are many in vitro 
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2D and 3D models currently utilised to study cell migration, with those used in this 
thesis described below. 
 
1.4.2.1 In vitro 2D models - Transwell Assay 
 
Transwell assays are commonly used for analysing neutrophil chemotaxis. This assay 
is primarily used to study directed migration from the top compartment to the bottom 
compartment of a chamber,  where a higher concentration of soluble chemoattractant 
has been applied to the bottom compartment (Nuzzi et al. 2007). The benefit of using 
this Transwell assay is the capability to perform multiple replicates, and to analyse 
the effect of various stimuli, inhibitors, or substrates on chemotaxis. However the 
results do not provide other evidence or details  about the migration phenotype 
(Nuzzi et al. 2007), which need to be further analysed by other methods. 
 
A basic transwell assay comprises two chambers separated by a microporous 
membrane (Figure 3a). Cells are placed in the upper chamber (Figure 3b) and 
allowed to migrate toward chemoattractants placed in the bottom chamber (Figure 
3c) (Artemenko et al. 2011). Quantification of cells passing through the membrane 
can be done using MACS Quant Analyser, trypan blue exclusion, and image 
captured by microscope. Cells fluorescence can also be read using a fluorescent plate 
reader (Justus et al. 2014).  
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Figure 3: 2D Transwell® Assay 
(a) Transwell® well have two different compartment; upper and lower which separated by a 
porous membrane (b) Cells are added onto upper compartment and lower compartment is 
filled with medium (with or without chemoattractant) (c) Cells are incubated for designated 
time to allow optimal migration. Once the incubation time for migration completed cells will 
collected and count (manually or using automation analyser such as MACS Quant Analyser) 
 
 
1.4.2.2 In vitro 3D models 
 
The majority of studies on neutrophil migration have used the 2D transwell assay 
described above, however one short coming of this 2D assay is that it does not 
closely relate to the reality of the environment encountered by neutrophils upon 
entering tissue. Better mimicking of the in vivo environment requires a 3D model 
where migrating cells can receive signals from the composition and structure of the 
tissue matrix. Furthermore in these models, migration in 2D has been identified as 
integrin dependent and migration 3D is integrin independent (Martin et al. 2015).  
 
a) Transwell Invasion Assay 
Transwell invasion assay can be modified to study cell migration in 3D 
environments. This can be done by overlaying a thin layer of specific extracellular 
matrix (ECM) components on the porous membrane before seeding the cells (Figure 
4) (Artemenko et al. 2011; Justus et al. 2014). To move through a 3D matrix cells 
must modify their shape and interact with the ECM. In some cases, cells will squeeze 
through existing pores and channels in the matrix, while in other circumstances 
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active restructuring of the 3D environment by the migrating cell occurs. This is 
defined as invasion (Justus et al. 2014). Nowadays, commercially available inserts 
pre-coated with ECM are available. The assay is conducted as described in the 
previous section, but with longer timescales to allow the cells to traverse the 3D 
ECM. This assay has all the same advantages as the 2D assay, but is more 
representative of the in vivo environment. 
 
Figure 4: 3D Transwell® Assay 
(a) Transwell® well have two different compartment; upper and lower which separated by 
membrane porous (b) Porous membrane is overlaid with collagen matrix and lower 
compartment filled with medium (with or without chemoattractant). Cells are added onto 
upper compartment and incubate for designated time to allow optimise migration. (c) After 
incubation the transmigrated cells have passed through the membrane. The upper chamber is 
removed. Migrated cells are visualised by microscopy and fixed and cell were counted using 
MACS Quant analyser. 
 
 
 b) 3D Chemotaxis using u-Slide Chemotaxis  
 
The 3D transwell assay is a useful tool, but does not  allow real-time visualisation of 
migrating cells, which may reveal important information about the mechanism of 
migration. A 3D migration assay developed by Ibidi addresses this shortfall. 
Neutrophils are embedded in a 3D collagen matrix in a central chamber, which is 
allowed to set before chemoattractant-free or chemoattractant containing medium is 
added to reservoirs on either side (Figure 5) (source https://ibidi.com/). The slides 
have cover glass bottoms, and three test samples can be observed concurrently in 
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each experiment. The slide chamber is sealed and placed onto a confocal microscope 
stage. Images are acquired every one minutes for several hours. The individual 
migration tracks of the cells can be analysed using software such as Fiji ImageJ 
manually or automatically. Using Chemotaxis Tool the information from the cell 
tracking for the parameter such as velocity, directionality, Euclidean distance and 
accumulated distance can be quantified statistically (Asano & Horn 2011). This 
assay allows heterogeneity in migration phenotypes to be more easily appreciated 
than in the transwell assay.  
 
 
Figure 5: Schematic set up for 3D Chemotaxis using u-Slide Chemotaxis by ibidi® 
The chamber was prepared as instructed in the manual from ibidi®. Three samples can be 
tested concurrently at one time. 1) Neutrophils were isolated and mixed with collagen. 
Samples were loaded into the chamber and allowed to solidify 2) Media without 
chemoattractant was added into the C0 space and immediately before imagin, media with 
chemoattractant was added into C100 space. 4) Three positions of each sample were imaged. 
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1.4.3 Live cell imaging technique 
 
While useful, extensive observations from 2D and 3D models still do not completely 
mimic the in vivo tissue environment, both structurally and in terms of the influence 
of interactions with other cell types. Thus to further improve our understanding of 
how cell migration is regulated in their native environment, live imaging technique  
in situ, such as by two photon laser scanning microscopy (TPLSM) is required 
(Dzhagalov et al. 2012). Commonly two techniques have been used to image cells in 
situ, which are post-mortem organ explant and intravital imaging in live 
anaesthetised mice. Two-photon imaging techniques using both methods have 
advantages and disadvantages (Sawtell 2015).  
 
Tissue explant is performed by excision of the tissue of interest which is maintained 
in oxygen-perfused media during imaging. Tissues can be imaged whole (e.g. lymph 
nodes), or sliced with a vibratome to allow deeper imaging (e.g. thymus). The major 
advantage of this technique is that it allows imaging of tissue not easily accessible in 
a live animal, and avoids performing unnecessary procedures on living animals. 
However, using explant methods mean that blood and lymph circulation are 
interrupted which also may alter cell behaviour. Intravital imaging is superior in this 
regard, as tissues are imaged in situ, with intact blood and lymph perfusion, thus 
exact cell behaviour in vivo can be observed precisely. However, mice may 
experience surgical trauma and the use of anaesthetics during imaging may also 
interfere with imaging data. The data on motility of lymphocytes shows close 
agreement between the two methods (Dzhagalov et al. 2012).  
The advantage of using TPLSM is that we are able to image deep into the tissue. 
Furthermore, this technique has the ability to visualize fibrillary collagen without 
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exogenous labelling, due to second harmonic generation (SHG). This offers extra 
visualisation of structural features of the tissue when investigating how cells move in 
3D in vivo. The 4D images obtained by TPLSM can be analysed using software such 
as IMARIS for the quantification of migration parameters such as velocity and 
directionality (Sawtell 2015).  
 
1.5 Streptococcus pneumonaie 
1.5.1 Background  
 
Streptococcus pneumoniae (commonly known as the pneumococcus) is a pathogenic 
extracellular, Gram-positive bacterium that colonises the mucosal surface of the 
human upper respiratory tract (Weiser et al. 2018). This microorganism lives in 
association with the human nasopharyngeal flora where it occurs  asymptomatically 
as a commensal (Kadioglu et al. 2008). About 25% of the global population are 
estimated to be carriers (Paterson & Orihuela 2011). Under certain circumstances, 
the pneumococcus can spread into the lung, blood and brain and might lead to severe 
life-threatening disease such as pneumonia, sepsis and meningitis (Bogaert et al. 
2004), particularly in situations when the host immune system is compromised 
(Kadioglu et al., 2008).  
 
Encapsulated pneumococci are organised in pairs and can only be seen in a chain of 
varying lengths in blood cultures and liquid media (Alonso et al. 1995).  
Pneumococci are catalase-negative bacteria and facultative anaerobes, grouped as 
alpha-hemolytic due to the production of a green zone of hemolysis around colonies 
growing on blood agar plates (Obaro and Adegbola, 2002). 
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 Pneumococci are a common cause of community-acquired pneumonia (CAP), which 
is accountable for a huge human disease and death toll in both economically 
developed and developing countries (Feldman & Anderson 2016). It is also the most 
common cause of hospitalisation and mortality in children in developing countries 
for pneumococcal septicemia (Kadioglu et al. 2008). While pneumococcal diseases 
may be tackled by the use of antibiotics, pneumococcal infections are associated with 
an unacceptably high rate of mortality and morbidity globally (Song et al. 2013) and 
may also lead to increasing risks of antibiotic resistance. In 2017, the pneumococcus 
was included by the WHO as one of the 12 priority pathogens causing continuous 
high burden disease and increasing rate of antibiotic resistance (Weiser et al. 2018). 
 
Figure 6: Life cycle of the pneumococcus and pathogenesis 
Pneumococci colonise the mucosal surface of the upper respiratory tract (URT) and allows 
for the onset of disease and transmission from carriers to non-carriers. Carriers can shed 
pneumococci in their nasal discharge and allow transmission of the bacteria. The spreading 
can thru nasal epithelium, either by aspiration, bacteraemia or local spread, which further 
contribute to invasive diseases, such as pneumonia, meningitis and otitis media. Picture 
adapted from (Weiser et al. 2018) 
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1.5.2 Pneumococcal colonisation  
 
Colonization of the nasopharynx is believed to be a prerequisite for the 
pneumococcus to develop into an infection. It lives in the upper respiratory track as a 
normal flora either entrapped in the nasal mucus, or attached to the surface of nasal 
epithelial cells. Pneumococcal transmission is believed to occur from one individual 
to another through droplets or aerosols. Invasion of the lower respiratory tract takes 
place when the pathogen gains entry into peripheral tissues either by local spread or 
aspiration, leading to mild diseases such as otitis media or life-threatening condition , 
such as bacteremia, pneumonia and meningitis (Figure 6) (Bogaert et al. 2004; 
Weiser et al. 2018).  
 
Koppe et al. suggested that two overlapping scenarios needed to take place to result 
in invasive pneumococcal disease (IPD). Firstly, when the immunity of the host are 
not properly established this will likely favour  colonisation by the bacteria (Koppe et 
al. 2012). Secondly, a breach needs to occur within the natural defense barriers or 
host immune balance present in the mucosal system (Koedel et al. 2002) 
 
1.5.3 Pneumococcal disease  
  
In 2000, the WHO reported that more than 800,000 deaths in children under 5 years 
of age and around 14.5 million cases were  due to  severe pneumococcal disease 
(Grant et al. 2003). Meanwhile, disease such as otitis media and  sinusitis have also 
become prominent cases (Bogaert et al. 2004). Young children are the age group 
with the highest incidence rate of pneumococcal disease, however, the elderly and 
any other age group can also be affected (Obaro & Adegbola 2002).  
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Based on previous studies, the occurrence of IPD can be affected by a number of 
variables such as season, serotype, age, geographical location, and vaccination status 
of the population (Torres & Cilloniz 2014). Currently 98 serotypes have been 
described on the basis of their polysaccharide capsule (Weiser et al. 2018) and some 
of these serotypes are associated with colonisation in nasopharynx (Koppe et al. 
2012). 
A significant morbidity and mortality was reported in areas of Asia-Pacific where the 
highest incidence of pneumococcal diseases is found among young indigenous 
children with incidence rates ranging between 100-200 cases/100,000 children aged 
less than 2 years. Meanwhile, around 1500 cases/100,000 children aged <5 years 
were reported in India (Torres & Cilloniz 2014). Around 450 million people per year 
were affected by pneumococcal pneumonia (Rudan et al. 2008) associated with a 
high case fatality rate (15% of hospitalized patients) and a high incidence (Torres & 
Cilloniz 2014). In the UK, S. pneumoniae was reported to be amongst the most 
common cause of bacterial meningitis, after Neisseria meningitidis, in the very 
young children (Randle et al. 2011). 
 
1.5.4 Pneumococcal virulence factors  
 
The pneumococcus has a number of virulence factors which promote the success of 
colonisation and allow it to spread from the upper to the lower tract respiratory tract. 
It requires extensive and complex interactions between the pneumococcus and the 
nasopharyngeal microbiota (Weiser et al. 2018). The capsule is the major virulence 
factor, and contributes to resistance to phagocytosis, binding of immune complement 
(Weiser et al. 2018), and is important for the entrapment in neutrophil extracellular 
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traps (Koppe et al. 2012). The other major virulence factor is pneumolysin (PLY), 
which is a toxin capable of forming large pores into mammalian cell membranes and 
is essential to the mechanisms of pneumococcal infection (Koppe et al. 2012; 
Mitchell & Mitchell 2010). The pneumococcus has many virulence factors and the 
major ones are shown in Table 1 and on schematic diagram Figure 7. 
 
Figure 7: Schematic diagram of virulence factors of S.pneumoniae 
Virulence factors on the pneumococcus compromise the capsule, cell wall, choline-binding 
pneumococcal surface proteins A and C, LPXTG-anchored neuraminidase, Hyl, Ply, 
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Table 1: Some of Penumococcal virulence factor and their functions 
CBP, choline-binding protein; CPS, capsular polysaccharide; Fe, iron; iC3b, inactive C3b; 
LPXTG, sortase-anchored surface protein; MAPK, mitogen-activated protein kinase; Mn, 
Manganase; Ply, pneumolysin; PspA, pneumococcal surface protein. Part of the table taken 
from (Weiser et al. 2018). 
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1.5.5 Pneumolysin   
 
More than 100 years have passed from the first report that pneumococi make a 
hemolysin (Libman 1905). Pneumolysin (PLY) is a thiol-activated cytolysin and 
membrane-damaging toxin synthesized by S.pneumoniae. It plays a multifunctional 
role as a pneumococcal virulence factor during infection by using pore forming 
activity and complement activation. It consists of a single 53-kDa protein, comprised 
of 471 amino acid  and is produced by all clinical isolates of the pathogen (Paton et 
al. 1993).  
 
1.5.5.1 PLY structure and pore forming activity 
 
The molecular model of PLY is long and rod-shaped with overall dimensions of 
11nm x 35nm x 33nm and is composed of four domains ( Figure 8)  (Rossjohn et al. 
1998). The N-terminal part of this molecule forms the domains 1-3, while the C-
terminal end forms domain 4 (residue 360-469). Domain-4 was identified to be 
critical in the membrane-binding and pore formation ability of PLY (Tilley et al. 
2005) and contains the undecapeptide sequence largely conserved in cholesterol 
dependent cytolysin (CDC) family (Anderluh & Gilbert 2014). 
Upon activation, the lytic pore formation is formed when PLY monomers assemble 
into a circle after undergoing conformational changes, and then oligomerizes into a 
pore to penetrate the membrane of the cells (Tilley et al. 2005; Förtsch 2012). This 
formation of lytic action enable it to lyse membranes containing cholesterol that 
present in all eukaryotic cells (Cockeran, Anderson, et al. 2002). The diameter of the 
pore is 260 Å and is comprised of about 40 monomer subunits (Kadioglu et al. 2008). 
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PLY is known to have various biological activities, with distinct cytolytic and 
complement-activating activities effects that interfere with the cell function 
(Rijneveld et al. 2002). For example, studies by Jounblat et al. have shown that 
PLY’s cytolytic and complement activities are involved in the inflammation and 
cellular influx in pneumonia, in the accumulation of T cells by complement-
activating activity, and in the neutrophil recruitment into the lung tissue (Jounblat et 
al. 2003). 
At relatively higher concentrations, PLY will cause widespread direct cellular and 
tissue damage as a result of its membrane pore forming properties causing lysis of 
the cell (Neill et al. 2015; Kadioglu et al. 2008). Meanwhile, at sub-lytic 
concentrations, the toxin can have a noticeable range of effects such as pro- 
inflammatory activation of neutrophils and macrophages (Cockeran, Anderson, et al. 
2002) and eukaryotic cell signalling (Neill et al. 2015). 
 
Figure 8:  Structural Model of the Bacterial Toxin Pneumolysin 
Pneumolysin (PLY) has four domains: domain 1 (in blue), domain 2 (in grey), domain 3 (in 
red), and domain 4 (in green). The N-terminal part of this molecule form domains 1-3 and 
the C-terminal end forms domain 4(residue 360-469). In pink is highlighted the 
undecapeptide conserved sequence characteristic of the cholesterol dependent cytolysin 
(CDC) family (Neill et al. 2015). 
 
30 | P a g e  
Chapter 1 - Introduction 
1.5.5.2 Effect of PLY on neutrophil function  
  
Several pieces of evidence showed that PLY is capable of a range of effects on 
neutrophil activities. At sub-lytic concentration, PLY was shown to inhibit 
chemotaxis and random migration of polymorphonuclear leukocytes (PMNL) and 
also blocks respiratory burst (Paton & Ferrante 1983).  Earlier studies have shown 
that  PLY can activate human serum in a dose-dependent manner, and this toxin  can 
act as chemoattractant for neutrophils and they also showed that PLY enhances 
neutrophil chemotaxis and secretion of lysosomal enzyme (Johnson et al. 1981).  
Studies by Cockeran et al. showed that PLY can potentiate neutrophils pro-
inflammatory activities resulting in Ca
2+
 influx and altering membrane potential. 
Treatment of human neutrophils with PLY showed an increased  production of 
superoxide, release of elastase, upregulation of CD11b/CD18 expression, and 
increased activity of phospholipase A2 (PLA2) after subsequent exposure to FMLP 
(Cockeran, Theron, et al. 2001). Subsequent studies by the same authors also showed 
PLY increased production of  prostaglandin E2 and leukotriene B4 by human 
neutrophils (Cockeran, Steel, et al. 2001), activates the synthesis and release of 
interleukin-8 (Cockeran, Durandt, et al. 2002) and also induce release of matrix 
metalloproteinase-8 and 9 (Cockeran et al. 2009).  
 
Neutrophil recruitment mediated by PLY has been shown to involve MIP-2 and IL-6 
(Rijneveld et al. 2002). Similarly, other studies showed PLY-induced neutrophil 
chemotaxis required a complex interaction between the pathogen and the host 
(Moreland & Bailey 2006). The release of sub-lytic concentrations of PLY by 
autolyzed pneumococci induces the activation of NADPH oxidase, and generation of 
reactive oxygen species (ROS). However, ROS is released into vesicular 
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compartments that lack microbes, which likely result in the deterioration and death of 
neutrophils and assist pneumococci to avoid phagocytic defence (Martner et al. 
2008). 
 
PLY can also induce K
+
 efflux which mediates NLRP3/ASC inflammasome and 
caspase-1 activation for the secretion of IL-1β by neutrophils. This study has shown 
IL-1β is essential in bacterial clearance (Karmakar et al. 2015). Currently studies 
showed that PLY stimulates vital NETosis in human neutrophils, where this toxin 
was found to activate NET formation in vitro. Studies have shown that PLY has 
potential to induce NETs which is good for the host defence but on the other side 
might also induce the severity of the disease by damaging host tissues (Nel et al. 
2016). 
 
1.5.5.3 Effect of PLY on cell types other than neutrophils 
 
Beside neutrophils, previous studies have also analysed PLY interaction on other 
immune cells. PLY was found to lyse platelets and activate serum to act as a 
chemoattractant (Johnson et al. 1981). Highly purified pneumolysin (at a 
concentration of 10ug/ml) was found to activate human complement in vitro (Paton 
et al. 1984). 
Earlier studies by Rubins et al. showed that during experimental pneumonia, PLY 
facilitates intra alveolar replication, penetration into the interstitium of the lung and 
dissemination of pneumococci into the blood stream (Rubins et al. 1995). 
 At sub-lytic concentrations, PLY was found to stimulate the production of pro-
inflammatory cytokines such as interleuking-1β (IL-1β) and tumor necrosis factor-α 
(TNF-α) produced by human mononuclear phagocyte monocytes (Houldsworth et al. 
32 | P a g e  
Chapter 1 - Introduction 
1994). Meanwhile, at the same concentration calcium-dependent pores and osmotic 
stress was induced by PLY in epithelial cells by activation of p38 mitogen-activated 
protein kinase (MAPK) signalling (Ratner et al. 2006). Other studies using sub-lytic 
concentrations have shown that PLY leads to formation of micro-pores in the plasma 
membrane, activation of rac1 and rhoA GTPases, and the formation of actin stress 
fibres in neuroblastoma cells (Iliev et al. 2007), inducing cytoskeletal rearrangements 
within the target cell involved in migration (Marriott et al. 2008). 
Maus et al. showed in their studies that, in response to PLY challenge, macrophages 
phosphoinositide 3-kinase (PI3K)-γ was activated and necessary  for the recruitment 
of inflammatory macrophages to the site of infection (Maus et al. 2007). Studies on 
human pharyngeal and bronchial epithelial cells in vitro has shown pro-inflammatory 
cytokines such as interleukin-6 and -8 release occurred upon stimulation with 
PLY(Küng et al. 2014). 
 
1.6 General aims of the thesis  
 
My research project has three main aims. The first aim (Chapter 3) was to determine 
whether Streptococcus pneumoniae and its toxin, pneumolysin (PLY), can inhibit 
neutrophil chemotaxis using two- and three-dimensional assays. The second aim 
(Chapter 4) was to elucidate the molecular mechanism through which PLY alters 
neutrophil migration and function. Following on from the work described in 
Chapters 3 and 4, the third aim (Chapter 5) was targeted at the global proteomic 
analysis of PLY-stimulated neutrophils, with the expectation that novel information 
would be discovered on the protein networks involved in PLY and its effect on 
neutrophil chemotaxis. 
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Chapter 2: Material and Methods 
 





In this study, female C57BL/6J mice (for in vitro study), aged 7- 12 weeks and 
female CD1 (for in vivo study), aged 7- 10 weeks, were used in accordance with 
project licenses granted under the Animals (Scientific Procedures) Act 1986, and 
approved by the University of Liverpool Animal Ethics Committee. Mice were 
culled by increasing CO2 followed by cervical dislocation. Tissues were harvested 
into ice cold media, as described in 2.2. 
 
2.1.2 Intranasal infection with S. pneumoniae 
 
Murine infection models were performed by Dr Laura Jacques from Aras Kadioglu’s 
Group. Briefly, CD1 (Female) mice (7-10 weeks) were infected intranasally with 
50μL of 10
6
 CFU of D39 bacteria strain whilst anaesthetized with 2.5% v/v 
Isofluorane over oxygen (1.4-1.6 litres/min) to induce pneumococcal pneumonia. 
After 24 hours, tissues (blood, lung and lymph nodes) from pneumococcal-infected 
and PBS-infected control mice were collected. Experiments were repeated three 
times and all work was carried out in the Biomedical Services Unit, University of 
Liverpool. Collected organs (blood, lung and mediastinal lymph nodes) were kept in 
3mL of sterile PBS and put on ice. Bloods were collected by cardiac puncture and 
placed in heparin (5μL heparin/1mL blood) tubes before transportation to CIMI 
Laboratory for further experiment. Tissues and blood were prepared before analyses 
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on flow cytometry and 20L was taken from homogenised tissue and blood for 
bacterial load (CFU) using the Miles and Misra method in Section 2.4.7.  
 
2.2 Processing of Mouse Tissues  
2.2.1 Isolation of Neutrophils from Bone Marrow  
 
Following Schedule 1 cull, femurs and tibias of C57BL/6J mice were removed, 
excess tissue trimmed, and stored in media (RPMI-1640, 25mM HEPES, 10%FCS) 
on ice until ready to use.  
Bone surfaces were sterilised by serially passing through four 60mm dishes 
containing 70% EtOH, then three containing ice-cold sterile PBS. Bones were finally 
transferred to a dish containing media (RPMI-1640, 25mM HEPES, 10%FCS). The 
bone marrow was exposed by cutting off the ends of the bones, and flushed out using 
a 25G needle into a new dish.  
The clumps of marrow were dispersed by carefully pipetting using a P1000 pipette. 
A 70μm cell strainer was used to filter the cell suspension before transfer into a 
50mL conical tube. Media (RPMI-1640, 25mM HEPES, 10%FCS, 2mM EDTA) was 
added to the cell suspension, and centrifuged for 7 minutes at 1400rpm. 
The supernatant was discarded, and the cell pellet resuspended in 5mL of filtered 
Red Blood Cell Lysis (1xRBC Lysis Buffer, Ebioscience) for 4-5 minutes.  Media 
(RPMI-1640, 25mM HEPES, 2%FCS) was added into the sample tube after the 
incubation and centrifuged for 7 minutes at 1400 rpm. The bone marrow sample was 
washed twice more with media before the cells were ready for neutrophil isolation.   
Some of the bone marrow cells were kept aside for comparison of neutrophil purity.  
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Three protocols were trialled or optimised in order to obtain neutrophils of 
consistently high purity: 
 
2.2.1a Percoll Density Gradient  
 
The bone marrow pellet was resuspended in 5mL media (RPMI-1640, 25mM 
HEPES, 2%FCS). Then, 5mL of 62.5% Percoll (GE Healthcare) was carefully 
layered underneath the cell suspension and centrifuged at 2300 rpm for 30 minutes at 
medium acceleration and brakes off.  
After centrifuging the cloudy interface (containing immature cells and non-
granulocytes) at the 5mL 62.5% Percoll level was removed, and the last 3mL of 
Percoll retained (containing a loose pellet of neutrophils). 
The cells were transferred into a fresh 15mL tube and washed twice with media at 
1500rpm for 5 minutes. Lastly, the pellet was re-suspended in 1mL media and 
quantified using trypan blue to determine yield and viability. 
 
2.2.1b Histopaque Density Gradient  
 
The bone marrow pellet was resuspended in 1mL media (RPMI-1640, 25mM 
HEPES, 2%FCS). 3mL of Histopaque 1119 (density, 1.119 g/mL, Sigma) was added 
into the 15mL conical tube. Next, 3mL of Histopaque 1077 (density, 1.077 g/mL, 
Sigma) was carefully overlayed on top of the Histopaque 1119. Later the bone 
marrow cell suspension was overlayed on top of Histopaque 1077. The cells were 
centrifuged at 2000 rpm for 30 minutes, 25°C, medium acceleration and brakes off. 
After centrifugation, the neutrophils at the interface of the Histopaque 1119 and 
Histopaque 1077 layers were collected.   
36 | P a g e  
Chapter 2 – Materials and Methods 
The collected neutrophils were washed twice with media and centrifuged at 1400 
rpm for 7 minutes at 4°C. Lastly, the pellet was re-suspended into 1mL media and 
quantified using trypan blue to determine yield and viability. 
 
2.2.1c MACS Neutrophil Isolation Kit (Miltenyi Biotech) 
 
The bone marrow pellet was resuspended in 200μL of media (RPMI-1640, 25mM 
HEPES, 2%FCS) per 5×10
7
 total cells and 50μL of neutrophil negative selection 
biotinylated antibody cocktail (Miltenyi) was added. After incubating for 10 minutes 
at 2−8 °C, 5-10 mL of media per 5×10
7
 cells was added for washing and centrifuged 
at 300×g for 10 minutes. The supernatant was completely aspirated. 
The cell pellet were re-suspended in 400μL media and 100μL of anti-biotin 
MicroBeads per 5×10
7
 total cells, and were mixed well before incubating for 15 
minutes in the refrigerator (2−8°C). After incubation, 5-10 mL of media per 5×10
7
 
cells were added for washing and centrifuged at 300×g for 10 minutes. The 
supernatant was completely aspirated. The pellet was re-suspended in 500μL of 
media before magnetic separation using an LS Column. 
Cell suspensions were applied to an LS Column and unlabelled (representing the 
enriched neutrophils) cells which passed through the column were collected. The 
column was washed three times with 3mL media to ensure unlabelled cells were 
flushed through. The entire unlabelled cell fraction was centrifuged at 1400 rpm for 7 
minutes. Lastly, the pellet was re-suspended in 1mL media and quantified using 
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2.2.2 Preparation of mouse lung cells  
 
Lung tissue was harvested, weighed, placed into a petri dish and then cut into smaller 
pieces using small scissors and placed into 2.5mL of media (RPMI-1640, 25mM 
HEPES, 2%FCS) containing 1mg/mL Collagenase D (to help release of immune 
cells through enzymatic digestion) and 200µg/mL of DNase I was added. Samples 
were incubated at 37°C
 
for 30 minutes in the water bath. After incubation, the 
contents of each tube were filtered through 70μm cell strainer into a 50mL centrifuge 
tube. 
The lung pieces were mashed using the plunger of a 3mL syringe and all remaining 
cells through the filter were rinsed using 5mL media. 200μL of each sample was 
taken for CFU count. Single cell suspensions were centrifuged at 1500 rpm for 5 
minutes at room temperature. After centrifugation, supernatants were discarded and 
2mL of Red cell lysis buffer was added to the pellet. Samples were mixed well and 
incubated for 2 minutes at room temperature. Immediately afterwards, 5mL of media 
was added into each tube to restore the osmotic balance for the cells.  Samples were 
centrifuged at 1500rpm for 5 minutes at room temperature and supernatant removed 
before re-suspended in 1mL media and placing on ice before staining for flow 
cytometry. 
 
2.2.3 Preparation of mouse blood  
 
Blood was collected by cardiac puncture on mice under terminal anaesthesia into 
Eppendorf tube containing heparin (5μL heparin/1mL blood). 20μL of blood from 
each Eppendorf tube was taken for CFU count by Miles and Misra method. All 
remaining cells were transferred into 50mL tubes, and 5mL of media (RPMI-1640, 
25mM HEPES, 2%FCS) added into each tube. Cell suspensions were centrifuged for 
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5 minutes, at 1500 rpm, at room temperature. Supernatants were discarded and 2mL 
of Red cell buffer lysis were added to lyse red blood cells. Samples were mixed well 
and incubated for 2 minutes at room temperature. Immediately afterwards, 5mL of 
media was added into each tube to restore the osmotic balance for the cells.  Samples 
were centrifuged at 1500rpm for 5 minutes at room temperature and supernatant 
removed before re-suspended in 1mL media and placing on ice before staining for 
flow cytometry. 
 
2.2.4 Preparation of mediastinal Lymph nodes (mLN)  
 
Each of mLN tissue was filtered through 70μm cell strainer (to eliminate clumps and 
debris) into labelled 50mL centrifuge tube. The MLN pieces were mashed using the 
plunger of a 3mL syringe and all remaining cells through the filter were rinsed using 
5mL media. Samples were centrifuged at 1500 rpm for 5 minutes at room 
temperature and supernatant removed before re-suspended in 1mL media and kept on 
ice before staining for flow cytometry. 
 
2.2.5 Preparation of living inguinal lymph node  (iLN) slices for ex vivo analysis         
of neutrophil migration 
 
Inguinal lymph nodes (iLN) were harvested from C57Bl/6J mice and kept on ice cold 
PBS. iLNs were carefully dissected to remove all connective tissues/fat and briefly 
dried before embedding in low melting point agarose (4% in PBS, Thermo Fisher) in 
Peel-A-Way embedding molds (Sigma). The molds were then put on ice for 5-10 
minutes to allow the agarose to solidify. 
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The solidified agarose blocks were trimmed to make 1.5cm
2
 blocks before mounting 
on a Vibratome (Ci Campden Intrument Ltd).  400μm slices were cut at amplitude 
1.5mm, frequency 90Hz, advance speed 0.11mm/s.  
Neutrophils were isolated as described in Section 2.2.1c, and labelled with CFSE 
dye. Briefly, cells were re-suspended in 5mM CFSE (Thermo Fisher) in PBS and 
incubated at 37°C in the water bath for 7 minutes. At the end of the incubation, 
neutrophils were washed twice in PBS+2%FCS (5 minutes, 1500rpm). Neutrophils 
(2.5x10
6
cells/25μL) were then applied to iLN slices cultured at the air-liquid 
interface on transwell supports, and incubated at 37°C in CO2 incubator for at least 2 
hours before imaging.  
iLN slices were imaged using the Zeiss LSM 880MP in the Centre for Cell Imaging 
(CCI), University of Liverpool, with the assistance of Dr. Laetitia Petit-Jentreau.  
Prior to imaging, iLN slices were washed to remove neutrophils remaining on the 
surface of the tissue (DME, 1000mg/L glucose, sodium bicarbonate, without L-
glutamine and phenol red) before being glued to cover glass. The cover glass was 
then put in the imaging chamber securely by spreading vacuum grease on the bottom. 
The sample was continuously perfused with oxygenated media, with or without 
added PLY. 15 minutes movies were recorded using the z-stack and time series 
functions in Zen Black (Zeiss). 50μm stacks were acquired at 2μm intervals, every 
minute. A W Plan-Apochromat 40x/1.0DIC objective was used, with filters 
combination of bandpass filter (emission filters) at 525nm and dichroic filters at 
490nm (excitation filters). Cells were tracked using IMARIS (Bitplane version 7.7.1) 
software using spot tracking tool. Set up experiment as Figure 9. 
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Figure 9:  Schematic set up for ex-vivo experiment 
Bone marrow and iLN were harvested. Neutrophils were isolated using MACS negative 
selection and labelled with CFSE dye. Vibratome-cut iLN slices were prepared and overlaid 
with labelled neutrophils. Sliced were incubated for 2 hours to allow neutrophils to migrate 
into the tissue. Live imaging was performed using Zeiss LSM 880MP microscope and cell 
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2.3 Flow cytometry Analysis  
Table 2: List of antibodies used for flow cytometric analysis 
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cells of whole marrow or isolated neutrophils were plated in a 
96 well U-bottom plate for staining. The plate was centrifuged at 1500 rpm for 5 
minutes and the supernatants were removed.  
 
2.3.2 Live and dead staining  
 
Live and dead stain (violet LIVE/DEAD dye, Ebioscience) was prepared by diluting 
1μL dye in 1mL PBS (no protein). 100μL of LIVE/DEAD dye was used to re-
suspend cell pellets, and incubated for 30 minutes at 4°C. After incubation, cells 
were washed twice in 100μL of media (RPMI-1640, 25mM HEPES, 2%FCS) for 5 
minutes at 1500 rpm. Cells were re-suspended in 200μL PBS (with 2%FCS) for flow 
cytometry, or further stained with specific antibodies.  
 
2.3.3 Fc-block and specific antibody staining 
  
Cells were incubated with Fc Block (anti-CD16/32, mouse/monoclonal, Ebioscience) 
for 15 minutes at 4°C. After incubation, cocktails of specific antibodies (Table 2) 
were added, and the cells incubated for a further 30 minutes. 100μL of PBS (with 
2%FCS) was topped up into each well after the incubation and plate was centrifuged 
for 5 minutes at 1500 rpm. Where biotinylated antibodies were used, further 30 
minutes incubation with Streptavidin conjugates was performed. After washing in 
PBS (with 2%FCS) for 5 minutes at 1500rpm, cells were re-suspended with 200μL 
PBS (with 2%FCS), ready for flow cytometry.  
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2.3.4 Flow cytometry analysis 
 
Flow cytometric analysis was performed using a MACS Quant analyser (Miltenyi®) 
version 2.11. Unstained and single stained samples were used to set voltages and 
perform compensation. Isotype and fluorescence minus one control (FMO) were 
used to determine gates. 
 
2.4 Preparation of bacterial stocks  
2.4.1 Growth Media 
 
Standard growth media Blood agar base(BAB) and Brain heart infusion (BHI)  were 
used during my PhD study as described in  Tabel 3. 
Table 3:  Standard media used during PhD 
Medium Procedure 
A. Blood agar base (BAB) (Sigma) 16g in 400mL dH2O  
B. Brain heart infusion (BHI) (Sigma) 14.8g in 400mL dH2O  
 
2.4.2 Blood agar base (BAB) culture plates 
 
16 grams of (A) was added to 400mL of dH2O, then autoclaved for 30 minutes at 
15psi (103kPA). Next, 20mL of sterile debrinated horse blood (Sigma) was added 
after the media has been cooled to approximately 56
o
C before pouring into sterile 




2.4.3 Blood agar base (BAB) culture plates with gentamicin (used in all murine 
in vivo experiments) 
 
Preparation as above (2.4.2) but with addition of 2ug/mL of gentamicin (Sigma), 
which was added with 20mL of horse blood to 400mL of autoclaved BAB culture 
medium and gently mixed. 
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2.4.4 Brain heart infusion (BHI) broth 
 
14.8 grams of (B) was added to 400mL of dH2O, then autoclaved for 30 minutes at 
15psi (103kPA). Medium was stored at room temperature for up to 4 weeks.  
 
2.4.5 BHI Serum broth 
 
Preparation as above (2.4.4) with small alteration. To make up 80%  v/v BHI broth 
and 20% v/v Foetal Bovine Serum (FBS), 20mL of FBS was added to 80mL of 
medium in (2.4.4). The BHI serum broth was prepared fresh for each use.  
 
2.4.6 Preparing stocks of pneumococci 
 
All bacterial stocks underwent a confirmation test to distinguish pneumococcus 
isolates from other bacteria species. These tests included: Gram stain, optochin 
(Ethylhydrocupreine hydrochloride) sensitivity, haemolytic test on blood agar plates 
and catalase tests. These were provided by a member of Aras’s Kadioglu group.  
To prepare pneumococcal stocks, laboratory bacterial bead collections of 
pneumococci were streaked onto blood agar base plates supplements with 5% v/v  
sterile defibrinated horse blood under sterile conditions and incubated invertedly  at 
37
o
C 5% CO2 overnight in a sealed jar. An optochin antibiotic disk (Oxiod) was also 
placed on the same plate to confirm pneumococci are present and no contamination 
has occurred.  
After overnight growth on BAB plates, a sweep pneumococci was transferred from 
the plate and inoculated into 10mL sterile BHI broth. The inoculated broth was 
incubated overnight for 16-18 hours at 37
o
C. The following day, cultured tubes were 
centrifuged at 3000 rpm for 15 minutes to pellet the bacteria so supernatants could be 
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discarded. Bacterial pellets were then resuspended in 1mL BHI serum borth (80%  
v/v BHI broth and 20% v/v Foetal Bovine Serum (FBS, Sigma). Into 10mL fresh 
BHI serum broth, 700μL of re-suspended bacterial pellet was added to make stock 
tubes. These stock tubes were incubated for between five and eight hours at 37
o
C. 
When stock tubes reached an OD500 >1.2 value, they were divided into 500μL single 
use aliqouts in sterile cryotubes and stored at -80
o
C.  





2.4.7 Viable counts of bacteria  
 
The viable count of bacteria was determined using the Miles and Misra method, 
bacterial numbers are shown as colony forming units (CFU) in bacterial suspension 
or homogenate.  
 
To examine the CFU of tissue homogenates, blood or in vitro culture supernatant: 
20μL of the liquid culture (e.g. blood) was added to 180μL of sterile phosphate-
buffered saline (PBS, Sigma) into sterile round-bottomed 96 well plates (Thermo 




. The dilution contents were thoroughly mixed 
before changing to next dilution and the tip were discarded after each dilution. Next 
the blood agar plates were divided into six sections and 60L (3x20L) each dilution 
was spotted and plated on each corresponding sector. BAB culture plates were then 
incubated at 37
o
C in a closed CO2 jar, overnight. 
 
Calculation of numbers of colony forming units: The grown pneumococcal colonies 
on BAB plates were counted on the dilution where between 30-100 colonies were 
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visible. The number of bacteria was determined as colony unit (CFUs) per mL, using 
the following equations: 
CFU/mL = (Total number of colonies counted in sector) x dilution factor x (1000/60)  
 
2.4.8 Preparation of D39 for neutrophil viability assay  
 
The bacterial aliquot vial from -80
o
C freezer was thawed and centrifuged at 13000 
rpm for 2 minutes. Supernatant were removed and sample were re-suspended in 
media CFU/mL dilution at 1x10
7
. Neutrophils were plated in a 24-well plate at 
1x10
6
/well. Bacteria were added at a range of MOI. Plates were incubated for 45 
minutes at 37
o
C. At the end of the incubation, neutrophil viability was assessed by 
flow cytometry as described in Section 2.3.2 and bacterial CFU was determined. 
 
2.5 Purified pneumolysin (PLY) 
 
Throughout my PhD study I also received purified PLY and PdB stocks which were 
prepared and tested for haemolytic activity by Emma Dearing and Hesham Malak 
from Aras Kadioglu’s group.  
PLY was produced in vitro by expressing the toxin on a pJW208 plasmid in MC1061 
strain Escherichia coli (E.coli) as described by Mitchell et al. (Mitchell et al. 1989). 
The toxin was then purified from sonicated cell extract supernatant using the high 
performance Affinity chromatography system (GE healthare). The PLY concentration 
was determined by Nanodrop spectrometry at 280nm, and then purified toxin was 
passed through and EndoTrap endotoxin removal column (Profos AG, Germany) three 
times to remove LPS contamination. The batches received had an activity of 2.41 x 10
4
 
Haemolytic Units (HU)/mg with a concentration of 352.5ug/mL. An endotoxin assay 
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also done to check Lipopolysaccharide (LPS) content of purified toxins using the 
Pierce
®
 LAL Chromogenic Endotoxin Quantitation Kit with the detection limit of 
0.1EU/mL (approximately 0.01ng endotoxin per mL). During this study, for in vitro 
experiments, the purified toxin had less than 0.4EU/µg of LPS. Previously published 
literature on PLY uses a concentration cut-off of <0.6 Endotoxin Units (EU)/µg 
protein). 
 
2.5.1 Toxicity Assay 
 
A series of PLY dilutions were prepared.  Toxicity assays were performed at three 
different concentration ranges: (a) from 40.8 – 1305.6 HU PLY/mL, for 45 minutes 
(b) from 0.29-40.80 HU PLY/mL, for 45 minutes, and (c) from 1.2-2.5 HU PLY/mL, 
for 45 minutes, 2 hours and 4 hours.  
Neutrophils were incubated with varying concentrations of PLY at 1x10
5
cells/well in 
a 96-well U-bottom plate. At the end of the incubation period, neutrophil viability 
was analysed by flow cytometry. 
 
2.6 In vitro Migration Assays–using Transwell® 96 well plate  




cells/mL), PLY-treated neutrophils (final concentration 1.5HU 
PLY/mL), LPS-treated neutrophils (200ng/mL final concentration), and PdB-treated 
neutrophils (165ng/mL final concentration) were prepared and kept on ice during 
plating.  
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For assays using live bacteria, neutrophils were pre-mixed with bacterial isolates at 
an MOI of 10 (Table 4). 
For analysis of the role of FES in neutrophil migration, neutrophils were treated with 
two different concentrations (1uM and 10uM) of a Fes inhibitor, Herbimysin A (sc-
3518-Santa Cruz Biotechnology) or DMSO. 
 
Table 4: List of bacterial stock strains and trigger molecules used 
Strains /Triggers  molecules Concentration 
D39 , serotype 2 2x10
7 
CFU/mL  
D39 Heat Killed, serotype 2 2x10
7 
CFU/mL  
PLN-A, serotype 2 2x10
7 
CFU/mL  
ST217, serotype 1 2x10
7 
CFU/mL  
ST306, serotype 1 2x10
7 
CFU/mL  








 96 plates (HTS Transwell-96 Permeable Support with 5.0um Pore 
Polycarbonate Membrane, Corning) have an upper and lower compartment separated 
by a porous membrane (5.0um pore size) across which the cells migrate.  
50μL (1x10
5
) neutrophils, with or without chemoattractant (KC, 100ng/mL final 
concentration) were placed into the upper compartment (Figure 10). 50μL of media 
(RPMI-1640, 25mM HEPES, 2%FCS) with or without KC (100ng/mL final 
concentration) was placed in the lower compartment. Plates were incubated at 37
o
C 
for 45 minutes and successful migration was confirmed by light microscopy. The 
number of neutrophils migrating (from upper to lower compartment) was determined 
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by counting neutrophils (count/mL) in the lower compartment using a MACS Quant 
analyser (Miltenyi®).  
 
Figure 10: Schematic of basic set up for 2D Chemotaxis Assay using 96-well Transwell 
plates 
(A) Prepare the plate (B) The neutrophils (+/- PLY) were placed into the upper 
compartment, and the chemoattractant (or media alone) placed in the lower 
compartment (C) The plate was incubated at 37
o
C for 45 minutes and (D) 
confirmation of migration was checked using light microscopy. The absolute number 
of neutrophils migrating (from upper to lower compartment) was determined by 
counting neutrophils settling in the lower compartment using a MACS Quant flow 
cytometer (count/mL). 
 
2.6.3 Transwell® Invasion Assays  
 
Collagen gels (1.5mg/mL) were prepared in 1.5mL Eppendorf tubes according to 
Table 5, and kept on ice. Rat tail Collagen was kindly provided by Mark’s Morgan 
Group (Nuffield Building, University of Liverpool). 
Table 5:  Preparation of 1.5mg/mL collagen gel for Invasion Assays 
Component Volume 
10x DMEM 





NaOH 1 M As necessary to obtain neutral pH 
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15μL of collagen gel was added into each well to evenly cover the porous membrane. 
Care was taken not to create any bubbles. Gels were solidified in a 37
o
C incubator 
for 30-45 minutes. 
150μL of media with or without KC (100ng/mL final concentration) were added on 
the lower transwell compartment after the collagen gel had solidified. Plates were 
further incubated at 37
o
C for 20 minutes to allow the chemoattractant to establish a 
gradient in the collagen gel. 50μL/1x10
5
 neutrophils treated as described in 2.6.1 
were placed into the upper compartment. Plates were incubated at 37
o
C for 2 hours.  
20μL of 0.5M EDTA was added into each of the lower compartment to detach cells 
that had migrated across the membrane, but remained attached to the underside, 
incubated for 10 minutes on ice, and gently agitated.  
The absolute number of neutrophils migrating (from upper to lower compartment) 
was determined by counting neutrophils (count/mL) in the lower compartment using 
the MACS Quant analyser (Miltenyi®). 
 
2.7 In vitro Migration Assays - 3D Chemotaxis Assay using Ibidi u-
Slide Chemotaxis Chambers 
 
Ibidi u-slide chemotaxis contains two large-volume reservoirs separated by a smaller 
reservoir into which cells embedded in a 3D collagen gel are placed. When the 
reservoir on one side is filled with chemoattractant, this will form a concentration 
gradient inside the gel, stimulating chemotaxis.  
 
Neutrophils prepared as above were embedded in rat tail collagen (1.5mg/mL) as 
described in Table 6. 
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Table 6: Preparation of 1.5mg/mL collagen gel for 3D Chemotaxis Assay using u-Slide 
Chemotaxis 
Component Volume 
Rat tail collagen (stock 7.1mg/mL) 
DMEM (10x) 
NaOH ( check pH ) 
 





as needed to adjust 




Media (RPMI-1640, 25mM HEPES, 2%FCS) with and without chemoattractant (KC, 
100ng/mL final concentration) was prepared for the assay.  
Collagen gels containing neutrophils were seeded into the central chamber of the u-
Slide 3D Chemotaxis Chamber following the manufacturer’s protocol in the 
Application Note 17 (ibdi GmbH 2016). Reservoirs on either side of the gel were 
filled with media or media containing chemoattractant. Heather Swift provided 
assistance and guidance with the set-up and execution of this assay. The schematic 
set up for this experiment is shown in Figure 11. 
 
52 | P a g e  
Chapter 2 – Materials and Methods 
 
Figure 11: Schematic set up for 3D Chemotaxis using u-Slide Chemotaxis 
Neutrophils were left untreated, or stimulated with PLY or LPS, and mixed into the collagen 
matrix. Collagen/neutrophil mixtures were loaded into the central chamber of u-slide 
chemotaxis, and allowed to solidify at 37
o
C. Media without KC was added into the C0 space, 
and before the chamber put under the microscope, buffer with KC was added into the C100 
space. Images were acquired at three stage positions per condition, at 1 minute intervals. 
Neutrophil migration in the resulting time-lapse movies was tracked using Fiji software. 
Figure adapted from (ibdi GmbH 2016). 
 
The u-slide chemotaxis chamber was placed in the incubation chamber of a 
Hamamatsu 3i spinning disk confocal microscope, and imaged using bright field and 
a 10x objective. The images were taken every 1minute for up to 8 hours.  
Neutrophil migration was manually tracked for two hours, and the cells x and y 
positions at each time-point used to quantify; speed, directionality, Euclidean 
distance and accumulated distance using Fiji ImageJ-win64. The parameters feature 
can be seen in 2D trajectory plots in Figure 12. Data were also tracked by using auto-
tracking in IMARIS x64 7.7.1 for speed.  
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Figure 12:  2D trajectory plot 
Plot shows the meaning of “i" is the index of different single cells.  
Cells were manually tracked using MTrackJ in ImageJ-win64 and using the Migration and 
Chemotaxis Tool to quantify cell migration parameters.  The cells x and y positions at each 
time-point were used to quantify; speed (um/min), euclidean distance (length of cell start and 
end point in straight line), accumulated distance (cell path taken for migration), and 
directionality/confinement index (Euclidean distance divided by Accumulated distance). 
















54 | P a g e  
Chapter 2 – Materials and Methods 
2.8 Adhesion Assay 
2.8.1 TC-treated plate (96 well flat bottom)  
 
Neutrophils were re-suspended in RPMI at 5x10
6
/mL, and labelled with 5uM calcein 
AM (Vybrant
TM
 Cell Adhesion Kit [V-131810]-Molecular Probes) for 30 minutes at 
37
o
C before being washed twice with pre-warmed RPMI. Neutrophils were re-
suspended at 5x10
6
/mL and left untreated or treated with 1.5HU PLY/mL, 200ng/mL 
LPS, or 165ng/mL PdB. 
5x10
5
 (100μL) neutrophils were then added to each well of a 96-well plate. Each 
condition was performed in triplicate. Plates were incubated at 37
o
C for 45 minutes, 
2 hours or 4 hours. Non-adherent calcein-labelled cells were carefully removed by 
washing with pre-warmed RPMI. The washing steps were repeated four times and 
after the final wash, 200μL of PBS was added into each well. Sample fluorescence 
was measured using a Fluorescein filter set (494-517nm) on a Tecan Analyser.  
 
2.8.2 Non-treated plated (96 well flat bottom) 
 
96-well flat-bottom plates were pre-coated with 40μL bovine fibronectin (Thermo 
Scientific) at a concentration of 25ug/mL. Plated were incubated for 1 hour at 37
o
C 
or overnight at 4
o
C. Plates were washed three times with 200μL PBS. Plates were 
then blocked with blocking solution (PBS with 1% FCS) for 1 hour at room 
temperature and then washed three times with PBS. Adhesion assays were performed 
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2.9 Immunofluorescent Staining of F-actin and Grancalcin 
 
Sterilised glass coverslips (round, 13mm, No1.5, VWR) were placed in 24-well flat 
bottom plates. Coverslips were submerged in 0.01% Poly-L-lysine (Sigma), and left 
overnight at 4
o
C. Coated glass coverslips were washed twice with pre-warmed 
PBS
+Ca/Mg
 without touching the glass. Neutrophils (1x10
6 
cells/mL), PLY-treated 
neutrophils (final concentration, 1.5HU PLY/mL), LPS-treated neutrophils 
(200ng/mL final concentration), and PdB-treated neutrophils (165ng/mL final 
concentration) were applied to the coated glass coverslips, and incubated for 
45minutes at 37
o
C. After incubation, media was gently aspirated and the glass 
coverslips washed gently with pre-warmed PBS
+Ca/Mg
. Adhered cells on the 
coverslips were checked with the light microscope. The adhered cells were fixed by 
adding 4% paraformaldehyde/PFA (Pierce™16% Formaldehyde(w/v), Methanol-
free, Thermo Fisher scientific) 400μL/well for 30 minutes at room temperature. After 
fixation, coverslips were washed twice with PBS, submerged in PBS, and left at 4
o
C 
in the fridge overnight.  
 
For F-actin staining, neutrophils were stained with Rhodamine-Phalloidin (1:250, 
Life Technologies) and DAPI (2 drops/mL, NucBlue@Fixed Cell Ready Probe-
Thermofisher Scientific) in 1% Triton X-100 with 10% FCS. Samples were 
incubated for 1 hour at room temperature, before being washed gently three times for 
5 minutes each with PBS. Glass coverslips were air-dried and mounted onto glass 
slides using Aquamount (VWR). 
 
For Grancalcin staining, neutrophils were incubated in blocking solution (10% 
normal goat serum with 1% Triton x-100) for 1 hour on a rocker. Neutrophils were 
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then stained with anti-Grancalcin (1:200 in blocking solution) for 1 hour on a rocker. 
After 1 hour of incubation samples were carefully washed with PBS 3 times, with 3 
minutes gap between each wash. Neutrophils were then incubated with goat anti-
mouse-A647 (1:200), Rhodamine-phalloidin (1:250) and DAPI (2 drops per mL) in 
wash buffer (PBS, 1% FCS with 0.1% Triton x-100) for 1 hour. Neutrophils were 
carefully washed with PBS 3 times with a 3 minutes gap between each wash. 
Coverslips were air-dried and mounted onto glass slides using Aquamount (VWR).   
 
Stained neutrophils were imaged on one of two confocal microscopes in the Centre 
for Cell Imaging: 
1) Zeiss BioAFM880 using alpha Plan-Apochromat, 100x/1.46 oil DICM27 
objective and 405nm (DAPI), 561nm (Rhodamine) laser lines. 
2) Zeiss LSM780 using alpha Plan-Fluar, 100x/1.45oil objective and 405nm (DAPI), 
561nm (Rhodamine) laser lines. 
 
 Images were further analysed using IMARIS (Bitplane version 7.7.1) software to 
obtain intensity mean of fluorescent actin, sphericity of neutrophils, and volume 
(um
3
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 2.10 Label-free sample preparation of neutrophils for quantitative 
proteomics  
 
2.10.1 Sample preparation  
 
Bone marrow and neutrophil isolation steps were performed as described previously 
in Section 2.2.1c. Three independent experiments were performed, with bone 
marrow from four mice pooled for each experiment.  
Neutrophils were plated alone, or with PLY or LPS and incubated at 37
o
C for 4 
hours in a 12 well flat bottom plate. After incubation, cells in suspension were 
harvested, and cells attached to the plastic wells were carefully scraped before being 
transferred into a 15mL conical tube. Small amounts of cell suspensions (100µL) 
were kept aside before and after incubation for FACS analyses of neutrophil purity 
and CD11b expression (Figure 13). 
The remaining cell suspensions were centrifuged down at 1500 rpm for 5 minutes, 
and the supernatants were discarded. Pellets were then washed twice with PBS, and 
all the buffer were aspirated entirely from the sample. Sample pellets were 
immediately frozen on dry ice and stored at -20
o
C for further proteomic analysis. 
Proteomic work and data analysis were performed by Dr. Stuart Armstrong, at the 
Infection Biology Department, University of Liverpool UK. Sample preparation for 
mass spectrometry and analysis was adapted from (Dong et al. 2017). 
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Figure 13: Schematic of Proteomic experimental 
Bone marrow was harvested from four mice (expected neutrophil yield around 1.5 - 2 x 10
7
 
cells, sufficient for proteomic and FACS analysis). Cells underwent neutrophil isolation 
protocol as described Section 2.2.1c. Neutrophils were plated alone, or with PLY or LPS and 
incubated at 37
o
C for 4 hours. After incubation, cells were transferred into tubes, and 
aliquots withdrawn for FACS. Live/Dead Staining, CD11b expression and purity were 
assessed. Remaining cells were washed twice in PBS. All remaining serum was completely 
removed and samples immediately frozen. All subsequent proteomic analysis steps were 
performed by Dr Stuart Armstrong from Department of Infection Biology, IGH. 
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2.10.2 Homogenisation and protein digestion 
 
Neutrophils, PLY-treated neutrophils, and LPS-treated neutrophils (in triplicate for 
each condition, n=9) each contained an average of 3.37 x10
7
 neutrophils. Samples 
were lysed in 0.1% (w/v) RapiGest (Waters) in 50mM ammonium bicarbonate. 
Following that, 3 cycles of sonication on ice (Vibra-cell 130PB sonicator) at 20Hz 
using a microprobe with alternating 30 seconds incubation on ice and 10 seconds 
sonication was performed. Next, all samples were centrifuged at 13,000 x g for 10 
minutes at 4°C and the supernatants were transferred to Eppendorf tube and stored  at 
-80°C until use. Protein Assay Kit assay by Pierce Coomassie Plus (Bradford) 
(Thermo Scientific) was used to measure total protein concentration and protein 
content for each sample was normalised to 100ug.  
Samples were heated at 80°C for 10 minutes and reduced with 10µl of 9.2mg/ml 
dithiothreitol (3mM final concentration (Sigma)) for 10 minutes at 60°C. Alkylation 
of the sample was performed by adding 10µl of 33mg/ml of iodoacetimde (9mM 
final concentration (Sigma)) and incubating at room temperature for 30 minutes in 
the dark. All these steps were performed with intermittent vortex-mixing. Proteomic-
grade trypsin (Sigma) was added at 50:1 of protein:trypsin ratio and samples were 
incubated for overnight at 37°C. RapiGest was removed by adding Trifluoroacetic 
acid (TFA) to a final concentration of 0.5% (v/v) and the digest incubated for 45 
minutes at 37°C. Finally, the peptide samples were centrifuged for 15 minutes at 
13000 x g to remove precipitates. The supernatant were collected for subsequent 
mass spectrometric analysis (LC-MS/MS). 
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2.10.3 NanoLC MS ESI MS/MS analysis 
 
In this experiment, we were using on-line nanoflow LC using the Ultimate 3000 
nano system (Dionex/Thermo Fisher Scientific) for peptide analyses. 1µg of samples 
were loaded onto a trap column (Acclaim PepMap 100, 2cm × 75μm inner diameter, 
C18, 3μm, 100 Å) at 9μL/min with an aqueous solution containing 0.1% (v/v) TFA 
and 2% (v/v) acetonitrile. After 3 minutes, the trap column was set in-line with an 
analytical column (Easy-Spray PepMap® RSLC 50 cm × 75 μm inner diameter, C18, 
2μm, 100 Å) fused to a silica nano-electrospray emitter (Dionex). The on-line 
nanoflow LC system was coupled to a Q-Exactive mass spectrometer (Thermo Fisher 
Scientific), and the trap column run at a constant temperature of 35°C. 
Chromatography was performed using a buffer system consisting of 0.1% formic 
acid (buffer A) and 80% acetonitrile in 0.1% formic acid (buffer B) and a linear 
gradient of 3.8 – 50% buffer B over 90 minutes at a flow rate of 300 nl/min was used 
to separate the peptides. The Q-Exactive mass spectrometer was run in data-
dependent mode with survey scans acquired at a resolution of 70,000 at 200 m/z, 
with a scan range between 300 to 2000 m/z. Up to the 10 most abundant isotope 
patterns from the survey scan with charge states from +2 to +5 were picked with an 
isolation window of 2.0Thand fragmented by higher energy collisional dissociation 
with normalised collision energies of 30. The ion target value was set at 1E6 for 
survey scans and 1E4 for the MS/MS scans and maximum ion injection times were 
250nm for the survey scan and 50ms for MS/MS scans. Acquisition was at a 
resolution of 17,500 for MS/MS events. The dynamic exclusion of the sequenced 
peptides for 20s was applied to minimize repetitive sequencing of peptides. 
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2.10.4 Protein Identification and Quantification  
 
Thermo RAW files were imported into Progenesis LC–MS (version 4.1, Nonlinear 
Dynamics) for data analysis. Runs were aligned using default settings and the 
reference run automatically selected by the software. Only peaks with a charge state 
between +2 and +7 were chosen by the software using default settings. The reference 
run was used to normalise the peptide intensities and to highlight differences in 
protein expression between control and treated samples with supporting statistical 
analysis (ANOVA p-values). Spectral data were converted to .mgf files and exported 
to the Mascot (version 2.3.02, Matrix Science) search engine for peptide 
identification. Tandem MS data were searched against a database comprising; 
translated ORFs from the Mouse genome (Uniprot, Feb 2015), a background bovine 
genome (Uniprot, Feb 2015) and a contaminant database (cRAP, GPMDB, 2012) 
(combined 25513 sequences; 12610778 residues). The search parameters for this 
experiment were: 10 ppm for precursor mass tolerance, 0.01 Da for fragment mass 
tolerance, two missed tryptic cleavages and fixed modification for 
Carbamidomethylation (cysteine) and variable modification for oxidation 
(methionine). In addition to this, the machine learning algorithm Percolator 
embedded within Mascot was used to validate the search results. The false discovery 
rate was <1%, while individual percolator ion scores >13 indicated identity or 
extensive homology (p <0.05) were utilised in the Mascot decoy database function 
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2.10.5 Software used for data analysis  
 
Analysis was performed using free online software with default settings during 
searches.   The programmes used were: 
STRING Database Version 10.5: This tool was used for assessing protein-protein 
interactions based on physical and functional interactions between the expressed  
proteins,  which can give meaning biologically for their cellular function (Szklarczyk 
et al. 2017). In our sample we were using this tool to understand how proteins 
upregulated in PLY-treated neutrophils influenced neutrophil functions such as 
migration.  
 DAVID Bioinformatics Resources 6.8: This tool was using to understand biological 
meaning from large gene/protein  where  the information extracted systematically 
from set samples (Huang et al. 2009a; Huang et al. 2009b). Using this, we performed 
a functional annotation of proteins identified by pairwise analysis as being 
significantly changed in PLY-treated, but not LPS-treated, neutrophils. 
Panther Classification System Version 13.1: Panther (Proteins Analysis Through 
Evolutionary Relationship) of gene families and annotated as; family and sub-family, 
protein class (biological process, molecular function and cellular component) and 
gene function (Mi et al. 2013; Thomas et al. 2003). We used this classification 
system to characterise the identified proteins according to biological process in our 
extracted neutrophils compared to mouse proteome. 
Morpheus, https://software.broadinstitute.org/morpheus: This interactive tool the see 
the protein cluster display as a heat map base on intensity value in our dataset.  
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Venny 2.1.0 (Oliveros, J.C (2007 -2015) Venny, an interactive tool for comparing 
with Venn Diagram. http//bioinfogp.cnb.csic.es/tools/venny/index. html.): Using this 
tool we are able to visual the common share and unique protein identified across our 
samples in Venn diagrams. 
 
2.11 Immunoblotting (Western Blotting (WB))  
 
Neutrophil isolation steps were carried out as described earlier. Samples (neutrophil 
and neutrophil treated with 1.5HU/mL PLY) were prepared by incubating for 45 
minutes at 37°C. Samples were centrifuged at 1500 rpm for 5 minutes and the 
supernatant removed. Each sample was mixed with lysis buffer (equivalent with 
pellet) and sonicated for 5 seconds and incubated for 10 minutes at 95°C to obtain 
neutrophil lysate. Samples were stored at -80°C until use. 
 
10μL sample lysate and 8μL of Spectra
TM 
Multicolour Broad Range Protein 
Ladder(26634, Thermofisher) were loaded onto 12% SDS/acrylamide-separating gel 
(5mL of 1.5M Tris pH 8.8, 30% acrylamide (Acrylamide/Bis-acrylamide, 30% 
solution A3699-100mL, Sigma), dH20, 20% SDS, 10%APS and N,N,N’,N’-
Tetramethylethylenediamine (TEMED, Sigma, T9281-25mL) and a 5% stacking 
(0.5M Tris pH6.8, 30% acrylamide, H2O, 20% SDS, 10% APS and TEMED), and 
run in electrophoresis buffer at 60V, 200mA and 100W for 1:30 hour, the at 200V, 
200mA for 1 hour till the end of running. 
The protein was electrophoresed and blotted onto a nitrocellulose membrane 
(Immobilon-P Transfer Membrane, IVPH00010, Merck) in cold conditions and run 
at 200V, 350mA, and 100W for 1:15 hour in transfer buffer. Then, membranes were 
blocked in 5% skim milk/TBS-T (0.1% Tween 20, 5g NaCl, 20mL of Tris-HCL) 
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overnight with shaking at 4°C. The membranes were incubated with primary 
antibody (Table 7) for 2 hours on the shaking rotor at room temperature, after 
washing with TBS-T with shaking followed by incubation with conjugated 
secondary antibody (Table 8) for 1 hour. 
 The membrane was washed and processed for detection by chemiluminescence 
(ECL) reagents (Clarity
TM
 Western ECL Substrate, 200mL #1705060, BioRad) and 
developed in ChemiDoc
TM
 touch Imaging Systems (Bio-Rad,1708370). 
 
Table 7: List of primary antibodies used in Western Blotting 
Primary Antibodies / Supplier Source/Application 
Fes (E-1) : sc-166371 
(Santa Cruz Biotechnology, Inc) 
Mouse monoclonal of human origin. 
Detection - Fes of mouse , rat and human 
origin 
Grancalcin (H-11) : sc-393681 
(Santa Cruz Biotechnology, Inc) 
Mouse monoclonal of mouse origin. 
Detection - Grancalcin on mouse. 
Csk (B-7): sc-166513 
(Santa Cruz Biotechnology, Inc) 
Mouse monoclonal of human origin. 
Detection – Csk of mouse, rat and human 
origin 
FGD3 (A-3) : sc-390256 
(Santa Cruz Biotechnology, Inc) 
Mouse monoclonal of mouse origin 




Loading Control Monoclonal antibody 
 
 
Table 8: Secondary antibody used in Western Blotting 
Control  Antibodies / Supplier Application 
Goat anti-mouse IgG 
(A44d16/Sigma)  
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2.12 Statistical Analyses 
 
All statistical data were analysed using GraphPad Prism 7.0 unless stated. Results 
were analysed by one-way and two-way analysis of variance (ANOVA) followed by 
Tukey’s multiple comparison tests to identify significant difference between 
individual groups. Probability (p) value <0.05 were considered statistically 
significant. Statistically significant differences in this work are indicated by 
*(p<0.05), ** (p<0.01), *** (p<0.001), **** (p<0.0001). 
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Chapter 3: Streptococcus pneumoniae and its toxin, 
pneumolysin, inhibit neutrophil chemotaxis in two and 
three dimensional assays. 
 
3.1 Brief Introduction  
 
Neutrophils are the most abundant white blood cells in circulation, and play a crucial 
role in immune responses to pathogens during infection. To defend the host, they 
must migrate from the blood into the tissue through a multistep process, and then 
onwards through the tissue interstitium (Artemenko et al. 2011).  
Neutrophil migration can occur in four main forms: random migration, 
chemokinesis, chemotaxis, and haptotaxis. Chemotaxis and haptotaxis are 
directional, and occur along a soluble (chemotaxis) or substrate-bound (haptotaxis) 
gradient of chemoattractant. Meanwhile, random migration and chemokinesis are 
non-directional. Chemokinesis occurs in the presence of a uniformly applied 
stimulus, and random migration occurs without stimuli (Martin et al. 2015). 
Extravasation of neutrophils from blood capillaries is a multistep process which is 
initiated by tethering and rolling of the neutrophil, followed by slow rolling, 
activation of integrins, shear resistant arrest, crawling, diapedesis and, finally, 
migration across the epithelium and basement membrane (Lyck & Enzmann 2015). 
The neutrophil then migrates through the tissue interstitium to the site of infection, in 
response to chemoattractants. Extravasation is induced by chemokines and has been 
shown to be integrin dependent, however migration through the tissue is still poorly 
understood and may be either integrin dependent or independent. It is widely 
accepted that leukocyte migration on 2D surfaces requires adhesive forces (integrin-
dependent), while migration in 3D environments largely depends on cytoskeletal 
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deformability rather than adhesion (integrin-independent). In vivo studies confirm the 
integrin-independence of leukocyte interstitial migration (Weninger et al. 2014; 
Lämmermann & Sixt 2009; Lämmermann et al. 2008). However, in vitro studies 
show that dendritic cells (DCs) can rapidly adjust their migration mechanisms by 
switching from adhesive (integrin-dependent) to non-adhesive (integrin-independent) 
modes, allowing maintenance of cell speed and amoeboid migration across different 
surfaces (Renkawitz et al. 2009). Similarly, in a model of sterile tissue damage, 
neutrophils switch from integrin-independent to integin-dependent migration at the 
boundary of the tissue interstitium and wound site (Lämmermann & Germain 2014). 
Furthermore, integrins and their regulatory proteins have been shown to play a role 
in facilitating chemotaxis of neutrophils in 3D environments. Efficient directed 
migration within 3D matrix has been shown needed both integrin regulatory protein 
talin-1 and RIAM for proper cell polarization toward chemoattractant gradient 
stimuli (Yamahashi et al. 2015).  In lymph nodes, neutrophil migration mostly used a 
chemotactic mechanism involving phosphatidylinositde 3-kinase signalling and 
leukotriene B4, but migration was not totally integrin independent. This indicated that 
neutrophil phenotype and behaviour is environment dependent, and indicate the 
complexity of neutrophils migration mechanisms (Sawtell 2015).  
Pathogens such as Streptococcus pneumoniae or Staphylococcus aureus may 
manipulate neutrophil migration and function to avoid being killed by host cells. S. 
pneumoniae  itself has many virulence factors such as  its toxin pneumolysin (PLY) 
which has been shown in early studies to have the capability to inhibit neutrophil 
migration (Paton & Ferrante 1983). Likewise, Staphylococcus aureus has developed 
strategies to avoid neutrophil killing by secreting molecules that resist or fight back 
against neutrophil attack at the site of infection. For example, during extravasation 
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neutrophil rolling on endothelial cells can be inhibited when staphylococcal 
superantigen-like 5 (SSL5) blocks PSGL-1 interaction with  P-selectin and E-selectin 
on the neutrophil surface (Spaan et al. 2013).  
The interactions between neutrophils and PLY are complex (Johnson, Boese-
Marrazzo, & Pierce, 1981). Neutrophils exposed to pneumolysin have enhanced 
production of superoxide and neutrophil elastase, increased expression of 
CD11b/CD18, and membrane depolarization (Cockeran, Theron, et al. 2001). 
Increased cell surface expression of CD18 on neutrophils  leads to  neutrophil 
adhesion to alveolar epithelial cells (Smith et al. 1998). Using human 
polymorphonuclear neutrophils (PMNs) from healthy volunteers, Johnson et al 
showed that pre-treatment with PLY at sub-lytic concentrations inhibited neutrophil 
chemotaxis and random migration. Similarly, Paton & Ferrante described significant 
inhibition of chemotaxis following treatment of human PMNs with PLY (Paton & 
Ferrante 1983). When PLY was used as a chemoattractant, PMN migration was 
initially enhanced, but then inhibited as the cells migrated up the gradient (Johnson et 
al. 1981). However, it is not clear if the chemoattractive effects of PLY compete with 
host chemokines, potentially explaining the impaired chemotaxis observed in 
neutrophils pre-treated with PLY. 
Another in vitro study was done to examine the effects of serotype 2 (strain D39) S. 
pneumoniae and its pneumolysin-deficient mutant (PLN-A) on PMN migration 
across a monolayer of human pulmonary microvascular endothelial cells. They found 
that neutrophil migration was decreased in the presence of PLN-A, indicating that 
PLY promotes neutrophil endothethial transmigration (Moreland & Bailey 2006). 
Meanwhile, in vivo studies have found that treatment with PLY, but not its non- lytic 
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derivative, PdB, directly resulted in increased lung vascular permeability, which may 
lead to enhance neutrophil migration into the infected lung (Maus et al. 2004). 
This chapter, aims to provide valuable insight into how pneumolysin (PLY) may 
affect neutrophil chemotaxis using purified murine bone marrow neutrophils. Both 2-
D and 3-D in vitro chemotaxis assays were used to assess the effect of PLY on 
neutrophil migration. In addition these models were used to examine whether 
migration was an integrin dependent or independent process. Neutrophil migration 
within tissues and how the neutrophils and toxin interact in tissue microenvironments 
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3.2 Results   
3.2.1 Optimisation of Neutrophil Purification from Murine Bone Marrow 
 
To study the effects of S. pneumoniae and PLY on neutrophil migration, a highly 
pure population of neutrophils was required. Three isolation methods were 
compared: Percoll density gradient centrifugation, Histopaque density gradient 
centrifucaton, and negative selection by magnetic-activated cell sorting (MACS). 
The detailed protocols are mentioned in Chapter 2. The purity of the isolated 
neutrophil fraction was assessed by flow cytometry, with cells double positive for 
both CD11b and Ly6G considered to be neutrophils. Viability of the cells was 
determined by trypan-blue exclusion. 
Percoll Density Gradient Centrifugation was the first isolation method attempted. 
Briefly, bone marrow was resuspended in 5mL media. Next, 5mL of 62.5% Percoll 
was carefully layered underneath the cell suspension and centrifuged at 2300 rpm for 
30 minutes. The cloudy interface (containing immature cells and non-granulocytes) 
was removed and the last 3mL of Percoll (containing a loose pellet of neutrophils) 




 cells /mouse were isolated, of 




, and 94.1 + 2.8% were viable (Figure 14), 
with n=7 independent experiments. Altering the media, FCS concentration, and 
centrifugation speed did not improve purity (data not shown). 
The next isolation method attempted was Histopaque Density Gradient Separation 
(Histopaque 1119 and 1077). Briefly, bone marrow was resuspended in 1mL media. 
3mL of Histopaque 1077 (density, 1.077 g/mL) was carefully overlayed on top of 
3mL of Histopaque 1119 (density, 1.119 g/mL). The bone marrow cell suspension 
was then overlayed on top of the Histopaque 1077. The sample was centrifuged at 
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2000 rpm for 30 minutes, and the neutrophils at the interface of the Histopaque 1119 









, and 93.5 + 
3.3% were viable (Figure 15), with n=12 independent experiments.    
As neither protocol achieved sufficiently high purity, neutrophils were next isolated 
by negative selection using MACS. Briefly, bone marrow was labelled with a 
cocktail of antibodies to non-target (or unwanted) cells, which were removed from 
the mixture by retention in the MACS column. Meanwhile, the unlabelled 
neutrophils will run through the column and be collected. Using this method, 5.3x 
10
6 





96.8 + 1.8% were viable (Figure 16), with n=12 independent experiments. 
  
MACS isolation was superior to the Percoll Density Gradient Centrifugation and 
Histopaque Density Gradient. As this method consistently yielded high purity 
neutrophils, it was used for all future experiments. 
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Figure 14: Optimisation of Neutrophil Purification from Murine Bone Marrow using 
Percoll Density Gradient 
Flow cytometry analysis of whole marrow and purified neutrophils using Percoll Density 
Gradient The plots on the left show discrimination of live cells based on forward and side 
scatter, the middle plots show discrimination of single cells from doublets, and the right 
plots show percentage of cells stained with both CD11b and Ly6G in top right quadrant 






73 | P a g e  
Chapter 3 - Chemotaxis 
 
Figure 15: Optimisation of Neutrophil Purification from Murine Bone Marrow using 
Histopaque Density Gradient 
Flow cytometry analysis of whole marrow and purified neutrophils using Histopaque 
Density Gradient. The plots on the left show discrimination of live cells based on forward 
and side scatter, the middle plots show discrimination of single cells from doublets, and the 
right plots show percentage of cells stained with both CD11b and Ly6G in top right 
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Figure 16: Optimisation of Neutrophil Purification from Murine Bone Marrow using 
MACS Neutrophil Isolation Kit 
Flow cytometry analysis of whole marrow and purified neutrophils using MACS Neutrophil 
Isolation kit. The plots on the left show discrimination of live cells based on forward and 
side scatter, the middle plots show discrimination of single cells from doublets, and the 
right plots show percentage of cells stained with both CD11b and Ly6G in top right 
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3.2.2 Determination of a non-cytolytic, but biologically active, concentration of 
PLY  
 
To assess the effect of PLY on neutrophil chemotaxis, we needed to determine the 
concentration of PLY that would produce a biological effect on neutrophils, but not 
cause significant cell death (sub-lytic). If cell death occurs, it will be impossible to 
determine if the toxin has a specific effect on neutrophil chemotaxis beyond general 
effects on cell viability. Throughout this thesis, purified PLY was provided by Aras 
Kadioglu’s Group.  
For each assay, freshly isolated neutrophils were treated with a range of concentrations 
of PLY, between 45 minutes and 4 hours. At the end of the incubation period, 
neutrophil viability was assessed by flow cytometry using a LIVE/DEAD fluorescent 
dye. We also assessed the ability of PLY to increase expression of CD11b (integrin 
αM) on neutrophils, to ensure that low, sub-lytic concentrations were still altering cell 
phenotype. Previous studies have shown that PLY increases expression of CD11b on 
neutrophils (Williams et al. 2003). 
 For the first experiment, a concentration range from 40.8 – 1305.6 haemolytic units 
(HU) PLY/mL was used (Figure 17A). At all concentrations, the toxin killed a high 
proportion of the neutrophils, as evidenced by uptake of the LIVE/DEAD dye (Figure 
18). On the few remaining cells, the mean fluorescence intensity (MFI) of CD11b 
decreased dramatically relative to untreated cells. (Figure 17B) CD11b levels are 
expressed as a ratio of the MFI on PLY-treated neutrophils, relative to untreated 
controls.  
For the next experiment, a concentration range between 0.29 – 40.80 HU PLY/mL was 
selected (Figure 17C and Figure 19). We observed good viability at PLY 
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concentrations of <3 HU/mL. However, neutrophil viability began to decrease at PLY 
concentrations of >5 HU/mL (Figure 17C). Surface expression of CD11b also 
increased at PLY concentrations of between 1.16 HU/mL and 5.73 HU/mL, but 
declined dramatically when cell viability was lost at higher concentrations (Figure 17 
D).  
From this experiment, it was determined that neutrophils stimulated for 45 minutes 
with PLY at a concentration range of 1.16 to 2.83 HU/mL were viable and showed 
increased surface expression of CD11b. To provide final confirmation that this 
concentration range was suitable for all of the assays performed in this chapter, 
neutrophil viability was next assessed for up to 4 hours following treatment with PLY. 
This assay was performed at an optimal concentration range of 1.2 – 2.5 HU/mL 
(Figure 17E). More than 95% of neutrophils remained viable for the duration of the 
experiment (Figure 20) and the expression of CD11b (Figure 21) was also elevated at 
all time points.  
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Figure 17: Determination of a non-cytolytic, but biologically active, concentration of 
PLY 
Neutrophils were incubated with the indicated concentrations of PLY and stained with 
live/dead dye and antibody to CD11b before analysis by flow cytometry. The left column (A, 
C, E) Graphs depict flow cytometric analysis of neutrophil viability following stimulation 
with PLY. (B, D, F) Flow cytometric analysis of CD11b on PLY pre-treated neutrophils. 
CD11b levels are expressed as a ratio of the MFI on PLY-treated neutrophils, relative to 
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Figure 18:  Representative flow cytometry plots for analysis of cell viability in Figure 
17 (A) 
Neutrophils were treated for 45 minutes with the indicated concentrations of PLY, followed 
by staining with a Live/dead dye (A) Flow cytometric analysis of untreated control 
neutrophils. (B) Flow cytometric analysis of neutrophils treated with 40.8 HU PLY/mL. 
Values in red are the percentage of live cells. 
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Figure 19:  Representative flow cytometry plots for analysis of cell viability in Figure 
17 (C) 
Neutrophils were treated for 45 minutes with the indicated concentrations of PLY, 
followed by staining with a Live/dead dye (A) Flow cytometric analysis of untreated control 
neutrophils. (B) Flow cytometric analysis of neutrophils treated with 1.16 HU PLY/mL. (C) 
Flow cytometric analysis of neutrophils treated with 40.8 HU PLY/mL. Values in red are the 
percentage of live cells. 
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Figure 20: Representative flow cytometry plots for analysis of cell viability in 17(E) 
Neutrophils were treated for 45 minutes, 2 and 4 hours with 1.5 HU/mL PLY concentration 
of PLY, followed by staining with a  fluorescent LIVE/DEAD dye (A) Flow cytometric 
analysis of untreated control neutrophils. (B-D) Flow cytometric analysis of neutrophils 
treated with 1.5HU PLY/mL on three different time points (45 minutes, 2 and 4 hours). 
Values in red are the percentage of live cells. 
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Figure 21: Representative flow cytometry histograms for analysis of CD11b expression 
on neutrophils treated with PLY in Figure 17(F) 
Neutrophils were treated for 45 minutes, 2 and 4 hours with 1.5 HU/mL PLY, followed by 
staining with a Live/dead dye and an antibody to CD11b. The [purple] peak shows 
fluorescent intensity of unstained control cells. The [orange] peak shows CD11b staining on 
untreated neutrophils. The [green] peak shows CD11b staining on neutrophils treated with 
1.5HU PLY/mL (A) Flow cytometric analysis of untreated control neutrophils. (B-D) Flow 
cytometric analysis of neutrophils treated with 1.5 HU PLY/mL for three different time 
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3.2.3 Neutrophils are more resistant to PLY-mediated cell death than whole 
bone marrow  
 
Bone marrow derived cells and purified bone marrow neutrophils were treated with 
increasing concentrations of PLY (0.2 – 10 HU/mL), stained with a fluorescent 
live/dead dye, and analysed by flow cytometry. Interestingly, we found out that 
whole bone marrow was notably more susceptible to PLY-induced cell death than 
purified neutrophils (Figure 22). Flow cytometric analysis showed that the remaining 
cells were predominantly B cells (CD45R
+
) and T cells (CD3
+
), suggesting that 
lymphocytes are more sensitive to PLY than neutrophils (Figure 23).  
 
Figure 22: Neutrophils are more resistant to PLY-mediated cell death than whole bone 
marrow 
Whole bone marrow and purified neutrophils were treated for 30 minutes with the indicated 
concentrations of PLY, before being stained with a fluorescent LIVE/DEAD dye and 
analysed by flow cytometry. Graph depicts the percentage of live cells. 
 
83 | P a g e  
Chapter 3 - Chemotaxis 
 
Figure 23: Representative flow cytometry plots for analysis of CD3 and CD45R 
expression on neutrophil and whole bone marrow treated PLY in Figure 22 
Flow cytometry analysis of whole marrow and purified neutrophils using MACS Neutrophil 
Isolation kit. (A)Whole bone marrow and (B) Isolated neutrophils; From left to right, plots 
show discrimination of live cells based on forward and side scatter and next discrimination of  
live cells based on fluorescent LIVE/DEAD dye staining, percentage of cells stained with 
CD45R
+
 (for B cells) and percentage of cells stained with CD3
+
 (for T cells). Data are from a 
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3.2.4 Optimisation of neutrophil transwell chemotaxis assay  
 
The effect of PLY on neutrophil migration was first assessed using a basic transwell 
chemotaxis assay, which essentially models cell migration in 2D. Transwell® plates 
consist of a lower and an upper compartment separated by a porous membrane. Cells 
are plated in the upper compartment and the lower compartment is filled with media 
containing a neutrophil chemoattractant (KC). Next, cells are left to migrate for an 
appropriate time. The absolute number of cells migrating (from upper to lower 
compartment) through the Transwell® membrane is then determined by counting 
cells settling in the lower compartment. 
  
To optimise this assay, we tested varying concentrations of the neutrophil 
chemoattractant, KC, and varying concentrations of FCS, in order to find a 
combination that produced high levels of neutrophil chemoattraction through the 
transwell, when compared to control wells lacking chemokine. 1x10
5 
cells 
neutrophils were added to the upper compartment, and 150μL of media (with or 
without KC) added to the lower compartment of a 96-well Transwell® plate. 
Migration was checked after 30 minutes using a light microscope, and the total 
number of neutrophils that had migrated to the lower compartment was counted 
using a MACS Quant Analyser. In the absence of FCS, cell migration toward 
1μg/mL KC was twice that of the observed migration toward 100ng/mL KC. There 
was essentially no difference between the two chemokine concentrations on other 
conditions. In the presence of FCS, neutrophil chemotaxis increased above 
background levels but again there was no difference between the two chemokine 
concentrations (Figure 24). Therefore, 2% FCS, with 100ng/mL KC was used for all 
future experiments.  
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Figure 24: Optimisation of neutrophil Transwell chemotaxis assay 
The neutrophils were placed into the upper compartment of 96-wells Transwell® plate. 
Chemoattractant (KC; 100ng/mL and 1μg/mL) was placed in the lower compartment to 
establish a gradient, or in both compartments to provide uniform stimulation of the cells. 
RPMI-1640 with three different percentages of FCS (0%, 0.5% and 2%) was utilised as 
indicated. The plate was incubated at 37°C for 30 minutes. The absolute number of 
neutrophils migrating (from upper to lower compartment) through Transwell®  membrane 
was determined by counting neutrophils settling in the lower compartment using a MACS 
Quant Analyser. Graph depicts the total number of neutrophils migrating into the lower 
compartment for each condition. Data are from single experiment. 
 
 
3.2.5 PLY inhibits neutrophil chemotaxis in a 2D Transwell Chemotaxis Assay 
 
The optimised Transwell chemotaxis assay was used to assess the effect of PLY on 
neutrophil chemotaxis to KC. PLY significantly inhibited neutrophil chemotaxis 
towards KC, when compared to untreated control cells (Figure 25). PdB, a toxoid form 
of PLY mutant with dramatically reduced haemolytic activity, had no effect on 
neutrophil chemotaxis, suggesting that the pore forming function of the toxin is 
required for inhibition of neutrophil chemotaxis (Figure 25A). In some experiments, 
neutrophils were treated with LPS as an additional control. LPS also had no effect on 
neutrophil chemotaxis, indicating that any remaining LPS contamination in the PLY 
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samples was not responsible for the observed effects on neutrophil migration (Figure 
25B).  
 
Figure 25: PLY inhibits neutrophil chemotaxis in a 2D Transwell Chemotaxis Assay 
Neutrophils were treated with PLY, PdB or LPS and placed in the upper well of a 96-
Transwell® plate. Chemotaxis towards KC placed in the lower compartment was assessed 
by counting the total number of migrated cells on a MACS Quant Analyser. (A-B) Graphs 
depict the total number of neutrophils migrating to the lower compartment under the 
indicated conditions. Untreated neutrophils are shown in red, PLY treated neutrophil in blue, 
LPS-treated neutrophils in purple, and PdB treated neutrophils in green. Each dot represents 
a single well of an assay performed in triplicate or greater. (A) Data are representative of 5 
independent experiments with 3 - 4 replicate wells and (B) Data are representative of 2 
independent experiments with 5 - 6 replicate wells. Statistical significance determined using 
two-way ANOVA with Tukey’s multiple comparison (p<0.05) with *** (p<0.001),**** 
(p<0.0001) and ns denote not significant.  
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3.2.6 PLY-mediated inhibition of neutrophil chemotaxis cannot be solely 
explained by loss of cell viability. 
 
Inhibition of neutrophil chemotaxis was not observed in the presence of PdB, a toxoid 
derivative of PLY with dramatically reduced haemolytic activity. To confirm that 
reduced migration was not driven solely by reduced viability of the neutrophils in the 
presence of PLY, flow cytometric analysis of cell viability was again performed. At 
conclusion of the experiment depicted in Figure 25A approximately 95% of cells were 
still viable, regardless of exposure to PLY (Figure 26C). For the experiment depicted 
in Figure 25B, a small reduction in cell viability was observed following PLY 
treatment. However this 23.0% reduction in viability cannot solely explain the more 
dramatic 91.7% reduction in cell migration.  
We concluded from this experiment that treatment of neutrophils with PLY inhibits 
chemotaxis to KC, and that this effect cannot be explained solely by loss of cell 
viability. 
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Figure 26 : Representative flow cytometry analysis of cell viability at conclusion of the 
chemotaxis assay in Figure 25(A) 
Neutrophils were left untreated, or treated with PLY or PdB, then placed in the lower 
compartment of a transwell plate for the duration of the chemotaxis assay. At conclusion of 
the assay, neutrophils were stained with a fluorescent LIVE/DEAD dye and analysed by 
flow cytometry. (A) Untreated neutrophils (B) Neutrophils treated PdB (C) neutrophils 
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Figure 27: Representative flow cytometry analysis of cell viability at conclusion of the 
chemotaxis assay in Figure 25(B) 
Neutrophils were left untreated, or treated with PLY or PdB, then placed in the lower 
compartment of a transwell plate for the duration of the chemotaxis assay. At conclusion of 
the assay, neutrophils were stained with a fluorescent LIVE/DEAD dye and analysed by 
flow cytometry. (A) Untreated neutrophils (B) Neutrophils treated PdB (C) Neutrophils 
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3.2.7 PLY does not act as a chemoattractant for neutrophils  
 
The inhibitory effect of PLY on chemotaxis towards KC might be explained by PLY 
(added with neutrophils to the upper compartment) acting as a chemoattractant, and 
outcompeting KC (added to the lower compartment). Here, PLY was added to the 
bottom well of the transwell chemotaxis assay, and its ability to chemoattract 
neutrophils determined. We found that PLY does not act as chemoattractant for 
neutrophils in two independent experiments (Figure 28A and 28B). PdB and LPS also 
did not attract neutrophils. Unexpectedly, PdB had an inhibitory effect on neutrophil 
chemotaxis when placed in the lower compartment, in one of two experiments 
analysed.  Since this effect was not seen in subsequent experiments, we cannot rule out 
that it was merely due to a technical issue with the transwell plate.  
 
From these experiments, we concluded PLY does not act as chemoattractant for 
neutrophils. Therefore, PLY-mediated inhibition of neutrophil chemotaxis cannot be 
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Figure 28:  PLY does not act as a chemoattractant for neutrophils 
Investigation of direct chemotactic effect of; (A) PLY, PdB and (B) PLY, PdB and LPS on 
neutrophils. Neutrophils were placed in the upper compartment of transwell, and PLY, PdB, 
LPS with or without KC placed in the lower compartment. Neutrophil chemotaxis towards 
PLY, PdB and LPS was assessed after 45 minutes migration. Mean + SEM of triplicate 
wells. Data representative of 3 independent experiment for (A) and 2 independent 
experiment for (B). Statistical significance determined using one-way ANOVA with Tukey’s 
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3.2.8 Neutrophil chemotaxis is inhibited following incubation with live S. 
pneumoniae  
 
We next assessed the effect of live bacteria on neutrophil chemotaxis. Pneumolysin 
(PLY) is expressed by virtually all clinical isolates of this pathogen (Rubins & Janoff 
1998). To confirm the role of PLY in inhibiting neutrophil chemotaxis, I used 
different bacterial serotypes with varying levels of haemolytic activity in our in vitro 
chemotaxis assay. I used two serotype 1 clinical isolates: ST217, which is highly 
haemolytic, and ST306, which is non-haemolytic.  I also included a serotype 2 (strain 
D39), and PLN-A, a PLY-deficient mutant of D39. Heat killed D39 was included as 
a control, in addition to PdB (non-lytic toxoid of PLY, with a Trp-433/Phe 
mutation)(Paton et al. 1991) and LPS (endotoxin of Gram negative bacteria). I then 
compared the ability of different strains of live bacteria to inhibit neutrophil 
chemotaxis with PLY.  
 
3.2.8.1 Selection of an MOI that does not cause loss of neutrophil viability.  
 
In order to study the effect of live bacteria on neutrophil chemotaxis, we needed to 
determine that co-incubation of neutrophils with bacteria would not adversely affect 
neutrophil viability. Since the purified PLY used at the beginning of the chapter came 
from the D39 strain background, D39 was used for the initial experiments. 
 
Neutrophils were incubated with varying MOIs of D39, for 45 minutes, followed by 
staining with a fluorescent LIVE/DEAD dye and analysed by flow cytometry. 
Neutrophils were further stained with CD11b to check that sufficient bacteria were 
present to trigger a response in the neutrophils. We tested an MOI range of 0 – 50 
(Table 9) in two separate experiments. Neutrophil viability remained high in the 
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presence of all concentrations of bacteria. CD11b expression was increased at MOI 
>10 (Figure 29). An MOI of 10 was therefore selected for chemotaxis experiments  
 
Table 9:  MOI Ratio of D39 strain bacteria infected on neutrophils   
The highlighted box orange in color indicated the chosen MOI for the experiment 
MOI Live /Dead Staining CD11b-MFI Ratio 
50 89.7 % 5.3 
25 90.1% 4.2 
5 95.6% 2.9 
0 94.5% - 
   
25 97.2% 1.9 
10 96.2% 1.8 
5 99.2% 1.2 
2.5 99.2% 1.0 
1 99.2% 0.86 
0.5 99.5% 0.66 
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Figure 29: Cell viability and CD11b expression on neutrophils following incubation 
with varying MOI of D39 
Neutrophils were incubated for 45 minutes with varying MOI of D39, serotype 2 bacteria, 
and stained with a fluorescent LIVE/DEAD dye and antibody to CD11b. (I-VII) Flow 
cytometry analysis of neutrophil viability (left column) and CD11b expression (right 
column) following incubation with the indicated MOI of D39, serotype 2 bacteria. The 
[purple] peak shows fluorescent intensity of unstained control cells. The [orange] peak 
shows CD11b staining on untreated neutrophils. The [green] peak shows CD11b staining on 
neutrophils treated with bacteria.  
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3.2.8.2 Effect of different S. pneumoniae isolates  on neutrophil chemotaxis in 
2D 
 
Purified PLY inhibited neutrophil chemotaxis in the assays described in 3.2.5. To 
determine if live S. pneumoniae has a similar effect, and if it is dependent on PLY, 
we compared the ability of a panel of S. pneumoniae isolates with varying 
haemolytic activity to inhibit neutrophil chemotaxis in 2D. Neutrophils were mixed 
with PLY, PdB, LPS, or the panel of S. pneumoniae strains listed in Table 10, and 
placed in the upper compartment of a transwell plate. Migration towards KC, which 
was placed in the lower compartment, was assessed after 45 minutes.  
Table 10: List of bacterial stock strains (highlighted in green) and trigger molecules 
Strains/  trigger molecules Description 
D39 S pneumoniae serotype 2 (strain D39) 
D39 HK serotype 2, (strain D39) heat killed 
Pln-A pneumolysin deficient mutant of (strain D39) 
ST217 clinical isolate of serotype 1, highly haemolytic 
ST306 clinical isolate of serotype 1, non-haemolytic 
PLY Pneumolysin hemolytic 
PdB toxoid derivative of pneumolysin  
(mutation at Trp-433/Phe)(Paton et al. 1991)  
LPS lipopolysaccharide (endotoxin) of gram 
negative bacteria 
 
Neutrophils were incubated with different S.pneumoniae isolates and placed in the 
upper compartments of transwell plate and incubated for 45 minutes then the total 
number of cells migrated to the lower compartment were counted. As expected, PLY 
inhibited neutrophil chemotaxis to KC, while PdB and LPS had minimal effects. 
Like PLY, D39 inhibited neutrophil chemotaxis to KC. As expected, heat killed D39, 
ST306 and PLN-A inhibited neutrophil chemotaxis to a lesser extent than PLY or 
D39 (Figure 30). However, the highly haemolytic isolate ST217 also inhibited 
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neutrophil chemotaxis but to a lesser extent compared to D39 or PLY (comparable to 
ST306). The inhibition of neutrophil chemotaxis by multiple strains of bacteria (and 
independently of PLY presence or haemolytic activity) may suggest the presence of 
other virulence factors besides the pore forming activities of PLY. In addition, I 
wanted to examine whether any of the bacterial strains had chemotactic effects on 
neutrophils. We showed that neutrophil migration across the transwell was enhanced 
when ST217, or ST306 were placed in the lower compartment, however D39, D39 
HK, PLN-A PLY, PdB, and LPS showed no significant chemoattractive effect on 
neutrophils when compared to media alone (Figure 31).   
 
Figure 30: Effect of different S. pneumoniae isolates on neutrophil chemotaxis in 2D 
Neutrophils were treated with the indicated stimuli and bacterial strains, and placed in the 
upper compartment of a transwell plate. After 45 minutes the total number of cells migrating 
towards KC in the lower compartment was assessed using a MACS Quant flow cytometer. 
Data are compiled from at least 3 independent experiments for each condition, and are 
normalised to the mean total number of neutrophils migrating towards KC in the absence of 
any bacterial stimulus, in each experiment. Each dot represents a single well from one of at 
least three independent experiments per condition. Statistical significance was determined 
using one-way ANOVA with Tukey’s multiple comparisons test, with *(p<0.05), 
***(p<0.001) and ****(p<0.0001) and ns denote not significant. 
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Figure 31: Effect of different stimuli on neutrophil migration 
Investigation of the direct chemotactic effect of the indicated stimuli towards neutrophils. 
Here, neutrophils were placed in the upper compartment of the transwell, and all other 
stimuli in the lower compartment. Neutrophil chemotaxis from the upper compartment into 
the lower compartment was assessed by counting migrated cells on the MACS Quant. Graph 
depicts mean + SEM for 4 replicate wells. Data are representative of two independent 
experiments. Statistical significance determined using one-way ANOVA with Bonferroni’s 




3.2.8.3 Cell viability and CD11b expression on neutrophils following incubation 
with different S. pneumoniae isolates 
 
To confirm that the observed reduction in neutrophil chemotaxis in the presence of live 
bacterial isolates was not due to cell death, we used a LIVE/DEAD dye to analyse 
neutrophil viability following 45 minutes incubation with different stimuli or S. 
pneumoniae isolates, in addition to CD11b expression on neutrophils. Both chemotaxis 
and FACS staining were performed concurrently. In Figure 32, we show that more 
than 90% of neutrophils were still viable at the end of the assay. Meanwhile CD11b 
expression was significantly increased in the presence of PLY, D39, ST217, but not 
PdB, D39HK, PLN-A, LPS and ST306 when compared to untreated neutrophils 
(Figure 33 and Figure 34). 
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Figure 32: Neutrophil viablity following incubation with S. pneumoniae isolates 
Neutrophils were treated with the indicated stimuli and after 45 minutes incubation, were 
stained with a fluorescent LIVE/DEAD dye and analysed on a MACS Quant Flow 
cytometer. Graph depicts the percentage of viable neutrophils following treatment with the 




Figure 33:  CD11b expression on neutrophils following incubation with S. pneumoniae 
isolates 
Neutrophils were treated with the indicated stimuli and after 45 minutes incubation, were 
stained with a fluorescent LIVE/DEAD dye and an antibody to CD11b and analysed on a 
MACS Quant Flow cytometer. Graph depicts the fold-change in CD11b expression relative 
to unstimulated controls following treatment with the indicated stimuli. Data are 
combination of 3 experiments except for ST306 from one experiment. Statistical 
significance determined using one-way ANOVA with Tukey’s multiple comparison, with 
**(p<0.01), ***(p<0.001), ****(p<0.0001) and ns denote not significant. 
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Figure 34:  Representative histograms of CD11b expression on neutrophils treated with 
different stimuli in Figure 33 
Neutrophils were treated with different stimuli and placed in the 96-U bottom well and 
stained with an antibody CD11b before analysis by flow cytometry.  The [purple] peak 
shows fluorescence intensity of unstained control cells. The [blue] peak shows isotype 
control and [orange] CD11b staining for untreated neutrophils. The [red] peak shows isotype 
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3.2.9 Effect of PLY on neutrophil chemotaxis in 3-D  
 
Mechanisms of two-dimensional (2D) migration are different from three-dimensional 
(3D) migration, whereby cells use adhesion/integrin-independent modes of 
migration. Furthermore, using 3D migration assays are better representatives of the 
environment faced by neutrophils once they enter tissue. Therefore, the use of 3D in 
vitro models to mimic the in vivo tissue environment will increase the reliability of 
our understanding of the role of PLY in manipulating neutrophils migration.  Here 
we have used collagen type I gels to represent interstitial migration. Two different 
3D chemotaxis models were used, the first one was u-slide chemotaxis 3D chambers 
from Ibidi® where cells were embedded in a 3D collagen matrix and the migration of 
cells was recorded and tracked using specialist image analysis software 
(Fiji/IMARIS). The second model was a Transwell® Invasion Assay, where 
transwells were overlaid with a fibrous collagen gel, and neutrophils placed on top 
(details were described in Chapter 2). Neutrophils that migrated through the collagen 
to the bottom well were collected and counted using the flow cytometer.  
 
3.2.9.1 PLY impairs the ability of neutrophils to chemotaxis in 3D 
environments.  
 
Using u-slide chemotaxis 3D chambers from Ibidi®, neutrophils were embedded in a 
3D collagen matrix and the reservoirs on either side of the matrix filled with either 
chemoattractant-free or chemoattractant-containing medium to establish a gradient. 
Collagen type I was chosen for these assays as it forms fibrillar gels that allow tissue 
interstitium to be modelled in vitro. Images were acquired every 60 seconds for a 
total of 8 hours using a 3i spinning disk confocal microscope.  For the first 2 hours of 
the recorded migration, cells were manually tracked using MTrackJ from ImageJ-
101 | P a g e  
Chapter 3 - Chemotaxis 
win64 and cell velocity, directionality (confinement index), euclidean distance and 
accumulated distance were obtained using the Migration and Chemotaxis Tool from 
ImageJ-win64. Control, PLY, and LPS -treated neutrophils all migrated in the 
direction of the chemoattractant-containing well, as expected (Figure 35). However, 
PLY-treated neutrophil migration was more confined (Figure 36 I), and migration 
appeared to be slower compared to control and LPS treated neutrophils (Figure 36 
II). Conversely, LPS treated neutrophils migrated faster, and were less confined in 
their migration that untreated neutrophils (Figure 35). Cell motility was not analysed 
after 2 hours, as neutrophils in all conditions showed loss of motility.  
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Figure 35:  PLY impairs neutrophil ability to migrate toward KC in 3D collagen gels 
Representative cell trajectory plots of neutrophil cells embedded in a 1.5mg/mL rat tail 
collagen type I gel in a u-slide 3D Ibidi® chamber (I) untreated neutrophils, (II) neutrophils 
treated with PLY and (III) neutrophils treated with LPS. Reservoirs were filled with either 
(left) chemoattractant-containing (KC) medium or (right) chemoattractant-free and the 
ability of the neutrophils to migrate towards KC was determined. Movies were recorded for 
8 hours using the 3i spinning disk confocal microscope.   
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Figure 36:  Summary of neutrophil migration characteristics represented in Figure 35 
 Cells were manually tracked for 2 hours at three different stage positions for each sample 
(control, PLY treated, LPS treated)  (I) Confinement Index (CI),  (II) Speed,  (III) Mean 
Euclidean Distance  and  (IV) Mean Accumulated Distance were calculated. Analysis was 
done using ImageJ-win64 (Fiji Software) Data represent mean + SEM. Each point represents 
an individual cell. Statistical significance was determined using one-way ANOVA with 
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3.2.9.2 Pneumolysin (PLY) also inhibits neutrophil migration in a 3D transwell 
chemotaxis assay 
 
As an alternative approach to assessing neutrophil migration in 3D, we also used 
Transwell® Invasion Assays where we coated the upper compartment of a transwell 
plate with a fibrillar type I collagen gel. Neutrophils were placed on the top of the gel 
and observed for migration to the lower compartment, using KC as a 
chemoattractant. Neutrophil migration through the collagen gel was found to be 
inhibited in the presence of PLY, whereas migration was enhanced in the presence of 
LPS and PdB (Figure 37A). We conclude from this experiment that treatment of 
neutrophils with PLY can also inhibit neutrophil migration in 3D.  
.  
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Figure 37: Pneumolysin (PLY) also inhibits neutrophil chemotaxis in 3D 
Neutrophils were added to empty transwells (2D) or transwells containing collagen gels 
(3D). After 2 hours, migration of neutrophils towards KC in the lower compartment were 
assessed by counting migrated cells on the MACS Quant. (A) Effect of PLY, LPS and PdB 
on neutrophil 3D chemotaxis towards KC. (B) Effect of PLY, LPS and PdB on neutrophil 
2D chemotaxis towards KC. Data are combined from three independent experiments. 
Statistical significance was determined using one-way ANOVA with Tukey’s multiple 
comparisons test, with *** (p<0.001) and **** (p<0.0001).  
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3.2.10  Ex vivo experiment on  neutrophil migration in lymphatic tissue  
 
Despite the 3D collagen gel model being more representative of the tissue 
environment faced by neutrophils in vivo, key features such as presence of tissue 
resident cells and tissue-specific structures were missing (Condliffe et al. 2011; 
Martin et al. 2015; Perez-Castillejos 2010). We therefore wanted to investigate the 
effect of PLY on neutrophil migration in a living tissue environment. Explant 
imaging and intravital microscopy studies have been important in offering insight 
into immune cell migration in vivo. Neutrophils are recruited to lymph nodes (LN) 
following S. pneumoniae infection, where they appear to be highly dynamic and 
exhibit swarming behaviour (Sawtell 2015). We therefore decided to assess 
neutrophil migration in a lymph node slice model. To confirm that neutrophils are 
recruited into LN tissue, mice were infected intranasally with a high dose of D39 
(10
6
 CFU) for 24 hours to induce pneumonia (Kadioglu et al. 2000). Draining 
mediastinal LN (mLN) were analysed by flow cytometry at 24 hours post-infection. 
Following infection, neutrophils migrated to mLN, as can be seen in the increased 




) in infected mice (Figure 38 and Figure 
39).   
 
3.2.10.1 Neutrophil migration in lymphatic tissue is enhanced by treatment with 
PLY 
 
After confirming that neutrophils can migrate to lymph nodes, we next proceeded to 
image neutrophil migration in explanted and vibratome-sliced lymph node tissue. For 
ex vivo analysis of neutrophil migration, inguinal LN (iLN) were harvested and 
embedded in 4% agarose. 400µm slices were cut using a vibratome. Meanwhile, 
neutrophils were isolated from bone marrow by negative selection and labelled with 
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CFSE. Labelled cells were overlayed onto iLN slices and incubated for 2 hours to 
allow them to migrate into the tissue. Neutrophil migration was then assessed by 
two-photon microscopy. During imaging the sample was perfused with media alone, 
and later with media containing 1.5 HU PLY/mL. 
 
 
Figure 38: Neutrophils are recruited to mediastinal LN following infection with D39 
strain bacteria 
CD1 mice were infected intranasally with 10
6
 CFU of D39 bacteria. Mice were culled at 24 
hours post-infection and samples of mLN were collected from infected (n=6) and sham 





) after gating on CD45
+
 cells. Mean + SEM for 6 mice per 
condition is shown. Significance of p<0.05 was determined using an unpaired t-test (two-
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Figure 39: Neutrophils are recruited to mediastinal LN following intranasal infection 
with D39 strain bacteria 
Mice were infected with D39 strain bacteria for 24 hours before mLN tissues were analysed 
for flow cytometry. First, SSC vs FSC for whole cell gate, next plot show discrimination of 
single cells from doublets (SSC-H vs SSC-A), and CD45 expression (for leukocyte). Last 




) cells were gated on.   
 
 
Our analysis revealed that neutrophils migrated faster, had longer track lengths and 
were less confined, following perfusion with 1.5 HU/mL PLY (Figure 40, Figure 
41and Figure 42). This result was unexpected, as our 3D chemotaxis assay using u-
slide chambers (Figure 35 and Figure 36) showed that PLY inhibited neutrophil 
migration. However, another two-photon movie recording taken from separate 
experiment where we perfused lymph node tissues with 1.2 HU/mL PLY showed 
neutrophil migration did not increase following perfusion with PLY (Figure 43, 
Figure 44 and Figure 45).  
It was therefore possible that PLY-treated neutrophils showed enhanced migration on 
live tissue dependent on the concentration of PLY. However, this experiment 
perfusing live tissue with 1.2 HU/mL PLY has only been performed once, and would 
need to be repeated multiple times to draw any conclusions. 
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Figure 40:  PLY enhanced neutrophil migration in lymphatic tissue 
Neutrophils were tracked migrating in LN tissue slices before (left) and after (right) 
perfusion with 1.5 HU/mL PLY. Two movies per condition were recorded for 15 minutes 
each. Cell positions were tracked using IMARIS software, and cell speed (top), track length 
(middle) and confinement index (bottom) calculated. Graph shows mean + SEM for 1 movie 
per condition (recorded at the same tissue position before and after PLY perfusion). Each 
point represents an individual cell. Statistical significance was determined using unpaired t-
test (two-tailed) with *(p<0.05) and ****(p<0.0001).   
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Figure 41:  Neutrophils migration without PLY perfusion (Figure 40) 
A single time point from a representative of two-photon movie of neutrophils labelled with 
CFSE (green) migrating in an inguinal LN slice. Neutrophil migration across the whole 
period of imaging is shown as time-coded tracks. Tissue was perfused with oxygenated 
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Figure 42: Neutrophil migration in lymph nodes was enhanced following perfusion 
with PLY at 1.5 HU/mL (Figure 40) 
A single time point from a representative of two-photon movie of neutrophils labelled with 
CFSE (green) migrating in an inguinal LN slice. Neutrophil migration across the whole 
period of imaging is shown as time-coded tracks. Tissue was perfused with oxygenated 
media containing 1.5 HU/mL PLY.  
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Figure 43:  1.2 HU/mL PLY did not enhance neutrophil migration in lymphatic tissue 
Neutrophils were tracked migrating in LN tissue slices before (left) and after (right) 
perfusion with 1.2 HU/mL PLY. Two movies per condition were recorded for 15 minutes 
each. Cell positions were tracked using IMARIS software, and cell speed (top), track length 
(middle) and confinement index (bottom) calculated. Graph shows mean + SEM for 1 movie 
per condition. Each point represents an individual cell. Statistical significance was 
determined using unpaired t-test (two-tailed) with * (p<0.05) and ** (p<0.01)  
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Figure 44: Neutrophils migration without PLY perfusion (1.2 HU/mL PLY) was 
enhanced on lymphatic tissue (Figure 43) 
A single time point from a representative of two-photon movie of neutrophils labelled with 
CFSE (green) migrating in an inguinal LN slice. Neutrophil migration across the whole 
period of imaging is shown as time-coded tracks. Tissue was perfused with oxygenated 
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Figure 45: Neutrophils migration was not enhanced in lymph node slices following 
perfusion with PLY at 1.2 HU/mL (Figure 43) 
A single time point from a representative of two-photon movie of neutrophils labelled with 
CFSE (green) migrating in an inguinal LN slice. Neutrophil migration across the whole 
period of imaging is shown as time-coded tracks. Tissue was perfused with oxygenated 
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3.3 Discussion  
 
Previously published reports suggest that pneumolysin, a key virulence factor 
produced by S. pneumoniae can inhibit neutrophil migration (Paton & Ferrante 1983 
; Johnson et al. 1981 ;Paton et al. 1993). However, whether PLY targets particular 
modes of migration, or acts competitively, remains poorly understood. Here, we have 
shown that PLY can directly inhibit neutrophil migration in in vitro 2D assays, and in 
3D assays, which are highly representative of the tissue interstitium. Live S. 
pneumoniae also inhibited neutrophil migration toward chemoattractant; however 
there did not seem to be a correlation between haemolytic activity of the different 
strains. These data contribute to our understanding of how neutrophil host defence 
may be impaired during a bacterial infection, specifically with S. pneumoniae  
  
3.9.1 PLY inhibits neutrophil migration to KC, but not by acting competitively 
as a chemoattractant.  
 
Previous studies using neutrophils isolated from the blood of healthy volunteers have 
shown that PLY inhibits chemotaxis (direct migration) and chemokinesis (random 
migration) (Paton & Ferrante 1983; Johnson et al. 1981; Paton et al. 1993). These are 
in agreement with our current data, whereby we demonstrate an inhibitory effect of 
PLY on chemotaxis of murine neutrophils in 2D and 3D environments. This could be 
the result of direct inhibition of neutrophil migration by the toxin, or by the toxin 
acting competitively as a chemoattractant. In support of the latter hypothesis, previous 
studies by Johnson et al suggested that PLY can chemoattract neutrophils at low 
concentrations in vitro, while instillation of PLY onto rabbit conjunctiva tissue led to 
neutrophil recruitment (Johnson et al. 1981). In contrast, in this study we found no 
chemoattractive effect on PLY on neutrophils. These differences may simply reflect 
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differences in experimental approaches.  However, another possible explanation is that 
PLY acts on other cells resident in tissues and stimulates these cells to produce a 
neutrophil chemoattractant. Alternatively PLY activation of complement may 
contribute to neutrophil influx during infection (Rubins et al. 1995). Therefore PLY 
may indirectly enhance neutrophil influx into tissues, whilst also acting directly on 
neutrophils to constrain their migration upon arrival. Possible mechanisms for the 
direct inhibitory activity of PLY on neutrophil migration will be explored in 
subsequent chapters. 
 
3.9.2 Inhibition of neutrophil chemotaxis by PLY depends on pore-forming 
activity, but is not accompanied by significant cell death.  
 
PLY form pores has cell inhibition and activation properties (Kadioglu et al. 2008; 
McNeela et al. 2010). Both activities are required for in vivo virulence of the 
bacteria, but only the haemolytic activity regulates neutrophil recruitment (Jounblat 
et al. 2003). The pore-forming activity of PLY makes it toxic to a variety of cell 
types. When present in high concentration it can lyse any cell membrane that 
contains cholesterol. Meanwhile at sub-lytic concentrations, the functional effects of 
PLY on cells  may also still be dependent on the formation of micropores (Martner et 
al. 2008) including inhibition of neutrophil chemotaxis, as we showed for the first 
time in this chapter. In our experiments, sub-lytic concentrations of PLY inhibited 
neutrophil chemotaxis without causing significant cell death. However, this effect 
was still be dependent on the pore forming activity of the toxin, since a toxoid 
derivate of PLY (PdB) did not alter neutrophil chemotaxis (Paton et al. 1991). 
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Similar to our data, a number of previous studies have demonstrated that the pore-
forming activity of PLY is required to alter host cell behaviour at sub-lytic 
concentrations (i.e. independently of cell death). For example, nanomolar 
concentrations of PLY result in the formation of small numbers of sub-cytolytic 
pores in epithelial cell membranes. This leads to osmotic stress, activation of P38 
mitogen-activated protein kinase, and innate responses, allowing them to act as an 
early warning system to the host immune response. This effect was dependent on 
pore formation, as it was lost in the presence of PdB (Ratner et al. 2006). In 
neuroblastoma cells, sub-lytic concentrations of PLY lead to formation of micro-
pores in the plasma membrane, activation of  rac1 and rhoA GTPases, and the 
formation of actin stress fibres (Iliev et al. 2007). This brought about cytoskeletal 
rearrangements within the target cells, and suggests a possible mechanism for the 
effects we observe on neutrophil migration (Marriott et al. 2008). Rac1 and RhoA are 
Rho GTPases which can produce morphological changes in the cell after responding 
to changes in the surrounding environment (Iliev et al. 2007). Both are involved in 
cell motility where rhoA facilitates actin-myosin contractility, and rac1 influences 
actin polymerization and the formation of lamellipodia (Wennerberg 2004). This   
suggests a possible mechanism for the effects we observe on neutrophil migration.  
 
Sub-lytic concentrations of PLY also affect immune cell function, and again many of 
these effects are dependent on its pore-forming function. THP-1 monocytic cells 
exposed to PLY upregulate ICAM-1, but this effect is not seen in response to PdB 
(Thornton et al. 2005). In neutrophils, the release of sub-lytic concentrations of PLY 
by autolyzed pneumococci induces the activation of NADPH oxidase, and generation 
of  reactive oxygen species (ROS) (Martner et al. 2008). However, contrary to our 
results, neutrophil recruitment into infected lung tissue was largely dependent on the 
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pore forming function of PLY (Jounblat et al. 2003). A possible explanation for this 
discrepancy is discussed below. 
 
 3.9.3 PLY can enhance neutrophil recruitment to the site of infection, but may 
subsequently inhibit interstitial migration  
 
Our current study shows that PLY inhibits neutrophils chemotaxis in vitro. However, a 
number of murine infection studies have already demonstrated that PLY plays an 
important role in stimulating neutrophil recruitment to the site of infection. For 
example, a study by Kadioglu et al. has shown neutrophil recruitment to infected lungs 
is slower and less intense in the presence of PLY-mutant bacteria compared to WT 
controls (Kadioglu et al. 2000; Hirst et al. 2004). This function of PLY is dependent on 
its cytolytic, pore-forming activity (Jounblat et al. 2003). Furthermore,  in vitro studies 
using Transwell system to study neutrophil migration across a pulmonary endothelial 
monolayer has demonstrated PLY to be necessary for pneumococcus-induced PMN 
recruitment (Moreland & Bailey 2006). As noted above, this discrepancy may be 
explained by PLY acting on endothelial or other stromal cells to indirectly enhance 
neutrophil recruitment, but then acting directly upon extravasated neutrophils to inhibit 
interstitial chemotaxis and function. We can’t conclude here, are neutrophils stopping 
before reaching foci of live bacteria (bad) or are they receiving stop signal upon 
reaching foci of live bacteria (good, as that is where they need to be to perform 
function).  
Despite the large influx of neutrophils in response to wild-type-pneumococci, 
susceptible hosts fail to eliminate bacteria from the lungs. This might be explained by 
neutrophil activity being significantly inhibited by PLY upon arrival in the lung, which 
is consistent with our results, and with earlier studies showing that pneumolysin-
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treated mononuclear phagocytes showed significantly depressed ability to kill S. 
pneumoniae in vitro (Kadioglu et al. 2000; Mitchell et al. 1991; Nandoskar et al. 
1986). Studies by Paton et al. have shown PLY to markedly depress the respiratory 
bust and bactericidal activity of PMNL cells (Paton & Ferrante 1983). In contrast, 
other studies have shown that PLY activates NADPH oxidase, and production of ROS. 
However, ROS produced in response to pneumolysin is formed mainly intracellularly, 
where it functions in cell signalling rather than bacterial killing. ROS is released into 
vesicular compartments lacking microbes, likely resulting in deterioration and death of 
the neutrophils and lessening pneumococci defence (Martner et al. 2008). Furthermore, 
PLY-induced damage to neutrophil membranes enhances release of lysozyme and 
possibly other hydrolytic enzyme from this cells, contributing to tissue damage 
(Johnson et al. 1981; Paton & Ferrante 1983).  
 
Altogether, this work suggests that pneumolysin could function in pathogenesis by (1) 
stimulating a tissue inflammatory response that recruits large numbers of neutrophils 
(2) shifting the balance of neutrophil activity from bactericidal function to tissue 
damage, and (3) inhibiting neutrophil interstitial chemotaxis. Future studies should 
address the molecular details of how neutrophil behaviour is altered in lung tissue after 
PLY stimulation, or infection with S. pneumoniae. 
 
3.9.4 Effect of live S. pneumoniae with varying haemolytic activity on neutrophil 
chemotaxis. 
 
Our current results have shown that the haemolytic, pore-forming function of PLY is 
essential for inhibition of neutrophil chemotaxis. Thus, we hypothesised that the 
inhibitory effect of various bacterial strains on neutrophil migration would be 
dependent on their haemolytic activity, and might explain disease pathogenesis.   
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Reliant on the immunochemistry profile of their capsular polysaccharide, the 
pneumococci can be divided into 90 serotypes (Henrichsen 1995). However the 
serotypes that are found to cause the majority of disease account for less than 20% of 
all serotypes (Hausdorff et al. 2000). PLY is usually preserved in all serotypes of  S. 
pneumoniae, and is needed for full invasive disease (Kirkham et al. 2006).  ST217 
and ST306 are serotype 1 pneumococci, which is known as one of the most common 
invasive serotypes (Kirkham et al. 2006). African ST217 is highly haemolytic while, 
European ST306 isolates have been shown to have mutations in their ply gene that 
have resulted in pneumolysin being unable to form functional pores in the host cell 
membrane, leaving no residual haemolytic activity (Marriott et al. 2008; Littmann et 
al. 2009). We therefore expected that ST217 would show greater inhibition of 
neutrophil chemotaxis in our assay than ST306. Surprisingly, however, both strains 
inhibited neutrophil migration to similar levels, albeit less than that of purified PLY 
or D39 serotype 2 pneumococci. Interestingly, ST306 does not require hemolytically 
active pneumolysin to cause invasive pneumococcal disease, nor to attract 
neutrophils to the site of infection. This suggests either the presence of other 
virulence factors, or alternative activities of PLY. Either could explain the reduction 
in neutrophil chemotaxis observed in our experiments. In support of the latter 
hypothesis, S. pneumoniae lacking the haemolytic activity of PLY was more virulent 
than S. pneumoniae in which the PLY gene was deleted (Alexander et al. 1998). 
However, we observed no inhibitory effect of PdB on neutrophil chemotaxis, 
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3.4 Conclusion 
 
We have shown that PLY is able to inhibit neutrophil migration in 2D and 3D 
chemotaxis assay. The 3D context is more representative of the tissue interstitium and 
helps us to understand further how neutrophils behaviour and interactions are modified 
by S. pneumoniae toxin, PLY. We hypothesise that in vivo, neutrophils are recruited 
from blood but are unable or delayed in their ability to reach foci of infection and use 
effective defence mechanisms to eradicate the pathogen. If we could understand the 
mechanism, we might be able to manipulate neutrophil migration in disease or 
inflammation to perform effective defensive action for killing the pathogen and 
minimise the risk of tissue damage to the host. 
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Chapter 4: Understanding the molecular mechanism 
through which PLY alters neutrophils migration and 
function 
 
4.1 Brief Introduction  
 
In chapter 3, we showed that S.pneumoniae and its toxin, PLY could inhibit 
neutrophil chemotaxis in 2D and 3D in vitro models. In this chapter, the molecular 
mechanism through which PLY alters neutrophil migration will be explored. 
Understanding how PLY inhibits neutrophil migration may reveal new ways to 
inhibit neutrophil migration in other disease settings, preventing them from 
damaging host tissues. 
 
We have shown that neutrophil motility in 2D and 3D models is inhibited by PLY.  
Studies have identified that there are significant differences in the adhesive, 
chemoattractant and signalling processes which regulate neutrophil migration in 2D 
and 3D. In vitro, 2D migration is largely integrin-dependent, while 3D migration can 
be integrin-dependent or independent. In vivo, integrins play an important role in the 
recruitment of neutrophils from the blood stream into the site of S. pneumoniae 
infection by binding complementary receptors on endothelial cells, immobilising 
neutrophils (Hogg 1995). However, the role of integrins in subsequent chemotaxis of 
neutrophils through the tissue interstitium remains unclear.  
 
One potential mode is using an adhesion-dependent pathway where neutrophils use 
extracellular matrix (ECM) as their platform of movement. In this pathway, integrins 
mediate interactions between neutrophils and extracellular matrix components 
(Weninger et al. 2014). Integrins are heterodimeric cell surface receptors which play 
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an important role  in the transduction of cell-matrix adhesion signals (Wiesner et al. 
2005). Integrins promote cell adhesion and migration, and connect the ECM with the 
actin cytoskeleton. They regulate actin based structures in the cell, which in turn 
regulate the stability of adhesions.  
 
Integrins can play an important role in chemotaxis, even in 3D. This can be seen in 
studies done by Cera et al, where interstitial migration of neutrophils towards an  
inflammatory stimulus was impaired in the absence of JAM-A, which regulates 
integrin recycling (Cera et al. 2009). Studies by Heit et al have suggested that 
CD11b/CD18 (αMβ2, Mac1) is the dominant integrin involved in chemotaxis to 
fMLP, and CD11a/CD18 (αLβ2, LFA-1) is the dominant integrin involved in 
chemotaxis to IL-8, using a 3D agarose assay (Heit 2005). 
 
In vivo studies by Werr et al demonstrated that neutrophil migration in  extravascular 
tissues is crucially dependent on CD49b/CD29 (α2β1) function (Werr et al. 2000), 
and that CD29 is critically involved in the chemokinetic movement of  neutrophils in 
rat extravascular tissue (Werr et al. 1998). Meanwhile another in vivo study has 
shown CD29 to be involved in the movement of neutrophils from the interstitium 
into alveoli using electron microscopy. It has also been suggested that CD49b and 
CD49d (α4) mediate CD18-independent neutrophil accumulation during pulmonary 
inflammation (Ridger et al. 2001). 
 
Alternatively, other studies have shown neutrophil migration in 3D environments can 
be integrin-independent. Integrin-independent modes of migration are also dependent 
on actin polymerisation as it is the assembly and disassembly of the actin 
cytoskeleton that enables the cell to move toward cues such as chemoattractants. 
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Studies by Lammermann and colleagues, conducted both in vivo and in 3D in vitro 
assays, showed that murine leukocytes can migrate solely using the expansive force 
of the actin-network, that promotes protrusive flowing of the leading edge  without 
integrin involvement (Lämmermann et al. 2008). Another study by Lammermann et 
al has shown that LTB4 promotes rapid integrin-independent neutrophil recruitment 
through tissues, though integrins were required to maintain neutrophil swarms 
(Lämmermann et al. 2013). Other studies have shown, in the absence of integrins, 
alternative mechanisms of cell adhesion are utilised. Confinement of cells in a 3D 
matrix enables the cells to push against a substrate and use weaker affinity, integrin-
independent, interactions. More transient interactions with matrix proteins allow for 
rapid motility required by leukocytes (Sahai & Pinner 2009).  
 
We hypothesise that differences in integrin expression or function might explain the 
decrease in neutrophil motility in the presence of PLY. The assessment in this 
chapter will involve in vitro and in vivo experiments to determine the effect of S. 
pneumoniae or PLY on expression of selected integrins (CD11b, CD18, CD29, 
CD49b and CD49d) on neutrophils. The effect of PLY on actin polymerization and 
adhesion will also been assessed. The outcome of this study will be to better 
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4.2 Results 
4.2.1 Effect of PLY on neutrophil adhesion 
 
While working with PLY-treated neutrophils, we noticed that they were more difficult 
to dislodge from tissue culture plates than their untreated counterparts. We therefore 
assessed the effect of PLY treatment on neutrophil adhesion to TC-treated plastic, and 
to fibronectin-coated plates. Remodelling of the actin cytoskeleton is required for 
neutrophil chemotaxis. Our previous results in Chapter 3 have shown PLY inhibits 
neutrophil chemotaxis. Therefore we also investigated the effect of PLY-treatment on 
f-actin polymerisation, as measured by phalloidin staining. 
 
4.2.1.1 Treatment with PLY increases neutrophil adherence to TC-treated 
plastic  
 
To assess the effect of PLY on neutrophil adhesion, neutrophils were loaded with 
calcein-AM and treated with PLY, LPS or PdB before plating onto tissue culture 
treated plastic. Adhesion was quantified by measuring fluorescence of adhering cells 
at 45 minutes, 2 hours and 4 hours.  
Neutrophils treated with PLY and LPS were more adhesive to tissue culture plastic 
than untreated controls (Figure 46 I–II). On the other hand, cells treated with PdB 
showed no difference in adhesiveness, compared to untreated controls (Figure 46 III). 
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Figure 46 : PLY and LPS increase neutrophil adherence to TC treated plates 
Neutrophils were stained with a fluorescent dye (Calcein AM) and incubated for 30 minutes 
at 37
o
C before stimulation with PLY (I) or LPS (II) or PdB (III). Calcein-labelled 
neutrophils were allowed to adhere for three different time points (45 minutes, 2 hours and 4 
hours). Thereafter non-adherent neutrophils were removed by washing, and the amount of 
neutrophils adhering to the plate was measured using a plate reader. Data are pooled from 
three independent experiments, each performed in triplicate. Graph show mean + SEM. 
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4.2.1.2 PLY causes a transient increase in adhesion to fibronectin-coated plates 
 
We next assessed adhesion of neutrophils to fibronectin (FN). Previous studies have 
shown CD11b/CD18-dependent neutrophil haptotaxis on FN (Henry et al. 2013). FN 
also has a role in inducing adherence of neutrophils on collagenous and non-
collagenous substrates (Marino et al. 1985). FN is a ligand for CD49d/CD29 (α4β1) 
integrin (Plow et al. 2000), and CD49d/CD29 has been shown to be important for 
neutrophil recruitment during S. pneumoniae infection (Kadioglu et al. 2011). 
 
Plates were pre-coated by adding 25µg/mL of fibronectin per well for 1 hour at 37
o
C, 
or overnight at 4
o
C. Neutrophils were loaded with calcein-AM and treated with PLY, 
LPS or PdB before plating onto fibronectin-coated plates.  Adhesion was quantified by 
measuring fluorescence of adhering cells at 45 minutes and 3 hours.  
After 45 minutes, we found that PLY- and LPS- treated neutrophils showed  increased 
adhesion to fibronectin coated plates compared to control neutrophils. This effect was 
dependent on the pore-forming activity of the toxin, since neutrophils treated with PdB 
behaved similarly to untreated controls (Figure 47 I-II). However, after 3 hours, we 
observed that neutrophils treated with PLY no longer showed any increase in 
adherence compared to control neutrophils. In contrast, neutrophils treated with LPS 
showed a highly significant sustained increase in adhesion to fibronectin compared to 
untreated controls (Figure 47II). Untreated neutrophils showed no significant 
difference in adhesion to uncoated or fibronectin-coated wells, while PLY-, LPS- and 
PdB- treated neutrophils adhered significantly better to fibronectin-coated versus 
uncoated wells (Figure 47 I-II).  
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Figure 47: PLY causes a transient increase in adhesion to fibronectin-coated plates 
Calcein-labelled neutrophils were allowed to adhere for 2 different time points 45 minutes (I) 
and 3 hours (II) at 37
o
C. Non-TC treated plates were used and coated with 25µg/mL 
fibronectin. Thereafter, non-adherent neutrophil were removed by washing four times with 
PBS, and the fluorescence of adherent neutrophils to the plate was measured using a plate 
reader. Data represent mean + SEM (n=3 wells per condition). Statistical significance was 
determined using two-way ANOVA with Tukey’s multiple comparisons test, with *(p<0.05), 





4.2.1.3 Effect of PLY on neutrophil morphology and actin polymerization  
 
LPS is known to increase neutrophil adhesion, and this is accompanied by actin 
filament re-arrangement (Watanabe et al. 2003). To assess if PLY induces changes in 
the actin cytoskeleton, we seeded neutrophils onto glass coverslips and treated with 
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PLY, LPS or PdB for 45 minutes. After fixing, neutrophil F-actin was labelled with 
Rhodamine-Phalloidin, before confocal imaging. Images were analysed using 
IMARIS software for the intensity mean of actin fluorescence and sphericity and 
volume of each neutrophil. 
 
In an initial experiment, PLY treated neutrophils markedly increased their F-actin 
fluorescence intensity and volume but decreased in sphericity (Figure 48 and 49).  
However, when analysing collective data from a total of five experiments, there was 
some variation in the results for fluorescence intensity of F-actin staining and 
sphericity (Figure 50 I–II). Overall, no significant difference was observed between 
control and PLY treated neutrophils for either of these measures. An enhanced 
fluorescence intensity was observed in all experimental replicates, however was only 
statistically significant in three of five experiments (data not shown, p<0.05 using 
paired t-test). In contrast there was a statistically significant increase in volume in 
PLY treated neutrophils in the collective data (Figure 50 III, p<0.05). No significant 
difference was observed between PdB treated neutrophils and untreated neutrophils 
in all three measures (Figure 49). Meanwhile, LPS treated neutrophils showed a 
modest increased in their volume, and F-actin fluorescence intensity, but no changes 
in sphericity, when compared to untreated neutrophils (Figure 49). No collective data 
is presented for LPS and PdB as the experiment was performed for three times. 
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Figure 48: Neutrophils treated with PLY are larger and show increased F-actin 
polymerisation 
Neutrophils were plated on glass coverslips and treated with PLY, LPS, or PdB for 45 
minutes before fixation and staining with rhodamine-phalloidin (green) for F-actin. 
Neutrophils were observed using 100x objective mounted on the Zeiss BIOAFM 880 
confocal microscope.  
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Figure 49: Neutrophils treated with PLY show increased f-actin polymerisation, 
increased volume, and decreased sphericity 
Neutrophils were plated on glass coverslips and treated with PLY, LPS, or PdB for 45 
minutes before fixation and staining with rhodamine-phalloidin and DAPI. Neutrophils 
were observed using 100x objective mounted on the Zeiss BIOAFM 880 confocal 
microscope. Graphs depict (I) fluorescence intensity of rhodamine-phalloidin, (II) cell 
sphericity, and (III) cell volume. Each point represents an individual cell. Mean + SEM for 
a single experiment is shown. Statistical significance was determined using one-way 
ANOVA with Tukey’s multiple comparisons test, with *(p<0.05), **(p<0.01), 
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Figure 50:  Neutrophils treated with PLY show increased volume, and a trend towards 
increased F-actin polymerisation 
Neutrophils were plated on glass coverslips and treated with PLY, LPS, or PdB for 45 
minutes before fixation and staining with rhodamine-phalloidin and DAPI. Neutrophils were 
observed using 100x objective mounted on the Zeiss BIOAFM 880 confocal microscope. 
Graphs depict (I) fluorescence intensity of rhodamine-phalloidin, (II) cell sphericity, and 
(III) cell volume. Each point represents the mean for an individual experiment. 5 
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4.2.2 Analysis of integrin expression on neutrophils following treatment with 
PLY 
 
The data presented in this chapter show that PLY-treated neutrophils show increased 
adhesion to TC plastic and fibronectin, and a trend towards increased polymerisation 
of F-actin. Human neutrophils adhering to plastic surfaces are rapidly activated and 
spread quickly upon adhesion,  inducing F-actin polymerization (Ginis et al. 1992). It 
has also been reported that binding of neutrophils to various biological substrates 
such as  fibronectin and other  non-biological surfaces such as plastic is dependent on 
the integrin subunit, CD18 (Werr et al. 1998). Neutrophils express a variety of 
adhesion receptors, including members of the well-studied integrin family.  Integrins 
are connected to F-actin and mediate neutrophil adhesion to extracellular matrix 
proteins. Thus we thought increased expression or activity of integrins might explain 
these findings. 
 
Here, we have assessed the effect of PLY on expression of : αMβ2 (CD11b/CD18), 
which plays a key role in transendothelial migration from blood to tissue during 
S.pneumoniae infection (Kadioglu et al. 2011); α2β1 (CD49b/CD29) which binds 
collagen and has been suggested to regulate neutrophil interstitial migration (Werr et 
al. 2000); and α4β1(CD49d/CD29) which binds fibronectin and may have an 
important role in neutrophil accumulation in S. pneumoniae infected lungs (Kadioglu 
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4.2.2.1 Analysis of integrin expression on neutrophils stimulated with PLY in 
vitro  
 
Neutrophils have previously been shown to upregulate CD11b following exposure to 
pneumococci (Cockeran et al. 2001). It also has been shown that CD11b expression 
is upregulated on neutrophils and endothelial cells in community acquired 
pneumonia (Glynn et al. 1999) and on neutrophils recruited to the lungs during 
bacterial pneumonia (Rijneveld et al. 2005). To confirm this finding we have 
performed experiments on neutrophils stimulated with PLY in vitro.  
To assess changes in CD11b expression, neutrophils were stimulated with 1.5 
HU/mL PLY for 30 minutes, 2 hours and 16 hours and further stained with a 
fluorescent live/dead dye before expression of CD11b was analysed by flow 
cytometry.  
Our experiment concluded that treatment with PLY increased expression of CD11b 
on neutrophils at all time points (Figure 51). The highest median fluorescence 
intensity (MFI) was observed at 30 minutes of culture, and then decreased over time. 
There was also a transient increase in CD11b expression on untreated neutrophils 
after 30 minutes of culture, but this was substantially less than that observed for 
PLY-treated neutrophils (Figure 51). 
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Figure 51:  CD11b expression increased on neutrophils after exposure to PLY 
Neutrophils were treated with 1.5 HU/mL PLY for the indicated times, stained with an 
antibody  to CD11b, and analysed by flow cytometry (I)  Graph depicts the MFI of CD11b 
expression on untreated neutrophils (blue) and treated neutrophils (red) at the indicated time 
point. (II-IV) Representative histograms depicting CD11b expression in control ( ) and blue
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We next assessed changes in expression of the integrin subunits CD18, CD29, 
CD49b and CD49d. Since PLY treated neutrophils are larger, and more auto-
fluorescent, fluorescence minus one (FMO) controls were used to determine gates 
and MFI normalised to FMO controls for the same experimental condition. Four 
independent experiments were performed, with a single replicate and time-point (45 
minutes) in each. Again, a statistically significant increase in CD11b expression was 
observed (Figure 52(I) and 53(V)). CD29 and CD49d were both expressed on 
neutrophils, but there was no change in expression in response to PLY treatment 
(Figure 52(III), 53(I) and Figure 52(V), 53(V)). CD49b was not expressed by bone 
marrow derived neutrophils, and was not induced by treatment with PLY (Figure 
52(IV) and 53(IV)). We also observed unexpectedly low levels of CD18 expression, 
either in the presence or absence of PLY (Figure 52(II) and 53(II)). This was 
surprising, as CD11b is expressed at very high levels, and pairs with CD18 at the cell 
surface. Similarly, a previous study showed that CD18 was absent or low on bone 
marrow neutrophils, and only increased upon exposure to Leishmania  (Falcão et al. 
2015). We hypothesis that this finding may be explained by the antibody clone we 
used only recognising active CD18, or less likely, that CD11b can be expressed at 
the cell surface in the absence of CD18. Even though heterodimers of CD11b/CD18 
has been shown to play key roles in leukocyte adhesion and migration, transfection 
of cell lines with either CD11b or CD18 alone revealed distinct roles in attachment, 
spreading and migration (Solovjov et al. 2005).  
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Figure 52:  Summary of flow cytometric analysis of integrin expression on neutrophils 
treated with PLY 
Neutrophils were treated with 1.5 HU/mL PLY for 45 minutes, stained with antibodies to 
CD11b (I), CD18 (II), CD 29 (III), CD49b (IV) and CD49d (V) and analysed by flow 
cytometry. Graphs show the normalized median fluorescence intensity (MFI) of the 
indicated integrin in control and PLY treated neutrophils. Each pair of data points represents 
one individual experiment, of four performed in total. Significance was determined using a 
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Figure 53: Representative histograms of integrin expression on neutrophils treated 
with PLY (Figure 52) 
Neutrophils were treated with 1.5 HU/mL PLY for 45 minutes, stained with antibodies to (I) 
CD29, (II CD18, (III) CD49d, (IV) CD49b, (V) CD11b and (VI) Anti Ly6G and FMO 
before analysed by flow cytometry.  The [blue] peak shows fluorescent intensity of control 
neutrophils. The [-------] peak shows intensity of FMO for control neutrophils. The [red] 
peak shows staining on neutrophils treated with PLY/mL and [------] peaks for FMO of PLY 
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4.2.2.2 Analysis of integrin expression on neutrophils in an in vivo S. 
pneumoniae infection model 
 
Our in vitro analysis revealed no expression of CD49b on neutrophils isolated from 
bone marrow. This was not entirely surprising, since expression of this integrin has 
been shown to increase upon extravasation of neutrophils from blood to inflamed 
tissue. We therefore decided to assess integrin expression on neutrophils isolated 
from the blood and lungs of mice infected intranasally with S. pneumoniae. CD1 
(female) mice were infected intranasally with 10
6
 CFU of S. pneumoniae D39 strain. 
24 hours post-infection, blood and lungs were collected from three infected and three 
control mice. Successful infection was confirmed by analysis of bacterial CFU in 
both blood and lung (Figure 54 I-II). 
Single cell suspensions were prepared from lung tissue, and both blood and lung 




) increased in 
proportion in both blood and lung following infection (Figure 55 I-II). We next 
assessed integrin expression on neutrophils. We focused on CD49d as it has been 
suggested to play a role in recruitment of neutrophils to S. pneumoniae infected lungs 
(Kadioglu et al. 2011), and CD49b as it has been suggested to promote intersitital 
migration (Werr et al. 2000), and migration from the interstitum to inflamed alveoli 
(Ridger et al. 2001).  
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Figure 54: Bacterial load in blood and lungs following intranasal infection with 
S.pneumoniae 
CD1 mice were infected intranasally with 10
6
 CFU of S. pneumoniae D39 strain. Samples 
of blood (I) and lung tissue (II) were collected from control (n=3) and infected (n=3) mice 24 
hours post-infection and plated on blood agar for Miles & Misra counts. Graphs depict 





Figure 55: Neutrophils significantly increase in proportion in infected blood and lung 
CD1 mice were infected intranasally with 10
6
 CFU of S.pneumoniae D39 strain. Samples of 
blood (I) and lung tissue (II) were collected from control (n=6) and infected (n=6) mice 24 





) after gating on CD45
+
 cells in (I) blood and (II) lung. Mean + 
SEM for 3 mice per condition is shown. Significance of p<0.05 was determined using an 
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We found that, unlike bone marrow neutrophils, blood and lung neutrophils 
expressed CD49b on the cell surface (Figure 56, 57 and 58). However, blood and 
lung neutrophils expressed similar levels of CD49b, indicating that expression is not 
modulated by extravasation from blood to tissue. There was also no change in 
CD49b expression in response to infection in either tissue (Figure 57 III and 58 III).  
 
Figure 56: No increase in CD49b expression in response to infection in blood and lung 
neutrophils 
 CD1 mice were infected intranasally with 106 CFU of S.pneumoniae D39 strain. Samples of 
blood and lung were collected from control (n=6) and infected (n=6) mice 24 hours post 





) after gating on CD45
+
 cells in blood and lung. The data 
represent the means + SEM of 6 mice and statistical significant using two-way ANOVA with 
post-hoc Tukey’s multiple comparison (p<0.05), ns denote not significant. 
 
 
142 | P a g e  
Chapter 4 – Molecular mechanisms 
 
Figure 57:  Representative flow cytometric analysis of CD49b in blood (for Figure 56) 
CD1 mice were infected intranasally with 10
6
 CFU of S.pneumoniae D39 strain. Samples of 
blood were collected from control (n=6) and infected (n=6) mice 24 hours post-infection and 
processed for flow cytometry. (I-II) Flow cytometric analysis of neutrophils from (I) control 
(n=6), and (II) infected (n=6) mice. Plots on the far left show discrimination of single cells 
from doublets (SSC-H vs SSC-A), followed by discrimination of leukocytes based on CD45 




) were gated on, and analysed for expression of 
CD49b. [Grey] histograms indicate FMO controls. (III) The [blue] histogram indicates 
CD49b expression on neutrophils control in blood. The [red] indicates CD49b expression on 
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Figure 58:  Representative flow cytometric analysis of CD49b in lung (for Figure 56) 
CD1 mice were infected intranasally with 10
6
 CFU of S.pneumoniae D39 strain. Samples of 
blood were collected from control (n=6) and infected (n=6) mice 24 hours post-infection and 
processed for flow cytometry. (I-II) Flow cytometric analysis of neutrophils from (I) control 
(n=6), and (II) infected (n=6) mice. Plots on the far left show discrimination of single cells 
from doublets (SSC-H vs SSC-A), followed by discrimination of leukocytes based on side 











) cells were gated on, and analysed for expression of CD49b. [Grey] 
histograms indicate FMO controls. (III) The [blue] histogram indicates CD49b expression on 
neutrophils control in lung. The [red] indicates CD49b expression on neutrophils infected 
with D39 bacteria in lung. Data are representative of two independent experiments. 
 
 
Our in vitro data showed that CD49d is expressed on isolated neutrophils, although 
no changes in expression were seen after PLY stimulation. Nevertheless, we 
analysed expression of CD49d on neutrophils from infected mice, as previous studies 
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have shown that neutrophil accumulation in S. pneumoniae infected lungs is related 
to CD49d expression (Kadioglu et al. 2011). 
 
We found that, similar to bone marrow neutrophils, blood and lung neutrophils also 
expressed CD49d on the cell surface (Figure 59, 60 and 61). However, blood and 
lung neutrophils expressed similar levels of CD49d, indicating that expression is not 
modulated by extravasation from blood to tissue. There was also no change in 
CD49d expression in response to infection in either tissue (Figure 60 III and 61 III). 
This agreed with our in vitro findings, which also showed no change in CD49d 
expression in response to PLY treatment.  
 
 
Figure 59: No changes in CD49d expression in response to infection in blood and lung 
neutrophils 
CD1 mice were infected intranasally with 10
6
 CFU of S.pneumoniae D39 strain. Samples of 
blood and lung were collected from control (n=6) and infected (n=6) mice 24 hours post-





) after gating on CD45
+
 cells in blood and lung. The data 
represent the means ± SEM of 6 mice and statistical significance was determined using two-
way ANOVA with post-hoc Tukey’s multiple comparison (p<0.05), ns denote not 
significant. 
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Figure 60: Representative flow cytometric analysis of CD49d in blood for (Figure 59) 
CD1 mice were infected intranasally with 10
6
 CFU of S.pneumoniae D39 strain. Samples of 
blood were collected from control (n=6) and infected (n=6) mice 24 hours post-infection and 
processed for flow cytometry. (I-II) Flow cytometric analysis of neutrophils from (I) control 
(n=6), and (II) infected (n=6) mice. Plots on the far left show discrimination of single cells 
from doublets (SSC-H vs SSC-A), followed by discrimination of leukocytes based on side 











) cells were gated on, and analysed for expression of CD49d. [Grey] 
histograms indicate FMO controls. (III) The [blue] histogram indicates CD49d expression on 
neutrophils control in blood. The [red] indicates CD49d expression on neutrophils infected 
with D39 bacteria in blood. Data are representative of two independent experiments. 
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Figure 61: Representative flow cytometric analysis of CD49d in lung for (Figure 59) 
CD1 mice were infected intranasally with 10
6
 CFU of S.pneumoniae D39 strain. Samples of 
blood were collected from control (n=6) and infected (n=6) mice 24 hours post-infection and 
processed for flow cytometry. (I-II) Flow cytometric analysis of neutrophils from (I) control 
(n=6), and (II) infected (n=6) mice. Plots on the far left show discrimination of single cells 
from doublets (SSC-H vs SSC-A), followed by discrimination of leukocytes based on side 











) cells were gated on, and analysed for expression of CD49d. [Grey] 
histograms indicate FMO controls. (III) The [blue] histogram indicates CD49d expression on 
neutrophils control in lung. The [red] indicates CD49d expression on neutrophils infected 
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Our in vitro data showed an increase in CD11b expression on neutrophils treated 
with purified PLY. Here, we assessed changes in CD11b expression on neutrophils 
in the blood and lungs of mice infected with D39 bacteria. We found that CD11b 
expression on neutrophils was increased in lung tissue compared to blood (Figure 62 
I-III). 
    
Figure 62: CD11b expression is significantly increased on neutrophil that have 
extravastated into lung in mice with S. pneumonia 
CD1 mice were infected intranasally with 10
6
 CFU of S.pneumoniae D39 strain. Samples of 
blood and lung were collected from control (n=6) and infected (n=6) mice 24 hours post-





) after gating on CD45
+
 cells in blood and lung.  (II) The [blue] 
histogram indicates CD11b expression on neutrophils control. The [red] histogram indicates 
CD11b expression on neutrophils infected with D39 bacteria. Data are representative of two 
independent experiments. The data represent the means ± SEM of 6 mice and statistical 
significance was determined using two-way ANOVA with post-hoc Tukey’s multiple 
comparison * (p<0.05), **(p<0.01) and ****(p<0.0001) and ns denote not significant. 
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4.3 Discussion 
 
In this chapter we aimed to better understand the molecular mechanism by which 
PLY inhibits neutrophil migration. Treatment with PLY increased CD11b expression 
on neutrophils, together with actin polymerisation and adhesion. How these finding 
might explain the impaired migration in 2D and 3D assays observed in Chapter 3 
will be discussed here. 
 
4.3.1 PLY increased neutrophil adhesion and actin polymerization 
 
We found that treatment with PLY increased neutrophil adhesion to both TC treated 
plastic and fibronectin-coated plates, although the latter was only transient. Adhesion 
to plastic is likely mediated by adhesion factors present in serum, such as vitronectin 
(Reutter 1985), and is accompanied by an increase in intracellular Ca
2+
, an increase 
in F-actin, and activation of the respiratory burst (Ginis et al. 1992). Meanwhile, 
adhesion to fibronectin results in a smaller increase in intracellular Ca
2+
, actin 
depolymerisation, and priming of the cells for subsequent activation of the 
respiratory burst by exogenous factors (Ginis et al. 1992). These differences might 
help explain why PLY treated neutrophils showed sustained increases in adhesion to 
plastic, but only transient increased adhesion to fibronectin in this study. 
 
Chemoattractants induce regular transient increases in intracellular free Ca
2+
 in 
neutrophils. Experiments where intracellular Ca
2+
 is buffered have shown that these 
transient fluxes are required for motility by promoting uropod retraction through 
activation of myosin II, and detachment and endocytosis of integrins. Blocking 
integrins in calcium-buffered neutrophils restores motility (Mandeville & Maxfield 
1997). By forming pores in the cell membrane, PLY can produce a strong cellular 
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Ca
2+ 
influx (Stringaris et al. 2002), which may promote initial adhesion, but also 
mask the transient Ca
2+
 fluxes required for motility. 
 
We also found that treatment with PLY produced increased actin polymerisation in 
some experiments. At sub-lytic concentrations, the pore forming function of PLY has 
been shown to be essential for rapid cytoskeletal reorganization leading to changes in 
astrocyte shape (Förtsch et al. 2011). In addition, PLY was shown to bind actin 
directly to increase actin polymerization in an in vitro assay (Hupp et al. 2013). This 
increase in actin polymerisation might explain increased adhesion to TC plastic, and 
decreased chemotaxis observed in Chapter 3, where PLY inhibited neutrophil 
chemotaxis in 2D and 3D assays. 
 
Meanwhile, LPS has already been shown to stimulate neutrophil adhesion to plastic 
(Dahinden et al. 1983). Studies have shown that stiffness of neutrophils was 
increased after stimulation with LPS, which related to actin re-organisation, and led 
to cell retention in pores of transwell filters (Erzurum et al. 1992). Another study 
found neutrophil chemotaxis was inhibited in response to LPS-induced autocrine 
ATP signalling, and increases in intracellular calcium (Wang et al. 2017). These 
studies contrast with our 2D and 3D chemotaxis assays, where LPS-treated 
neutrophils migrated normally, compared to untreated neutrophils.  
 
Signals induced by LPS or PLY may lead to activation of integrins (inside-out 
process) which changes the conformation and clustering of integrin on the cell 
membrane. This increases the affinity and avidity/valency of the integrin for its 
ligand, respectively. Ligand-occupied integrins connect to the actin cytoskeleton 
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regulating its reorganization, and driving outside-in signalling, which regulates 
activities such as cell spreading, adhesion and migration (Langereis 2013).  
 
4.3.2 PLY increased CD11b expression on neutrophils 
 
CD11b forms a heterodimer with CD18, known as Mac-1 or complement receptor 3 
(CR3). CD11b is expressed on neutrophils and has important role in migration (Wang 
et al. 2002) in vitro and in vivo during extravasation. It also plays a direct role in the 
phagocytosis of iC3b-coated bacteria. 
 
We showed that CD11b expression markedly increased on neutrophils after exposure 
to PLY in vitro, and in the lungs following intranasal infection with S.pneumoniae. 
Interestingly, calcium flux increases expression and activation of CD11b (Petersen et 
al. 1993). The strong cellular Ca
2+ 
influx produced by PLY may therefore explain the 
increase in CD11b. 
 
Previous studies have shown that during pneumococcal infection, modulation of 
CD11b expression on the neutrophil surface plays a functionally significant role in the 
recognition and clearance of these bacteria (Williams et al. 2003), PLY-mediated up- 
regulation of CD11b/CD18 expression on neutrophils (Cockeran et al. 2001) and 
upregulation of CD11b expression on neutrophils has been shown during 
pneumococcal infection (Glynn et al. 1999; Rijneveld et al. 2005). CD11b is an 
important regulator of neutrophil adhesion and migration, including recruitment to the 
lung during S.pneumoniae infection (Kadioglu et al. 2011). It has broad ligand 
specificity, including components of the ECM, cell surface receptors, and proteases. 
Therefore, the increase in CD11b expression upon treatment with PLY might help to 
explain the observed changes in neutrophil motility and adhesion. 
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4.3.3 Increased CD11b expression might explain increased adhesion to 
fibronectin 
 
CD11b has been shown to be involved in neutrophil adhesion to fibronectin (van den 
Berg et al. 2001). In addition, S100A9 (small abundant proteins found in human 
neutrophil cytosol) can promote neutrophil adhesion to fibronectin through activation 
of CD18, though in this case, blocking CD11b had only a minor effect on adhesion 
(Anceriz et al. 2007). Consequently, increased adhesion to fibronectin might be 
explained by increased CD11b expression. 
 
Surprisingly, we found that CD18 expression was almost absent on neutrophils, even 
after stimulation with PLY. Studies where CD11b and CD18 were expressed 
individually in cell lines showed each subunit has a distinct function, where CD11b 
to important for firm adhesion and CD18 is critical for cell migration. This would fit 
with our data, where increased CD11b expression is linked to increased adhesion. 
However , the physiological relevance of this finding, such as whether or not CD11b 
would ever be expressed on the cell surface in the absence of CD18, is unclear 
(Solovjov et al. 2005).  
 
4.3.4 CD49b and CD49d 
 
Since PLY can modulate surface expression of CD11b, we investigated the effects of 
PLY treatment on a panel of other integrin subunits, including CD49b and CD49d. 
 Studies have shown CD49b/CD29  (collagen-binding) and CD49d/CD29 (VCAM-
1/fibronectin-binding) have an important role in regulating neutrophil interstitial 
migration and accumulation in the lungs, respectively (Werr et al. 2000; Kadioglu et 
al. 2011; Hynes 1992; Plow et al. 2000; Ridger et al. 2001).  
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4.3.4.1 CD49b 
 
In the absence of infection, we found that neutrophils in the mouse bone marrow did 
not express CD49b, while those in the blood and lung did. Previous studies using rat 
models have shown that CD49b is absent on blood neutrophils, and is only expressed 
during neutrophil extravasation to sites of inflammation in response to chemotactic 
stimuli (Werr et al. 2000). However others have shown that CD49b is expressed on 
neutrophils in mouse peripheral blood (Ridger et al. 2001). It is possible that lack of 
expression in bone marrow is due to negative selection of CD49b
+
 NK cells in our 
neutrophil isolation procedure, which could also remove CD49b
+
 neutrophils. 
Alternatively, CD49b may be expressed upon export from the bone marrow to blood 
stream, rather than during extravasation from blood to tissue. It is unclear why rats 
and mice would differ in this respect. CD49b is highly expressed on platelets 
(Madamanchi et al. 2014), and platelets and neutrophils can adhere to each other to 
form platelet-neutrophil complexes, particularly in bacterial infection (Johansson et 
al. 2011). Therefore, CD49b expression on blood neutrophils may be an artefact of 
platelet-neutrophil complexes.  
 
We observed no change in CD49b expression upon exposure to PLY, or following 
intranasal infection with S.pneumoniae. Furthermore, no change in CD49b 
expression was found following extravasation from blood to lung. This contrasts 
with the findings of Werr et al, who showed that CD49b expression was induced 
during PMN extravasation in response to chemotactic stimulation. Studies done by 
Werr et al have shown CD49b/CD29 is a key factor in neutrophil locomotion and 
recruitment to extravascular tissue. Expression of CD49b/CD29 also supported 
neutrophil motility in 3D collagen gels (Werr et al. 2000). However, our findings 
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here show that alteration in CD49b expression cannot explain the observed motility 




CD49d expression was observed in bone marrow, blood and lung neutrophils. 
However, CD49d expression was not significantly altered following treatment with 
PLY, or intranasal infection with S.pneumoniae. It has been shown that CD49d is 
expressed at low levels on rodent neutrophils and its expression is elevated as 
neutrophils are mobilized from the bone marrow (Furze & Rankin 2008). 
Meanwhile, other studies show that CD49d/CD29 expression on migrated 
neutrophils decreased during pneumococcus infection (Tasaka et al. 2002). During 
pneumococcus infection, neutrophil adherence to the vasculature and accumulation 
into the lung tissue is dependent on CD49d/CD29 (Kadioglu et al. 2011). Our 
findings here do not support the idea that alteration in CD49d expression could 
explain the observed motility defect following treatment with PLY. We cannot rule 
out that changes in activation of the integrin at the cell surfaces might explain the 
observed defect in migration. 
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4.4 Conclusion  
 
The data presented in this chapter gives rise to a hypothesis where impaired 
chemotaxis in PLY-treated neutrophils may be linked to increased CD11b 
expression, which drives firm adhesion to ECM-components, limiting migration. The 
role of Ca
2+
 flux in this process should also be investigated. We unexpectedly found 
low or absent levels of CD18 expression on neutrophils, whether or not CD11b 
would ever be expressed on the cell surface in the absence of CD18, remains unclear. 
It is possible that there was a technical issue with the antibody, and the use of a 
positive control cell known to express CD18 may help to elucidate this matter. 
Nevertheless, since CD18 staining was absent in both presence and absence of PLY, 
it cannot explain the observed differences in migration 
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Chapter 5: Global proteomic analysis of PLY-stimulated 
neutrophils 
 
5.1 Brief Introduction  
 
The S. pneumoniae toxin, pneumolysin (PLY) alters neutrophil migration and function, 
For example, PLY alters the respiratory burst and bactericidal activity in neutrophils, 
and our own experiments show a reduction in chemotaxis in 2D and 3D environments. 
However, the exact molecular mechanisms underpinning these functional changes 
remain unclear. Global analysis of changes in gene or protein expression following 
exposure of neutrophils to PLY might help to identify the molecular pathways 
involved in these functional changes. 
 
In Chapter 3 it was determined that PLY inhibited neutrophil chemotaxis in 2D and 3D 
migration assays, and that inhibition depended on the haemolytic activity of the toxin. 
In Chapter 4, the aim was to understand the molecular mechanism by which PLY 
inhibits neutrophil migration. We found that PLY increased CD11b expression on 
neutrophils in vitro and infection with S. pneumoniae increased CD11b expression on 
blood and lung neutrophils in vivo. PLY also increased actin polymerization, and 
adhesion to tissue culture plastic and fibronectin. While these findings may help to 
explain impaired migration, they do not provide a detailed molecular mechanism for 
our findings.  
 
The aim of this chapter was to obtain further clues as to how PLY inhibits neutrophil 
chemotaxis and defensive function, revealing novel influences of PLY on neutrophil 
function. To achieve this, we used label-free quantitative mass spectrometry to 
perform a global analysis of the effect of PLY on protein expression in neutrophils. 
156 | P a g e  
Chapter 5 - Proteomics 
The knowledge gained from this global analysis will identify candidate proteins 
involved in regulating neutrophil migration and function, which may be targeted 




5.2.1 Preliminary proteomic analysis of isolated neutrophils 
 
Mass spectrometry analysis was performed on isolated neutrophils to determine the 
minimum number of cells required to be able to detect proteins involved in 
neutrophil defensive function and motility.  
Neutrophils were harvested from bone marrow before being plated and incubated for 
4 hours. From a single mouse, 0.95x10
6 





) determined by flow cytometry. After incubation, neutrophils 
were washed twice in PBS to remove remaining serum, and cell pellets immediately 
frozen. Protein extraction, protein digestion, LC-MS/MS analysis, and identification 
of differentially expressed peptides were performed by Dr Stuart Armstrong from 
Department of Infection Biology, IGH. 
Using an exclusion criterion of ≥ 2 peptides identified per protein, 1600 proteins 
were identified in the preliminary experiment. The gene list analysis tool Panther was 
used to characterise the identified proteins according to biological process. A number 
of proteins categorised as “immune system process”, “biological adhesion” and 
“locomotion” were identified (Figure 63A). Data were compared with predicted 
proteins from the whole Mus musculus proteome, derived from Uniprot (Figure 
63B). We found that the proportion of proteins categorised under each biological 
process was similar in our dataset, as in the whole mouse proteome, suggesting there 
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was no enrichment or bias in the collection of data. Our dataset contained 7.52% of 
all proteins classified as “immune system process”, 7.41% of all proteins classified 
as “biological adhesion”, and 5.86% of all proteins classified as “locomotion” (Table 
11). Specific proteins identified in these categories are listed in Table 12, 13 and 14. 
Of these, integrin alpha-M, integrin alpha-L, L-selectin, integrin beta-2 are already 
known to play a role in neutrophil migration or adhesion. From a single mouse, we 
were able to detect a number of proteins involved in neutrophil defensive function 
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Figure 63: The percentage of proteins classified under each biological process is similar 
in isolated bone marrow neutrophils as in the whole mouse proteome. 
Neutrophils were purified from bone marrow before being plated and incubated for 4 hours 
at 37°C. Proteins were extracted, digested, and subjected to mass spectrometry. 1600 
identified proteins were classified using Panther (A) and compared with the whole mouse 
(B).  
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Table 11:  Comparison of proteins identified in three biological process categories    












612 46 7.52 
Biological Adhesion 270 20 7.41 
Locomotion 290 17 5.86 
 
Table 12:  Proteins identified in bone marrow neutrophils and classified in Panther as 
belonging to the biological process, “biological adhesion” 
 Mapped IDs Gene Name  Gene Symbol 
1 Q61411 GTPase HRas   Hras 
2 Q3UV74 Integrin beta-2-like protein   Itgb2l 
3 P05555 Integrin alpha-M   Itgam 
4 Q3U2S8 Voltage-gated hydrogen channel 1 Hvcn1 
5 P61226 Ras-related protein Rap-2b Rap2b 
6 Q80ZJ1 Ras-related protein Rap-2a Rap2a 
7 Q9QVP9 Protein-tyrosine kinase 2-beta Ptk2b 
8 P62835 Ras-related protein Rap-1A Rap1a 
9 Q9ERD8 Gamma-parvin Parvg 
10 Q8BU31 Ras-related protein Rap-2c Rap2c 
11 P32883 GTPase KRas Kras 
12 Q60875 Rho guanine nucleotide exchange factor 
2 
Arhgef2 
13 P24063 Integrin alpha-L Itgal 
14 P18337 L-selectin Sell 
15 P08556 GTPase NRas Nras 
16 Q4LDD4 Arf-GAP with Rho-GAP domain, ANK 
repeat and PH domain-containing protein 
1 
Arap1 
17 Q9JIW9 Ras-related protein Ral-B Ralb 
18 P11835 Integrin beta-2 Itgb2 
19 P16879 Tyrosine-protein kinase Fes/Fps Fes 
20 P97797 Tyrosine-protein phosphatase non-
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Table 13:  Proteins identified in bone marrow neutrophils and classified in Panther as 
belonging to the biological process, “immune system process” 
 Mapped IDs Gene Name  Gene Symbol 
1 Q04207 Transcription factor p65 Rela 
    
2 P11352 Glutathione peroxidase 1 Gpx1 
3 P42232 Signal transducer and activator of 
transcription 5B 
Stat5b 
4 Q9CXY6 Interleukin enhancer-binding factor 2 Ilf2 
5 P06339 H-2 class I histocompatibility antigen, 
D-37 alpha chain 
H2-T23 
6 P48453 Serine/threonine-protein phosphatase 
2B catalytic subunit beta isoform 
Ppp3cb 
7 Q8BK64 Activator of 90 kDa heat shock protein 
ATPase homolog 1 
Ahsa1 
8 Q3U2S8 Voltage-gated hydrogen channel 1 Hvcn1 
9 P48025 Tyrosine-protein kinase SYK 
phosphatase 2B catalytic subunit alpha 
isoform 
Syk 
10 P48722 Heat shock 70 kDa protein 4L Hspa4l 
11 Q9QZS3 Protein numb homolog Numb 
12 P97315 Cysteine and glycine-rich protein 1 Csrp1 
13 P63087 Serine/threonine-protein phosphatase 
PP1-gamma catalytic subunit 
Ppp1cc 
14 Q9QVP9 Protein-tyrosine kinase 2-beta Ptk2b 
15 P63330 Serine/threonine-protein phosphatase 
2A catalytic subunit alpha isoform 
Ppp2ca 
16 P63328 Serine/threonine-protein  Ppp3ca 
17 P41216 Long-chain-fatty-acid--CoA ligase 1 Acsl1 
18 P30993 C5a anaphylatoxin chemotactic receptor 
1 
C5ar1 
19 P14234 Tyrosine-protein kinase Fgr Fgr 
20 O08807 Peroxiredoxin-4 Prdx4 
21 P18337 L-selectin Sell 
22 P42230 Signal transducer and activator of 
transcription 5A 
Stat5a 
23 Q64277 ADP-ribosyl cyclase/cyclic ADP-ribose 
hydrolase 2 
Bst1 
24 P48999 Arachidonate 5-lipoxygenase Alox5 
25 P27784 C-C motif chemokine 6 Ccl6 
26 P62137 Serine/threonine-protein phosphatase 
PP1-alpha catalytic subunit 
Ppp1ca 
27 P08103 Tyrosine-protein kinase HCK Hck 
28 Q91VI7 Ribonuclease inhibitor Rnh1 
29 P25911 Tyrosine-protein kinase Lyn Lyn 
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30 O88536 Formyl peptide receptor 2 Fpr2 
31 Q8K4I3 Rho guanine nucleotide exchange factor 
6 
Arhgef6 
32 P42225 Signal transducer and activator of 
transcription 1 
Stat1 
33 Q61805 Lipopolysaccharide-binding protein Lbp 
34 O54950 5'-AMP-activated protein kinase subunit 
gamma-1 
Prkag1 
35 Q3UND0 Src kinase-associated phosphoprotein 2 Skap2 
36 Q91XR9 Phospholipid hydroperoxide glutathione 
peroxidase, nuclear 
Gpx4 
37 P28293 Cathepsin G Ctsg 
38 Q91VE0 Long-chain fatty acid transport protein 
4 
Slc27a4 
39 P27870 Proto-oncogene vav Vav1 
40 P22437 Prostaglandin G/H synthase 1 Ptgs1 
41 Q99J93 Interferon-induced transmembrane 
protein 2 
Ifitm2 
42 P41241 Tyrosine-protein kinase CSK Csk 
43 P42227 Signal transducer and activator of 
transcription 3 
Stat3 
44 P16879 Tyrosine-protein kinase Fes/Fps Fes 
45 Q61316 Heat shock 70 kDa protein 4 Hspa4 
46 P97797 Tyrosine-protein phosphatase non-
receptor type substrate 1 
Sirpa 
 
Table 14:  Proteins identified in bone marrow neutrophils and classified in Panther as 
belonging to the biological process, “locomotion” 
 Mapped IDs  Gene Name Gene Symbol 
1 Q3UV74 Integrin beta-2-like protein Itgb2l 
2 Q8R527 Rho-related GTP-binding protein RhoQ Rhoq 
3 Q62178 Semaphorin-4A Sema4a 
4 P60766 Cell division control protein 42 
homolog 
Cdc42 
5 O35904 Phosphatidylinositol 4,5-bisphosphate 
3-kinase catalytic subunit delta isoform 
Pik3cd 
6 P30993 C5a anaphylatoxin chemotactic receptor 
1 
C5ar1 
7 Q7TMB8 Cytoplasmic FMR1-interacting protein 
1 
Cyfip1 
8 Q9CPW4 Actin-related protein 2/3 complex 
subunit 5 
Arpc5 
9 P27784 C-C motif chemokine 6 Ccl6 
10 Q9QUI0 Transforming protein RhoA Rhoa 
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11 P60764 Ras-related C3 botulinum toxin 
substrate 3 
Rac3 
12 O88536 Formyl peptide receptor 2 Fpr2 
13 P62746 Rho-related GTP-binding protein RhoB Rhob 
14 P11835 Integrin beta-2 Itgb2 
15 Q99J93 Interferon-induced transmembrane 
protein 2 
Ifitm2 
16 Q62159 Rho-related GTP-binding protein RhoC Rhoc 
17 P16879 Tyrosine-protein kinase Fes/Fps Fes 
 
 
5.2.2  Proteomic analysis of the effect of PLY on neutrophils  
 
We next proceeded with proteomic analysis of neutrophils stimulated with PLY. 
Unstimulated neutrophils were used as a negative control, and LPS treated 
neutrophils used to (1) reveal unique aspects of the neutrophil response to PLY vs 
general activation, and (2) control for any contaminating LPS in the PLY 
preparation. Neutrophils were isolated from bone marrow of four mice in each of 
three independent experiments. Neutrophils were left untreated, or treated with PLY 
or LPS, and plated for 4 hours at 37°C. Prior to proteomic analysis, quality control 
was performed by withdrawing small numbers of cells for flow cytometric analysis 
of purity, survival and CD11b expression. Since we observed increased adhesion of 
PLY-treated cells to TC plastic in Chapter 4, cells from each condition were also 
counted to check cell recovery was roughly equivalent. A summary of the quality 
control data is presented in Table 15. Purity exceeded 95% in all experiments; with 
more than 90% viable cells in all conditions with MFI ratio for CD11b expression on 
neutrophil at more than 3.0 for PLY and LPS treated neutrophils. Results for quality 
control were further supported by Figures in 64, 65, 66 and 67 with bar charts and 
representative flow cytometry histogram and plots.  
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Table 15: Summary of quality control results for proteomic samples 
(A) Neutrophils were stained with anti-CD11b and anti-Ly6G and analysed by flow 
cytometry to check pre-culture purity (B) Neutrophils was plated alone, or with PLY or LPS, 
and incubated at 37°C for 4 hours. After incubation, cells were stained with Live /Dead dye 
and anti-CD11b, and analysed by flow cytometry. 
Samples isolated  (3 independent 
isolations, 4 mice pooled for each)  
Yield (n=3) Purity (%)(n=3) 
(A) Neutrophils  3.37 x107 + 2.5 x106 96.7 + 1.4 
(B) Staining: Live/ Dead and CD11b   % of Live cells (n=3) MFI  Ratio (n=3) 
Neutrophils 97 + 0.2 1.0 + 0.0 
Neutrophils + PLY  95 + 0.5 3.6 + 0.5 
Neutrophils +LPS   93 + 1.0 12.9 + 2.2 
 
In Figure 64 (I), a summary of total cell counts recovered at the end of the culture 
period is presented. Even after thoroughly scraping off the neutrophils attached to the 
TC plastic plate, we still recovered slightly fewer PLY-treated neutrophils than 
untreated or LPS-treated neutrophil, which agrees with increased adhesion in our 
earlier experiments. In Figure 66, CD11b expression on neutrophils was increased 
after treatment with PLY and this agreed with our previous data in Chapter 3. This 
confirmed that the neutrophils had responded appropriately to PLY treatment. 
However, we also found that LPS treated neutrophils showed a more dramatic 
increase in CD11b expression when compared to PLY-treated neutrophils, and to our 
previous data in Chapter 3. This may due to the timing of the exposure to PLY: 45 
minutes in Chapter 3, and 4 hours in this chapter. As a final assessment of sample 
quality, Figure 67 shows that PLY (II) and LPS (III) -treated neutrophils have a good 
viability, comparable with control, untreated neutrophils. Our quality control results 














) to proceed with the full proteomic analysis.  
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Figure 64: Flow cytometry analysis of neutrophil purity in samples used for proteomic 
analysis. 
Neutrophils were purified from bone marrow and a small aliquot withdrawn and stained with 
anti-CD11b and anti Ly6G to check purity. From left to right, plots show discrimination of 
live cells based on forward and side scatter, discrimination of single cells from doublets, 
discrimination of live cells, and neutrophils identified by positive staining for CD11b and 




Figure 65: CD11b expression was increased on PLY-treated neutrophils used for 
proteomic analysis 
Neutrophils were plated alone, or with PLY or LPS, and incubated at 37°C for 4 hours 
before small aliquots were withdrawn for analysis of CD11b expression. The [purple] peak 
shows fluorescent intensity of unstained control cells. The [orange] peak shows CD11b 
staining on untreated neutrophils. The [green] peak shows CD11b staining on neutrophils 
treated with PLY and [red] peak for LPS treated neutrophils. Data are representative of three 
independent experiments. 
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Figure 66:  Summary of quality control analysis for proteomic studies 
Neutrophils was plated alone, or with PLY or LPS, and incubated at 37°C for 4 hours. After 
incubation, cells were recovered and analysed by flow cytometry. Graphs depict (I) Total 
cell counts at the end of the culture period (II) Percentage viability of neutrophils assessed by 
LIVE/DEAD staining, (III) Ratio of CD11b MFI in treated compared to untreated 
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Figure 67:  Flow cytometry analysis of cell viability in neutrophils used for proteomic 
analysis 
Neutrophils were plated alone, or with PLY or LPS, and incubated at 37°C for 4 hours. After 
incubation small aliquots were withdrawn for Live/Dead Staining dye and analysed by flow 
cytometry. (I) Untreated neutrophils (II) Neutrophils treated with PLY (III) Neutrophils 
treated with LPS. Plots are representative of 3 independent experiments. 
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 5.2.3  Global Analysis of the neutrophil response to PLY treatment 
 
Having confirmed sample quality for nine samples from three replicates for each 
condition (control, PLY and PLY –treated neutrophils) we proceeded to label free 
quantitative proteomic analysis. Sample processing and data analysis was performed 
by Dr Stuart Armstrong.  Group comparisons were performed using the Progenesis 
LC-MS proteomics software platform. Statistically significant differentially abundant 
proteins (ANOVA) from both pairwise comparisons and between all groups were 
used to investigate protein function and enrichment using the online tools DAVID 
and STRING, this was assisted by Dr Stuart Armstrong. Data obtained were run 
through UniProt Programme for additional protein identification and function. 
Candidate proteins from the analysis where then validated based on function related 
to migration using western blot, immunofluorescence staining and 2D chemotaxis 
assay. The summary of schematic workflow performed during this process is in 
Figure 68.  
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Figure 68: Schematic diagram of the workflow for proteomic analysis. 
Neutrophils were purified from bone marrow, and plated alone or with PLY or LPS. After 4 
hours, samples were collected for proteomic analysis. Following protein extraction and 
digestion, samples were analysed by label free quantitative mass spectrometry. Following 
quantification and identification of proteins, data were analysed in two ways to identify 
proteins altered in abundance by PLY, but not LPS; pairwise and multi-way comparisons. 
Post proteomic analysis to validate targets with a putative role in cell migration included 
western blotting, immunofluorescent staining, and function blocking experiments.  
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5.2.3.1 Pairwise comparison between PLY vs control and LPS vs Control, to 
identify proteins significantly changed only by PLY. 
 
Initially, pairwise comparisons between PLY-treated and control neutrophils, and 
between LPS-treated and control neutrophils were performed by Progenesis LC-MS 
where the peptide intensities were normalised against the reference, highlighting the 
differences in protein expression between both samples. Spectral data were then 
exported for peptide identification using Mascot. Using an exclusion criteria of q 
<0.05, >2 unique peptides, >2 fold change, 82 proteins changed in abundance 
following treatment with PLY (41 upregulated and 41 downregulated), and 57 
proteins changed in abundance following treatment with LPS (22 upregulated and 35 
downregulated) (Appendix 1-2). 
PLY-treatment of neutrophils results in impaired chemotaxis, whereas treatment with 
LPS does not. To identify proteins that change in abundance in response to PLY, but 
not LPS, we compared the lists of proteins significantly changed in abundance in 
PLY-treated samples vs controls, and in LPS-treated samples vs controls.  
 
We found 22 proteins significantly increased in abundance in PLY-treated 
neutrophils compared to control, but not in LPS-treated samples compared to control 
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Figure 69:  Venn diagram of the proteins upregulated in LPS-treated neutrophils 
(blue), and PLY treated neutrophils (yellow) vs control 




Table 16: List of protein upregulated in LPS- treated neutrophils vs control 
No. Accession Gene Protein 
1.  Q9R0U0 Srsf10 Serine/arginine-rich splicing factor 10  
2.  Q8VDM6 Hnrnpul1 Heterogeneous nuclear ribonucleoprotein U-like 
protein 1  
3.  Q8CHK3 Mboat7 Lysophospholipid acyltransferase 7  
4.  Q8BTI9 Pik3cb Phosphatidylinositol 4,5-bisphosphate 3-kinase 
catalytic subunit beta isoform  
5.  P36371 Tap2 Antigen peptide transporter 2  
6.  Q99MK8 Adrbk1 Beta-adrenergic receptor kinase 1  
7.  O88668 Creg1 Protein CREG1  
8.  Q8K352 Sash3 SAM and SH3 domain-containing protein 3  
9.  Q8QZY6 Tspan14 Tetraspanin-14  
10.  P58021 Tm9sf2 Transmembrane 9 superfamily member 2  
11.  O35841 Api5 Apoptosis inhibitor 5  
12.  Q9Z1F9 Uba2 SUMO-activating enzyme subunit 2  
13.  Q9JKB1 Uchl3 Ubiquitin carboxyl-terminal hydrolase isozyme L3  
14.  Q9D6R2 Idh3a Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial  
15.  Q6P1F6 Ppp2r2a Serine/threonine-protein phosphatase 2A 55 kDa 
regulatory subunit B alpha isoform  
16.  P97484 Lilrb3 Leukocyte immunoglobulin-like receptor 
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subfamily B member 3  
17.  Q80UG5 Sept9 Septin-9 OS  
18.  O08749 Dld Dihydrolipoyl dehydrogenase, mitochondrial  
19.  Q9DBC7 Prkar1a cAMP-dependent protein kinase type I-alpha 
regulatory subunit  
20.  Q9R062 Gyg1 Glycogenin-1  
21.  Q03267 Ikzf1 DNA-binding protein Ikaros  
22.  P63082 Atp6v0c V-type proton ATPase 16 kDa proteolipid subunit  
 
Table 17: List of protein upregulated in PLY-treated neutrophils vs control 
No. Accession Gene Protein 
1.  Q9Z1F9 Uba2 SUMO-activating enzyme subunit 2  
2.  Q9R0U0 Srsf10 Serine/arginine-rich splicing factor 10  
3.  Q9CR68 Uqcrfs1 Cytochrome b-c1 complex subunit Rieske, 
mitochondrial  
4.  O88668 Creg1 Protein CREG1  
5.  Q60931 Vdac3 Voltage-dependent anion-selective channel protein 
3  
6.  Q9JHK5 Plek Pleckstrin  
7.  Q8CHK3 Mboat7 Lysophospholipid acyltransferase 7  
8.  Q8BTI9 Pik3cb Phosphatidylinositol 4,5-bisphosphate 3-kinase 
catalytic subunit beta isoform  
9.  Q9D6R2 Idh3a Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial  
10.  P58021 Tm9sf2 Transmembrane 9 superfamily member 2  
11.  Q8VDM6 Hnrnpul1 Heterogeneous nuclear ribonucleoprotein U-like 
protein 1  
12.  P36371 Tap2 Antigen peptide transporter 2  
13.  Q8QZY6 Tspan14 Tetraspanin-14  
14.  Q9D0M3 Cyc1 Cytochrome c1, heme protein, mitochondrial  
15.  Q8K352 Sash3 SAM and SH3 domain-containing protein 3  
16.  P63028 Tpt1 Translationally-controlled tumor protein 7  
17.  Q6P8X1 Snx6 Sorting nexin-6  
18.  Q9JKB1 Uchl3 Ubiquitin carboxyl-terminal hydrolase isozyme L3  
19.  P97484 Lilrb3 Leukocyte immunoglobulin-like receptor subfamily 
B member 3  
20.  P63082 Atp6v0c V-type proton ATPase 16 kDa proteolipid subunit  
21.  Q9WTP6 Ak2 Adenylate kinase 2, mitochondrial  
22.  Q61768 Kif5b Kinesin-1 heavy chain  
23.  Q6P1F6 Ppp2r2a Serine/threonine-protein phosphatase 2A 55 kDa 
regulatory subunit B alpha isoform  
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24.  O09043 Napsa Napsin-A  
25.  Q99MK8 Adrbk1 Beta-adrenergic receptor kinase 1  
26.  Q9R062 Gyg1 Glycogenin-1  
27.  P54775 Psmc4 26S protease regulatory subunit 6B  
28.  Q80W54 Zmpste24 CAAX prenyl protease 1 homolog  
29.  Q80UG5 Sept9 Septin-9   
30.  Q921F4 Hnrnpll Heterogeneous nuclear ribonucleoprotein L-like  
31.  P16879 Fes Tyrosine-protein kinase Fes/Fps  
32.  B2RQC6 Cad CAD protein  
33.  A3KGF7 Plcb2 1-phosphatidylinositol 4,5-bisphosphate 
phosphodiesterase beta-2  
34.  Q8QZS1 Hibch 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial  
35.  P50637 Tspo Translocator protein  
36.  Q571E4 Galns N-acetylgalactosamine-6-sulfatase  
37.  O35593 Psmd14 26S proteasome non-ATPase regulatory subunit 14  
38.  Q03267 Ikzf1 DNA-binding protein Ikaros  
39.  Q3UMR5 Mcu Calcium uniporter protein, mitochondrial  
40.  Q8BGQ7 Aars Alanine--tRNA ligase, cytoplasmic  
41.  Q9WV54 Asah1 Acid ceramidase  
 
 
Table 18: List of proteins significantly upregulated in PLY-treated neutrophils only 
No.                                                                                                                                                                                                                                                                                                                                                                                                                                                UniP
Accession 
Gene Protein
1.  Q8BGQ7 Aars Alanine--tRNA ligase, cytoplasmic 
2.  Q9WTP6 Ak2 Adenylate kinase 2, mitochondrial 
3.  Q9WV54 Asah1 Acid ceramidase 
4.  B2RQC6 Cad CAD protein 
5.  Q9D0M3 Cyc1 Cytochrome c1, heme protein, mitochondrial 
6.  P16879 Fes Tyrosine-protein kinase Fes/Fps 
7.  Q571E4 Galns N-acetylgalactosamine-6-sulfatase 
8.  Q8QZS1 Hibch 3-hydroxyisobutyryl-CoA hydrolase, 
mitochondrial 
9.  Q921F4 Hnrnpll Heterogeneous nuclear ribonucleoprotein L-like 
10.  Q61768 Kif5b Kinesin-1 heavy chain 
11.  Q3UMR5 Mcu Calcium uniporter protein, mitochondrial 
12.  O09043 Napsa Napsin-A 
13.  A3KGF7 Plcb2 1-phosphatidylinositol 4,5-bisphosphate 
phosphodiesterase beta-2 
14.  Q9JHK5 Plek Pleckstrin 
15.  P54775 Psmc4 26S protease regulatory subunit 6B 
16.  Q6P8X1 Snx6 Sorting nexin-6 
17.  P63028 Tpt1 Translationally-controlled tumor protein 
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18.  Q9CR68 Uqcrfs1 Cytochrome b-c1 complex subunit Rieske, 
mitochondrial 
19.  Q60931 Vdac3 Voltage-dependent anion-selective channel protein 
3 
20.  Q80W54 Zmpste24 CAAX prenyl protease 1 homolog 
21.  O35593 Psmd14 26S proteasome non-ATPase regulatory subunit 
14 
22.  P50637 Tspo Translocator protein 
 
Meanwhile, 16 proteins significantly decreased in PLY-treated neutrophils compared 
to control, but not in LPS-treated neutrophils compared to control (Figure 70, Table 
19, Table 20 and Table 21). 
 
 
Figure 70:Venn diagram of the proteins of downregulated in LPS-treated neutrophils 
(blue), and PLY-treated neutrophils (yellow) vs control 
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Table 19: List of proteins downregulated in LPS-treated neutrophils vs control 
No. Accession Gene Protein 
1.  Q08093 Cnn2 Calponin-2  
2.  P80316 Cct5 T-complex protein 1 subunit epsilon  
3.  Q99LF4 Rtcb tRNA-splicing ligase RtcB homolog  
4.  P15702 Spn Leukosialin  
5.  Q9QZD9 Eif3i Eukaryotic translation initiation factor 3 subunit 
I  
6.  P97797 Sirpa Tyrosine-protein phosphatase non-receptor type 
substrate 1  
7.  Q99KE1 Me2 NAD-dependent malic enzyme, mitochondrial  
8.  Q9R1T4 Sept6 Septin-6  
9.  Q64324 Stxbp2 Syntaxin-binding protein 2  
10.  P27601 Gna13 Guanine nucleotide-binding protein subunit 
alpha-13  
11.  Q64277 Bst1 ADP-ribosyl cyclase/cyclic ADP-ribose 
hydrolase 2  
12.  P97315 Csrp1 Cysteine and glycine-rich protein 1  
13.  P99026 Psmb4 Proteasome subunit beta type-4  
14.  Q60590 Orm1 Alpha-1-acid glycoprotein 1  
15.  Q62426 Cstb Cystatin-B  
16.  P49446 Ptpre Receptor-type tyrosine-protein phosphatase 
epsilon  
17.  P82198 Tgfbi Transforming growth factor-beta-induced protein 
ig-h3  
18.  Q8BZQ2 Crispld2 Cysteine-rich secretory protein LCCL domain-
containing 2  
19.  Q504P2 Clec12a C-type lectin domain family 12 member A  
20.  Q9DCL9 Paics Multifunctional protein ADE2  
21.  Q6WVG3 Kctd12 BTB/POZ domain-containing protein  
22.  P51675 Ccr1 C-C chemokine receptor type 1  
23.  P07724 Alb Serum albumin  
24.  Q9EP69 Sacm1l Phosphatidylinositide phosphatase SAC1  
25.  Q8BK64 Ahsa1 Activator of 90 kDa heat shock protein ATPase 
homolog 1  
26.  Q8VH51 Rbm39 RNA-binding protein 39  
27.  Q9WTL7 Lypla2 Acyl-protein thioesterase 2  
28.  O70138 Mmp8 Neutrophil collagenase  
29.  Q8BGB5 Limd2 LIM domain-containing protein  
30.  Q52KI8 Srrm1 Serine/arginine repetitive matrix protein  
31.  Q8VEM8 Slc25a3 Phosphate carrier protein, mitochondrial  
32.  Q8R016 Blmh Bleomycin hydrolase  
33.  P35174 Stfa2 Stefin-2  
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34.  O09044 Snap23 Synaptosomal-associated protein 23  
35.  P40240 Cd9 CD9 antigen  
36.  Q6P5F9 Xpo1 Exportin-1  
37.  P11928 Oas1a 2'-5'-oligoadenylate synthase 1A  
38.  Q9R0X4 Acot9 Acyl-coenzyme A thioesterase 9, mitochondrial  
39.  Q9D154 Serpinb1a Leukocyte elastase inhibitor A  
40.  P50637 Tspo Translocator protein  
41.  O35593 Psmd14 26S proteasome non-ATPase regulatory subunit 
14  
 
Table 20: List of proteins downregulated in PLY-treated neutrophils vs control 
No. Accession Gene Protein 
1.  P97797 Sirpa Tyrosine-protein phosphatase non-receptor type 
substrate  
2.  P80316 Cct5 T-complex protein 1 subunit epsilon  
3.  Q08093 Cnn2 Calponin-2  
4.  P97315 Csrp1 Cysteine and glycine-rich protein 1  
5.  P07724 Alb Serum albumin  
6.  Q9R1T4 Sept6 Septin-6  
7.  Q9QZD9 Eif3i Eukaryotic translation initiation factor 3 subunit 
I  
8.  Q504P2 Clec12a C-type lectin domain family 12 member A  
9.  P12815 Pdcd6 Programmed cell death protein 6  
10.  P15702 Spn Leukosialin  
11.  Q9DB05 Napa Alpha-soluble NSF attachment protein  
12.  Q64324 Stxbp2 Syntaxin-binding protein 2 
13.  Q8VC88 Gca Grancalcin  
14.  P99026 Psmb4 Proteasome subunit beta type-4  
15.  Q8BFY6 Pef1 Peflin  
16.  Q99LF4 Rtcb tRNA-splicing ligase RtcB homolog  
17.  Q9CPQ8 Atp5l ATP synthase subunit g, mitochondrial  
18.  P59108 Cpne2 Copine-2  
19.  Q60590 Orm1 Alpha-1-acid glycoprotein 1  
20.  Q9EP69 Sacm1 Phosphatidylinositide phosphatase SAC1  
21.  P82198 Tgfbi Transforming growth factor-beta-induced 
protein ig-h3  
22.  Q9DCL9 Paics Multifunctional protein ADE2  
23.  Q6P5F9 Xpo1 Exportin-1  
24.  P27601 Gna13 Guanine nucleotide-binding protein subunit 
alpha-13  
25.  P41241 Csk Tyrosine-protein kinase CSK  
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26.  P56376 Acyp1 Acylphosphatase-1  
27.  Q52KI8 Srrm1 Serine/arginine repetitive matrix protein 1  
28.  Q99L04 Dhrs1 Dehydrogenase/reductase SDR family member 1  
29.  Q8BGB5 Limd2 LIM domain-containing protein 2  
30.  Q8BFR5 Tufm Elongation factor Tu, mitochondrial  
31.  Q64277 Bst1 ADP-ribosyl cyclase/cyclic ADP-ribose 
hydrolase 2  
32.  P35174 Stfa2 Stefin-2  
33.  P47968 Rpia Ribose-5-phosphate isomerase  
34.  Q501J6 Ddx17 Probable ATP-dependent RNA helicase DDX17  
35.  P40240 Cd9 CD9 antigen  
36.  P51675 Ccr1 C-C chemokine receptor type 1  
37.  Q8BK64 Ahsa1 Activator of 90 kDa heat shock protein ATPase 
homolog 1  
38.  P11928 Oas1a 2'-5'-oligoadenylate synthase 1A  
39.  O88842 Fgd3 FYVE, RhoGEF and PH domain-containing 
protein 3  
40.  P97930 Dtymk Thymidylate kinase  
41.  Q8BUK6 Hook3 Protein Hook homolog 3  
42.  P17433 Spi1 Transcription factor PU.1  
 
Table 21: List of proteins significantly downregulated in PLY-treated neutrophils only 
No. UniP 
Accession 
Gene Protein  
1.  P56376 Acyp1 Acylphosphatase-1 
2.  Q9CPQ8 Atp5l ATP synthase subunit g, mitochondrial 
3.  P59108 Cpne2 Copine-2 
4.  P41241 Csk Tyrosine-protein kinase CSK 
5.  Q501J6 Ddx17 Ddx17 
6.  Q99L04 Dhrs1 Dehydrogenase/reductase SDR family member 1 
7.  P97930 Dtymk Thymidylate kinase 
8.  O88842 Fgd3 FYVE, RhoGEF and PH domain-containing 
protein 3 
9.  Q8VC88 Gca Grancalcin 
10.  Q8BUK6 Hook3 Protein Hook homolog 3 
11.  Q9DB05 Napa Alpha-soluble NSF attachment protein 
12.  P12815 Pdcd6 Programmed cell death protein 6 
13.  Q8BFY6 Pef1 Peflin 
14.  P47968 Rpia Ribose-5-phosphate isomerase 
15.  Q8BFR5 Tufm Elongation factor Tu, mitochondrial 
16.  P17433 Spi1 Transcription factor PU.1 
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In order to assign functional information to all proteins identified, Uniprot Protein 
knowledgebase (http://www.uniprot.org/) was used. Using UniProt, we identified 




Table 22: List of proteins significantly changed in PLY treated neutrophils related to 













 Regulation and 
rearrangement of the actin 
cytoskeleton, cell adherence, 






 Involved in the regulation of 










 Filopodia organisation.  
 Regulation of CDC42 
activation in cells for; 
movement, actin 
cytoskeleton and shape.  
Down 
regulated 
Q8VC88 Gca Grancalcin  Increased neutrophil 
adhesion on fibronectin. 
 Involved in the arrangement 
of focal adhesions.  
 
  
178 | P a g e  
Chapter 5 - Proteomics 
5.2.3.2 Multi-way comparison of PLY-treated, LPS-treated, and control 
neutrophils  
 
A multiway comparison of PLY-treated, LPS-treated, and control neutrophils was 
also performed. We detected 1410 proteins in our experiment, which were filtered 
and the results are presented as a ternary plot (Figure 71) and heat map (Figure 72). 
For the ternary plot a filter of q ≤ 0.05 and ≥ 2 peptides per protein was applied 
resulting in 404 proteins being displayed in the plot (Figure 71). A list of proteins 
upregulated in PLY-treated neutrophils compared to both LPS-treated neutrophils 
and control, and a list of proteins downregulated PLY-treated neutrophils compared 
to both LPS-treated neutrophils and control is presented in Table 23. 
 
Figure 71: Ternary plot of normalized protein abundances in neutrophils treated with 
PLY or LPS compared to control 
Relative protein abundance was measured using a label free proteomic approach. Proteins 
with a q-value ≤ 0.05 and ≥ 2 peptides identified were included in the plot. Numbers along 
the three sides of the triangle represent the proportion of the total signal that belongs to each 
of the three groups and each point the summed value should equal to 100. Highly up-
regulated proteins for PLY-treated neutrophils only (proportion of signal >68%) are 
highlighted in red. Down-regulated proteins for PLY-treated neutrophil vs LPS and Control 
(proportion of signal < 20%) are highlighted in green. 
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Table 23: List of proteins (red) more abundant in PLY-treated neutrophils vs LPS-
treated /control (more than 68% signal belongs to PLY) and (green) less abundant in 




Gene Protein  
Q9CR68 Uqcrfs1 Cytochrome b-c1 complex subunit Rieske, mitochondrial 
Q6P8X1 Snx6 Sorting nexin-6 
P59108 Cpne2 Copine-2 
Q8VC88 Gca Grancalcin 
Q8BFY6 Pef1 Peflin 
P97930 Dtymk Thymidylate kinase 
P12815 Pdcd6 Programmed cell death protein 6 
 
The multi-way analysis is also presented as a heat-map (Figure 72). The colours 
represent the relative abundance of the indicated proteins: proteins with the highest 
intensity are highlighted in orange, while proteins with lowest intensity are white. 
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Figure 72:  Heatmap highlighting proteins with differential abundance following 
treatment with PLY or LPS 
Control, PLY-treated and LPS-treated neutrophils were stimulated for 4 hours before 
proceeding to proteomic analysis. Intensity values (log2) from proteins with a q-value ≤ 
0.05, ≥ 2-fold change and ≥ 2 peptides identified per protein were used to create the 
heatmap. Hierarchical clustering (one minus Pearson correlation, average linkage method) of 
the rows was performed using the Morpheus online tool (https:// software.broadinstitute 
.org/morpheus/). The heatmap is split into two halves, A and B, to assist viewing. Proteins 
upregulated in PLY-treated neutrophils, but not LPS-treated neutrophils are highlighted in 
red, while proteins downregulated in PLY-treated neutrophils but not LPS-treated 
neutrophils are shown in green. 
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5.2.3.3 Comparison between pair-wise and multi-way analysis  
 
We found some differences in the proteins identified using the pairwise and multi-
way comparisons. Comparison of datasets from pairwise analysis likely 
overestimated the differences between PLY- and LPS-treated neutrophils by 
including proteins that were similarly regulated in both conditions, but only reached 
statistical significance in one. All proteins identified in the multi-way analysis were 
also present in the pairwise analysis. Integrin alpha-M (CD11b), expression of which 
increased on the neutrophil surface in response to PLY (Chapter 2), was present in 
the proteomic analysis but did not change in abundance following treatment with 
either PLY or LPS. This could be explained by the cell redistributing CD11b to the 
cell surface, rather than making more CD11b proteins. 
 
5.2.3.4 Functional annotation of differentially expressed proteins 
 
Using DAVID Bioinformatics Database, we performed a functional annotation of 
proteins identified by pairwise analysis as being significantly changed in PLY-
treated, but not LPS-treated, neutrophils. We found no significant enrichment for any 
biological functions among the dataset (compared to whole Mus musculus genome).  
However, when the proteins identified (q ≤ 0.05, ≥ 2 fold abundance change) in the 
multi-way analysis (PLY v LPS v Control) were analysed in the same way, a 
significant enrichment (p-value 7.7E-4, 70 fold enrichment) for calcium-dependent 
cysteine-type endopeptidase activity (3/7 proteins, GO term Molecular function). 
These three proteins were grancalcin (GCA), penta-EF hand domain containing1 
(PEF1) and programmed cell death6 (PDCD6). The involvement of these three 
proteins will be reviewed in discussion. 
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5.2.4 Interactions between up-regulated and down-regulated proteins 
 
We wanted to understand on how proteins upregulated in PLY-treated neutrophils 
could affect neutrophil functions such as migration and defense. Thus, using data 
from pairwise and multi-ways comparison, we looked for interactions between 
proteins upregulated and downregulated in PLY-treated neutrophils (Figure 73). Our 
protein network exhibited more interactions than expected, with a PPI enrichment p-
value calculated as 0.00568 by STRING, meaning this group of proteins has more 
interaction among themselves than expected for a random set of proteins of similar 
size from the same genome, indicating that the proteins are at least partially 
biologically connected, as a group (Szklarczyk et al. 2017). 
CAD is multifunctional protein that showed the most interactions. CAD proteins 
together with UMP synthase are localized around and outside the mitochondria in the 
cytosolic compartment. CAD has a possible association with the cytoskeleton, since 
mitochondria themselves are known to be anchored to the cytoskeletal network 
(Evans & Guy 2004). 
Functional enrichment analysis of the network analysis highlighted that calcium-
dependent cysteine-type endopeptidase activity (GO: 0004198, false discovery rate = 
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Figure 73: Maps showing putative protein-protein interactions between differentially 
abundant proteins in PLY treated neutrophils 
Neutrophil proteins increasing or decreasing in abundance (q-value ≤ 0.05, ≥ 2-fold change 
and ≥ 2 peptides identified per protein) compared to control on treatment with PLY were 
entered into the online tool STRING version 10.5 (https://string-db.org/) (Szklarczyk et al. 
2017) using default settings  for proteins up and down -regulated in PLY. 
 
 
While there is no direct link observed in STRING for grancalcin (GCA), Peflin 
(PEF1) and programmed cell death6 (PDCD6) they share a putative link through 
programmed cell death6- interacting protein (PDCD6IP ), which is present in the 
proteomic dataset but does not change in abundance when treated with either PLY or 
LPS (Figure 74). 
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Figure 74: Maps showing interactions between 3 penta-EF-hand (PEF) proteins with   
programmed cell death6- interacting protein 
Identified proteins GCA, PEF1 and PDCD6 accession number were entered into the online 
tool STRING version 10.5 (https://string-db.org/) and observed on additional network 
available. Functional network enrichment, pathway description colour coded for proteolysis 
(blue) and protein dimerization activity (red). 
 
 
5.2.5 Post proteomic analysis  
 
To validate our data, we have performed post proteomic analysis focusing on four 
proteins identified in the pair-wise analysis, which have evidence for a role in cell 
migration (Table 22). Firstly, we tried to confirm changes in the abundance of the 
selected proteins by western blot (Figure 75). However, of the four antibodies tested, 
only the grancalcin antibody showed bands of the expected size using a 1:100 
dilution (Figure 75V). Using Image Lab version 5.2.1 Analysis Tool from Bio-Rad 
we measured the volume intensity of bands and found a reduction of 47.4 % in 
grancalcin band intensity in PLY-treated compared to control neutrophils. However, 
we also saw a 59.5% decrease in GAPDH band intensity, meaning that we can only 
conclude from this experiment that grancalcin is expressed in neutrophils, not that it 
is regulated by treatment with PLY. 
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5.2.5.1 Antibody analyses of grancalcin expression confirmed by western blot 
 
 
Figure 75: Western blot analysis of grancalcin expression in control and PLY-treated 
neutrophils 
Neutrophils were treated with PLY or media alone for 45 minutes prior to analysis of protein 
expression by western blot. (I) Samples were stained only with a secondary goat anti-mouse 
IgG antibody at 1:10000 dilution. (II) Samples wre stained with anti-GADPH antibody at 
1:2500 dilution. (III-V) Samples were stained with an anti-grancalcin antibody plus 
conjugated-secondary at (III) 1:1000 , (IV) 1: 500, and (V) 1: 100 dilutions. Arrows indicate 
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5.2.5.2 PLY treated neutrophils show decreased expression of grancalcin by 
confocal microscopy  
 
Our results agree with previous studies showing that grancalcin is abundant in 
neutrophils. To verify that grancalcin expression is decreased upon exposure to PLY, 
neutrophils were plated onto glass coverslips and stained with a primary antibody to 
grancalcin, followed by a secondary antibody conjugated to a fluorescent dye, 
AF467. Despite several attempts at optimisation, staining was weak, and would need 
to be repeated with a different antibody in order to be convincing. Nevertheless, 
staining intensity was greater in untreated neutrophils than in PLY-treated 
neutrophils, or neutrophils stained with only the secondary antibody (Figure 76, and 
77). This result supports the idea that expression of grancalcin in neutrophils is 
reduced after treated with PLY.  
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Figure 76: Neutrophils treated with PLY show weaker staining for grancalcin than 
untreated neutrophils 
Neutrophils were plated on glass coverslips alone (I, II) or in the presence of PLY (III, IV). 
Subsequently, neutrophils were fixed and stained with a goat-anti-mouse-AF647 secondary 
only (I and III) or an anti-grancalcin primary antibody plus secondary (II and IV). 
Neutrophils were observed using 100x/1.45 oil objective mounted on the Zeiss LSM780 
confocal microscope.  Images are representative from 3 independent experiments.  
 
189 | P a g e  
Chapter 5 - Proteomics 
 
Figure 77: Neutrophils treated with PLY show weaker staining for grancalcin than 
untreated neutrophils 
Neutrophils were plated on glass coverslips and treated with PLY for 45 minutes before 
fixation and staining with anti-grancalcin plus secondary antibody, or secondary antibody 
only. Graphs depict (I) fluorescence intensity of grancalcin staining for the indicated 
conditions (II) fluorescence intensity of grancalcin staining after subtracting background 
fluorescence from the secondary only controls. Statistical significance was determined using 
one-way ANOVA with Tukey’s multiple comparisons test with ***(p<0.001) and 
****(p<0.0001) for (I) and unpaired t-test with ****(p<0.0001) for (II). Mean + SEM for a 
single experiment is shown and each point represents an individual cell. 
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5.2.5.3 Treatment of neutrophils with a FES inhibitor, Herbimysin A, partially 
restores chemotaxis following exposure to PLY 
 
The tyrosine-protein kinase, FES, was found to increase in abundance following 
treatment with PLY. To assess if this increase in FES accounted for the observed 
migration defect, neutrophils were treated with herbimycin A, which acts as a FES 
inhibitor by irreversibly and selectively inhibiting tyrosine kinases. 
 
Following treatment with herbimycin A and/or PLY, chemotaxis towards KC was 
assessed using the 2D chemotaxis assay described in chapter 3 (Figure 78).  
We found that neutrophils treated with herbimysin A alone did not show any 
significant differences in chemotaxis compared to untreated controls (Figure 78A). 
However, herbimysin A was found to partially restore chemotaxis of PLY-treated 
neutrophil toward KC at 10uM (Figure 78B). 
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Figure 78:  Herbimysin A partially restores chemotaxis of PLY-treated neutrophil 
toward KC 
Untreated neutrophils (A) and PLY-treated neutrophil (B) were treated with DMSO vehicle 
or herbimysin A at the indicated concentrations, and placed in the upper well of a 96-
Transwell® plate. Chemotaxis towards KC placed in the bottom well was assessed by 
counting the total number of migrated cells on a MACS Quant Flow Cytometer. Graph 
depicts the total number of neutrophils migrating to the bottom well under the indicated 
conditions. Each dot represents a single well of an assay performed in duplicate or greater. 
Data are combination of 2 independent experiments (with the exception of DMSO controls, 
which are from a single experiment). Statistical significance was determined using one-way 
ANOVA with post-hoc analysis by Tukey’s multiple comparisons with ***( p<0.001), **** 
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5.3 Discussion 
 
In this chapter we aimed to obtain further clues on how PLY inhibits neutrophil 
chemotaxis and defensive function, revealing novel pathways targeted by PLY to 
influences the neutrophil response. We used label-free quantitative mass spectrometry 
to perform a global analysis of the effect of PLY on protein expression in neutrophils. 
Our results revealed two interesting clues: Firstly, using pair-wise analysis we found 
four candidate proteins with confirmed roles in cell migration; FES (Tyrosine-protein 
kinase Fes/Fps), CSK (Tyrosine-protein kinase CSK), FGD3(FYVE, RhoGEF and PH 
domain-containing protein 3) and GCA (Grancalcin). Preliminary experiments 
revealed that treating neutrophils with an inhibitor of FES partially restored the PLY-
mediated chemotaxis defect. Secondly, the group of proteins found to be significantly 
downregulated in the multi-way analysis was enriched for calcium-dependent cysteine-
type endopeptidase activity and EF-hand domains (containing a calcium binding site). 
This is of interest, since PLY-treatment of neutrophils results in elevated intracellular 
calcium levels. The knowledge gained from this global analysis may give clues both to 
how PLY manipulates neutrophil function, and also to the basic molecular mechanisms 
regulating neutrophil migration, which may be targeted therapeutically to modulate 




We found that after exposure to PLY, grancalcin expression was downregulated in 
neutrophils. It has been shown grancalcin is highly expressed in neutrophils and 
monocytes/macrophage, and is also highly expressed in leukocytes that have 
extravasated to sites of infection, suggesting that it plays an important role in host 
defense activities (Liu et al. 2004). However, studies in grancalcin knock-out mice 
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showed that the protein was largely dispensable for neutrophil recruitent and function. 
Knock-out mice were however more resistant to endotoxic shock, which may implicate 
grancalcin is restraining host-damaging functions of neutrophils  (Roes et al. 2003). 
Upon neutrophil activation, grancalcin has been shown to translocate to the granule 
membrane (Roes et al. 2003). It is possible that this occurs upon exposure to PLY, and 
the change in protein localisation (and/or extrusion of membrane bound secretory 
granules) may explain the reduction in grancalcin we observed in the mass 
spectrometry data. On the other hand, PLY has been shown to inhibit neutrophil 
degranulation (Paton & Ferrante 1983; Nandoskar et al. 1986) thus the decrease in 
expression of grancalcin may have another explanation. Studies using grancalcin-
deficient neutrophils conducted by Xu et al shown neutrophil adherence to 
fibronection decreases by 60% in the absence of grancalcin (Xu et al. 2006). This 
contrasts to our results where PLY-treated neutrophils showed reduced grancalcin 
expression, but increased adhesion. However, we were not able to perform any 
functional assays to confirm a role for grancalcin in PLY-mediated inhibition of 
chemotaxis. Future experiments could include using grancalcin-knockout mouse 





FES expression in PLY-treated neutrophils was found to be upregulated in our 
proteomic study.  FES is a protein-tyrosine kinase (PTK) that participates in many 
processes such as cell survival and migration, and is highly expressed in 
hematopoietic cells and their progenitors. It activity can enhanced by ligand binding 
to the SH2 domain, resulting in  regulation of the actin cytoskeleton and membrane 
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trafficking (Craig 2012). FES may also participate in cytoskeletal reorganization and 
motility by regulating cross-talk between Kit receptor  PTK and β1 integrins in  mast 
cells (Smith et al. 2010). Although, no studies of FES in neutrophils have been 
performed, the related protein, FER, has been shown inhibit neutrophil chemotaxis, 
suggesting that increased levels of FES could explain the chemotactic defect we 
observe in PLY-treated neutrophils (Khajah et al. 2013). To assess this we used 
herbimysin A, an inhibitor of FES, in the 2D chemotaxis assay, and showed partially 
restored chemotaxis in PLY–treated neutrophils exposed to herbimysin A. 
Herbimysin A is an antibiotic that can react with thiol groups and permanently 
inhibits tyrosine kinase activation (Fukazawa et al. 1991). Beside FES, it can also 
inhibit other tyrosine kinases such as SRC, YES, ROS, ABl, and ERBB (Uehara & 
Fukazawa 1991) and heat shock protein 90 (HSP90) (Santa Cruz Biotechnology-
CAS 70563-58-5). Therefore, we cannot yet conclude that upregulation of FES 
explains the chemotaxis defect in PLY-treated neutrophils. For example, another 
target of herbimysin A, HSP90, plays a role in cell migration (Snigireva et al. 2014; 
Kim et al. 2014). Another example is ABl, which has a role in regulation of the actin 
cytoskeleton for normal cells (Panjarian et al. 2013). Thus, a more specific inhibitor, 




Using DAVID Bioinformatics Database, the differentially regulated proteins 
identified in the multiway comparison were analysed, and we found a significant 
enrichment for calcium-dependent cysteine-type endopeptidase activity (3/7 proteins, 
Goterm MF direct), and EF-hand 1 calcium-binding site (3/7 proteins, Interpro). 
These proteins were: Peflin (PEF1), programmed cell death 6 (PDCD6) and 
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grancalcin (GCA). In addition, Copine-2 (CPNE2) is a calcium-dependent membrane 
binding protein (Cowland et al. 2003). 
 
Grancalcin, a 28 kDa protein (Maki et al. 2002), displays a Ca
2+
-dependent 
translocation to the granules and plasma membrane upon the activation of 
neutrophils (Boyhans et al. 1992). Grancalcin also increases adhesion of neutrophils 
to fibronectin  (Xu et al. 2006), and binds to the actin-bundling protein, L-plastin, in 
a Ca
2+
 dependent manner (Lollike et al. 2001). Peflin (also known as penta-EF hand 
domain containing1 protein) form cytosolic heterodimers with PDCD6, which 
dissociate in response to calcium. PDCD6 was also found to be down-regulated in 
PLY-treated neutrophils in our analysis. Recently, under basal conditions peflin was 
found to negatively regulate PDCD6/sec31A interactions and ER to Golgi transport 
(Rayl et al. 2016). PDCD6 has been shown by Vito et al to be involved in apoptosis 
in response to T cell receptor-, Fas-, and glucocorticoid receptor signalling. This 
protein has a function in Alzheimer's where it mediates Ca
2+
 regulated signals 
resulting in cell death and disease. Copine-2 (CPNE2) is from the C2-domain protein 
family which is another Ca
2+
-binding protein family (in addition to EF-hand and 
annexins). Copine-2 has been found to be expressed in immature neutrophil 
precursors, though the function remains unclear (Cowland et al. 2003).  
In our study we were treating neutrophils with sub-lytic concentrations of PLY.  PLY 
is a thiol-activated cytolysin membrane-damaging toxin synthesized by S. 
pneumoniae (Paton et al. 1993). PLY can mediate Ca
2+
 influx by forming pores in 
the host cell membrane. PLY-driven Ca
2+
 influx may potentiate neutrophil pro-
inflammatory activities such as CD11b-mediated adhesion, degranulation, and 
induction of NO synthase, for which increases in intracellular free calcium have 
previously been shown to be pre-requisite (Cockeran, Steel, et al. 2001; Lew et al. 
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1986; Pettit & Hallett 1996). Transient increases in cytosolic Ca
2+
 are important in 
cell migration, however sustained Ca
2+
 signalling in PLY-treated neutrophils may 
result in dysregulation of migration machinery, and impaired neutrophil chemotaxis 
(Cockeran, Steel, et al. 2001; Paton & Ferrante 1983).  
 
 5.4 Conclusion  
 
The aim of this chapter was to obtain further clues was succeeded. We found four 
candidate proteins which may be involved in migration; FES (Tyrosine-protein 
kinase Fes/Fps), CSK (Tyrosine-protein kinase CSK), FGD3 (FYVE, RhoGEF and 
PH domain-containing protein 3) and GCA (Grancalcin). We also found decreases in 
three calcium binding proteins GCA (Grancalcin)), PEF1 (Peflin) and PDCD6 
(programmed cell death6).  
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Chapter 6: Conclusion 
 
The aim of this thesis was to understand how neutrophil migration is modulated by 
the Streptococcus pneumoniae toxin, PLY.  
 
In Chapter 3, we determined that PLY could inhibit neutrophil chemotaxis in 2D and 
3D assays. This inhibitory activity was direct, and depended on the pore-forming 
function of the toxin, since PdB was unable to inhibit chemotaxis. However, in 
experiments with live bacteria, inhibition of chemotaxis did not completely correlate 
with haemolytic activity. Thus, we suggesting other virulence factors might also 
contribute to inhibition of neutrophil chemotaxis, which remain unidentified. What 
might be the outcome of PLY-mediated inhibition of neutrophil migration? We 
hypothesise that impaired neutrophil migration to the infection site will give an 
advantage to the bacteria, allowing them to multiply. To control the situation, more 
neutrophils will be recruited, leading to tissue damage. Alternatively, PLY may 
simply provide a “stop” signal once neutrophils reach the site of infection, allowing 
them to perform host defensive functions. Future studies should address the 
molecular details of how neutrophil behaviour is altered in tissue after PLY 
stimulation, or infection with S. pneumoniae. This will help us to understand the 
mechanism closely, and might allow neutrophil migration to be manipulated in other 
settings.  
 
In Chapter 4, we found PLY-treated neutrophil increased CD11b expression, 
increased actin polymerisation and increased adhesion to plastics. It has been shown 
that neutrophils adhesion to plastic is accompanied by an increase in intracellular 
Ca
2+
, an increase in F-actin, and activation of the respiratory burst (Ginis et al. 1992). 
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PLY can produce a strong cellular Ca
2+ 
influx (Stringaris et al. 2002) by forming 
pores in the cells membrane, potentially resulting in actin rearrangement, increased 
adhesion, and reduced motility. This is supported by our finding that PdB (a PLY 
toxoid without pore-forming function) does not inhibit neutrophil migration, nor 
increase F-actin intensity, sphericity or volume when compared to untreated 
neutrophils.  
 
CD11b alone has been shown to establish firm adhesion of neutrophils (Solovjov et 
al. 2005). Thus we raise the hypothesis that impaired chemotaxis in PLY-treated 
neutrophils may be linked to increased CD11b expression, which drives firm 
adhesion to the plate, thus limiting migration. This may also related to pore-forming 
activity and Ca
2+
 influx: PLY-driven Ca
2+
 influx potentiate neutrophil pro-
inflammatory activities such as CD11b-mediated adhesion, as has been shown in 
previous studies (Cockeran, Steel, et al. 2001; Lew et al. 1986; Pettit & Hallett 
1996).  
 
In Chapter 5, through global proteomic analysis, we found two sets of proteins 
regulated by PLY which might explain the observed changes in cell migration: those 
with confirmed roles in cell migration (FES, CSK, FGD3 and GCA), and members 
of penta-EF-hand family of Ca
2+
-binding proteins (GCA, PEF1 and PDCD6). FES, a 
protein tyrosine kinase, was upregulated during treatment with PLY, and has 
previously been shown to be involved in regulation of the actin cytoskeleton 
reorganization and motility in other cells (e.g. mast cells). In our study, treating 
neutrophils with an inhibitor of FES partially restored the PLY-mediated chemotaxis 
defect, however further validation will be needed. Grancalcin (GCA) has been shown 
to be involved in neutrophil defense mechanisms (Liu et al. 2004), and increased 
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adhesion on fibronectin (Xu et al. 2006). In addition to this, not only GCA but PEF1 
and PDCD6 are from the same family of penta-EF-hand Ca
2+
 binding proteins, which 
form cytosolic heterodimers which dissociate in response to calcium. PDCD6 itself 
has an important role in apoptotic cell death. How reduced abundance of these 
proteins regulates neutrophil motility, and how it may be related to sustained Ca
2+
 
levels following treatment with PLY, remains unclear. 
 
Data presented in our study may help our understanding of the pathogenesis of S. 
pneumoniae, it is useful to understand how neutrophils migrate through inflamed 
tissues in order to develop therapies which can prevent neutrophil-mediated damage 
to host tissues in sterile injury. 
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Appendix 1: List of Control vs PLY (Reference Table) 
 
No Uni P 
Accession 














O88842 0.0365878 0.041979438 2 115.76 285.0000728 Control PLY 
2.  
Q501J6 0.0149568 0.0255264 5 983.83 13.40821995 Control PLY 
3.  
P51675 0.0187957 0.029425617 2 119.64 7.649242456 Control PLY 
4.  
Q9R1T4 0.0001439 0.002905883 2 374.59 7.645676727 Control PLY 
5.  
P80316 6.383E-06 0.000483377 13 1277.32 5.813265792 Control PLY 
6.  
Q60590 0.0021747 0.010057787 2 183.6 5.419246827 Control PLY 
7.  
P12815 0.000273 0.003846594 4 282.38 4.795014896 Control PLY 
8.  
Q6P5F9 0.0032626 0.011979957 4 177.57 4.612835257 Control PLY 
9.  
P15702 0.0003689 0.004297827 2 291.51 3.900050721 Control PLY 
10.  
Q52KI8 0.0072771 0.01763585 2 155.12 3.814544545 Control PLY 
11.  
Q8BUK6 0.0459055 0.048568039 2 245.45 3.618174545 Control PLY 
12.  
Q8BK64 0.0285445 0.036603165 3 298.47 3.547858251 Control PLY 
13.  
P97930 0.0415324 0.045738784 2 153.87 3.503542666 Control PLY 
14.  
P82198 0.0026802 0.010898281 2 123.5 3.251812501 Control PLY 
15.  
Q8VC88 0.0007583 0.006380612 4 324.39 3.237152563 Control PLY 
16.  
Q64277 0.0104532 0.021252593 3 127.82 3.209977538 Control PLY 
17.  
P07724 0.0001316 0.002794996 25 3100.84 3.195460599 Control PLY 
18.  
P97315 0.0001166 0.002716354 4 376.23 3.14772092 Control PLY 
19.  
Q9EP69 0.0023733 0.01031226 2 86.91 3.122163117 Control PLY 
20.  
Q08093 1.84E-05 0.001013547 11 924.56 3.103282651 Control PLY 
21.  
Q9QZD9 0.0001819 0.003302468 4 278.82 2.948884264 Control PLY 
22.  
Q9DCL9 0.0028303 0.011198748 5 329.74 2.945982943 Control PLY 
23.  
Q64324 0.000671 0.005807896 8 1041.52 2.748842828 Control PLY 
24.  
P11928 0.0298225 0.037667079 3 228.56 2.662365212 Control PLY 
25.  
Q8BFY6 0.0018397 0.009685055 3 297.94 2.652681799 Control PLY 
26.  
Q8BGB5 0.009083 0.020200613 2 171.49 2.644583931 Control PLY 
27.  
Q504P2 0.0002414 0.00382513 6 313.2 2.530457392 Control PLY 
28.  
P35174 0.0110263 0.021895767 2 140.21 2.452092699 Control PLY 
29.  
P40240 0.0186613 0.029290935 3 299.39 2.437635852 Control PLY 
30.  
P97797 4.998E-06 0.000432571 3 145.4 2.401825412 Control PLY 
31.  
Q99LF4 0.0019023 0.009685055 2 92.01 2.308335451 Control PLY 
32.  
Q9DB05 0.0005576 0.005672782 4 318.52 2.275569489 Control PLY 
33.  
P27601 0.0044214 0.014036592 2 184.62 2.216869654 Control PLY 
34.  
P41241 0.005179 0.015457173 4 126.24 2.215873034 Control PLY 
35.  
P47968 0.0117639 0.022210637 6 713.06 2.196685098 Control PLY 
36.  
P59108 0.0020329 0.009853429 6 616.09 2.191263599 Control PLY 
37.  
Q8BFR5 0.0095958 0.020689729 2 204.6 2.180606727 Control PLY 
38.  
P99026 0.0015139 0.009238946 6 688.99 2.125548737 Control PLY 
39.  
Q99L04 0.0085311 0.019578559 4 132.06 2.060601484 Control PLY 
40.  
Q9CPQ8 0.0020297 0.009853429 3 215.36 2.042066723 Control PLY 
41.  
P56376 0.0060161 0.016136021 3 230.18 2.018735289 Control PLY 
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42.  
Q8QZY6 0.0012275 0.008547971 2 90.94 22.84828451 PLY Control 
43.  
O88668 0.0002462 0.00382513 2 183.51 19.27277039 PLY Control 
44.  
Q9CR68 0.0001853 0.003302468 2 58.61 9.770416919 PLY Control 
45.  
P50637 0.0206002 0.030553931 2 138.17 9.683984955 PLY Control 
46.  
Q8BTI9 0.0003481 0.004218207 2 32.35 9.503131362 PLY Control 
47.  
P36371 0.0010132 0.007486491 2 87.64 8.154471751 PLY Control 
48.  
Q9JKB1 0.0028086 0.011194924 2 73.97 6.276746414 PLY Control 
49.  
Q9R0U0 6.319E-05 0.002046041 2 80.7 5.674920404 PLY Control 
50.  
Q9Z1F9 3.842E-05 0.001454965 3 166.06 5.391237635 PLY Control 
51.  
Q6P8X1 0.0023668 0.01031226 2 64.81 4.978218746 PLY Control 
52.  
P63082 0.0029177 0.011402307 2 225.3 3.742700111 PLY Control 
53.  
Q9D6R2 0.0003881 0.004437029 2 71.93 3.687065805 PLY Control 
54.  
Q8CHK3 0.0003026 0.00389502 3 214.06 3.444056854 PLY Control 
55.  
P97484 0.0028465 0.011198748 3 180.55 3.241184918 PLY Control 
56.  
Q3UMR5 0.0316744 0.038668455 3 134.96 3.233488891 PLY Control 
57.  
P58021 0.0004702 0.005070038 3 130.81 3.204308426 PLY Control 
58.  
Q9JHK5 0.000293 0.00389502 4 330.55 3.082501484 PLY Control 
59.  
Q80UG5 0.0110794 0.021895767 3 88.86 3.028984504 PLY Control 
60.  
Q9WV54 0.0416229 0.045738784 3 132.27 2.995008879 PLY Control 
61.  
Q8K352 0.0016252 0.00928918 4 283.62 2.914438493 PLY Control 
62.  
Q03267 0.0313252 0.038668455 3 163.72 2.830604805 PLY Control 
63.  
O35593 0.0276605 0.035892248 2 189.41 2.793714592 PLY Control 
64.  
Q8BGQ7 0.0319081 0.038819419 2 103.36 2.768705818 PLY Control 
65.  
A3KGF7 0.0177778 0.02834467 3 182.64 2.767238083 PLY Control 
66.  
Q8QZS1 0.018113 0.028677584 2 119.47 2.633048383 PLY Control 
67.  
Q8VDM6 0.000477 0.005070038 5 461.13 2.556843668 PLY Control 
68.  
Q9WTP6 0.0032535 0.011979957 9 735.16 2.508224533 PLY Control 
69.  
Q99MK8 0.0059217 0.016088535 5 222.33 2.390539564 PLY Control 
70.  
P63028 0.0018892 0.009685055 5 555.09 2.332319438 PLY Control 
71.  
Q60931 0.0002705 0.003846594 8 752.68 2.326708026 PLY Control 
72.  
O09043 0.0058401 0.015938521 4 345.24 2.30900194 PLY Control 
73.  
B2RQC6 0.0146186 0.025161674 4 126.6 2.281366423 PLY Control 
74.  
Q9D0M3 0.0013245 0.008679737 3 158.59 2.261408343 PLY Control 
75.  
Q9R062 0.0068486 0.017005549 6 423.97 2.141446938 PLY Control 
76.  
Q80W54 0.0105412 0.021359731 7 469.47 2.117800839 PLY Control 
77.  
Q61768 0.0037047 0.012974388 6 312.38 2.081376144 PLY Control 
78.  
P16879 0.0137322 0.024373772 4 323.6 2.080058639 PLY Control 
79.  
P54775 0.0087423 0.019763825 5 204.93 2.049196828 PLY Control 
80.  
Q571E4 0.0207772 0.030553931 3 304.51 2.038553168 PLY Control 
81.  
Q921F4 0.0111485 0.021895767 5 280.51 2.032927852 PLY Control 
82.  
Q6P1F6 0.0056851 0.015775858 3 208.33 2.031302144 PLY Control 
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Q99KE1 0.0001429 0.0048657 2 100.21 17.146468 Control LPS 
2.  
P51675 0.0042407 0.022489 2 119.64 6.0797201 Control LPS 
3.  
Q9R1T4 0.0001674 0.0051483 2 374.59 5.9323713 Control LPS 
4.  
Q8BK64 0.0050269 0.0231882 3 298.47 5.0343103 Control LPS 
5.  
P80316 2.763E-05 0.0022299 13 1277.32 4.862362 Control LPS 
6.  
P82198 0.0022063 0.0164914 2 123.5 4.4221119 Control LPS 
7.  
Q52KI8 0.0084222 0.0301831 2 155.12 3.808754 Control LPS 
8.  
Q60590 0.0016795 0.0160762 2 183.6 3.7903199 Control LPS 
9.  
Q08093 9.815E-06 0.0016044 11 924.56 3.4727571 Control LPS 
10.  
Q9DCL9 0.0026708 0.018017 5 329.74 3.4404281 Control LPS 
11.  
Q64277 0.0004921 0.0091417 3 127.82 3.4263484 Control LPS 
12.  
P40240 0.0207516 0.0472458 3 299.39 3.4059111 Control LPS 
13.  
Q9QZD9 7.925E-05 0.0035008 4 278.82 3.3478351 Control LPS 
14.  
P15702 5.419E-05 0.0031014 2 291.51 3.2530028 Control LPS 
15.  
P07724 0.0045736 0.0231882 25 3100.84 2.9340495 Control LPS 
16.  
Q64324 0.0002288 0.0057853 8 1041.52 2.7251972 Control LPS 
17.  
Q8BGB5 0.0082371 0.0297902 2 171.49 2.4482476 Control LPS 
18.  
P97315 0.0006639 0.0115014 4 376.23 2.441635 Control LPS 
19.  
Q9EP69 0.0049147 0.0231882 2 86.91 2.4307097 Control LPS 
20.  
Q62426 0.0018402 0.0163292 2 154.49 2.4160873 Control LPS 
21.  
Q99LF4 3.231E-05 0.0022299 2 92.01 2.3863395 Control LPS 
22.  
P97797 0.0001085 0.0042248 3 145.4 2.3659165 Control LPS 
23.  
O70138 0.0079248 0.02947 15 1319.53 2.3556364 Control LPS 
24.  
P49446 0.0021822 0.0164914 4 245.93 2.2712067 Control LPS 
25.  
P27601 0.000298 0.0071647 2 184.62 2.2543541 Control LPS 
26.  
Q8BZQ2 0.0023213 0.0169399 6 275.03 2.1850341 Control LPS 
27.  
P99026 0.0011722 0.0142369 6 688.99 2.1664273 Control LPS 
28.  
Q6WVG3 0.0032309 0.019656 8 728.24 2.1524471 Control LPS 
29.  
O09044 0.0150089 0.0414139 2 225.94 2.1463496 Control LPS 
30.  
Q504P2 0.0024535 0.017225 6 313.2 2.1160534 Control LPS 
31.  
P35174 0.0141065 0.0400344 2 140.21 2.0949734 Control LPS 
32.  
Q9WTL7 0.0057014 0.0251892 5 209.25 2.0608326 Control LPS 
33.  
Q8R016 0.0140952 0.0400344 2 104.16 2.0532288 Control LPS 
34.  
Q8VEM8 0.0105922 0.0337021 8 325.84 2.0512815 Control LPS 
35.  
Q8VH51 0.005589 0.0250999 3 155.89 2.03636 Control LPS 
36.  
O08749 0.0112942 0.0345332 4 339.53 2.0004381 LPS Control 
37.  
O35841 0.0014071 0.0145585 2 275.41 2.0212475 LPS Control 
38.  
Q9R062 0.0183236 0.0450278 6 423.97 2.0507925 LPS Control 
39.  
Q03267 0.0211852 0.0474952 3 163.72 2.1144002 LPS Control 
40.  
Q8K352 0.0009682 0.0136434 4 283.62 2.1401487 LPS Control 
41.  
Q6P1F6 0.0040053 0.0221197 3 208.33 2.2864333 LPS Control 
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42.  
Q99MK8 0.0007025 0.0115014 5 222.33 2.3092782 LPS Control 
43.  
Q9DBC7 0.0124534 0.0366407 3 249.55 2.3413522 LPS Control 
44.  
P63082 0.0233685 0.0495674 2 225.3 2.4536399 LPS Control 
45.  
Q8VDM6 0.0003216 0.0074808 5 461.13 2.5709448 LPS Control 
46.  
P97484 0.004046 0.022184 3 180.55 2.6713044 LPS Control 
47.  
P58021 0.0013836 0.0145585 3 130.81 3.1141283 LPS Control 
48.  
Q8CHK3 0.0004196 0.008165 3 214.06 3.2794242 LPS Control 
49.  
Q9D6R2 0.0032386 0.019656 2 71.93 3.4569697 LPS Control 
50.  
Q80UG5 0.010099 0.0335815 3 88.86 3.6088672 LPS Control 
51.  
Q9JKB1 0.0027226 0.0180919 2 73.97 4.9835972 LPS Control 
52.  
Q9Z1F9 0.001517 0.0151211 3 166.06 5.6112069 LPS Control 
53.  
P36371 0.0005291 0.0096108 2 87.64 5.9417368 LPS Control 
54.  
Q9R0U0 0.0001519 0.0049673 2 80.7 6.2109502 LPS Control 
55.  
Q8BTI9 0.0004452 0.0084632 2 32.35 6.6660153 LPS Control 
56.  
O88668 0.0008152 0.0123389 2 183.51 12.352202 LPS Control 
57.  
Q8QZY6 0.00133 0.0145585 2 90.94 20.819341 LPS Control 
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